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2 ZUSAMMENFASSUNG 
 
Chromatin ist mehr als ein inerter Komplex, der genetische Information speichert. Die 
Modifikation von Chromatin und Histonen sind vielmehr zentrale Ereignisse in der Regulation der 
Geneexpression. Es ist gut etabliert, dass die Trimethylierung von Histon H3 Lysin 27 (H3K27me3) 
durch ‚Polycomb group’ (PcG) Proteine den reprimierten Zustand von entwicklungsbiologisch 
relevanten Transkriptionsfaktoren als epigenetisches Gedächtnis aufrechterhält. Genomweite 
Analysen haben jedoch gezeigt, dass ein großer Teil des nicht-exprimierten Genoms die 
H3K27me3 Modifikation trägt. Daraus ergibt sich die Frage ob diese Histonmodifikation auch 
außerhalb des Entwichlungs-Zusammenhangs funktional relevant ist um die Aktivierung von 
Genen durch physiologische Signalwege zu verhindern.   
In dieser Arbeit habe ich RNA-seq und ChIP-seq auf Plasmatozyten, Makrophagen-artige 
Immunzellen aus Drosophila, angewendet und ein hochauflösendes Chromatinprofil sowie eine 
transkriptionelle Blaupause dieser homogenen Zellpopulation generiert. Dadurch konnte ich 
zeigen, dass eine Gruppe von Immungenen, die durch H3K27me3 markiert sind, nach einer 
Immunstimulierung rasch hochreguliert wird. Weiterhin konnte ich durch die Anwendung eines 
neu entwickelten Genomanalyse-Algorithmus zeigen, dass diese H3K27me3 positiven Gene in 
einem Chromatinzustand sind, der sich von kanonischem Polycomb Chromatin unterscheidet. 
Dieser Chromatinzustand hat zwei wichtige Eigenschaften: Erstens, indem ich zeige, dass 
H3K27me3 in Plasmatozyten nach einer Immunaktivierung an Immungenen verloren geht, 
beweise ich, dass H3K27me3 als Antwort auf physiologische Stimuli dynamisch reguliert wird. 
Zweitens, indem ich etabliere, dass Immungene hochreguliert werden, wenn H3K27me3 durch 
Mutationen in PcG Proteinen oder Histon H3 reduziert wird, weise ich nach, dass es für den Erhalt 
eines reprimierten Genezustands instruktiv ist. Daher bezeichne ich diesen Chromatinzustand als 
dynamisches Polycomb Chromatin. 
Meine weiteren Analysen haben gezeigt, dass dieses dynamisches Polycomb Chromatin in 
Drosophila Plasmatozyten mit einer großen Zahl anderer dynamisch regulierter Gene assoziieret 
ist. Einige dieser Gene wurden ebenfalls nach der Depletion von H3K27me3 durch genetische 
Manipulation hochreguliert. Deshalb schlage Ich vor, dass dynamisches Polycomb Chromatin 
einen neuartigen Chromatinzustand darstellt, der an Genen zu finden ist, deren Transkription 
durch unvorhersehbare Ereignisse ausgelöst wird. Die Reprimierung durch dynamisches 
Polycomb Chromatin bildet demnach eine Aktivierungschwelle gegen aberrante Transkription, 
die aber trotzdem eine rasche Geninduktion in physiologisch relevanten Situationen erlaubt.
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3 ABSTRACT 
Chromatin is more than an inert complex that stores genetic information. Modification of 
chromatin and histones are central events in regulating gene expression. It is clearly established 
that histone H3 lysine 27 trimethylation (H3K27me3) by Polycomb group (PcG) proteins 
maintains the repressed state of developmental transcription factors in epigenetic memory. 
Genome wide analysis revealed, however, that much of the non-transcribed genome carries the 
H3K27me3 modification. This raises the question, whether this modification is functionally 
relevant outside of development to preclude activation of genes through physiological signaling, 
analogous to its function in epigenetic memory. 
Here, I applied RNA-seq and ChIP-seq to Drosophila plasmatocytes, a macrophage-like immune 
cell, generating a high resolution chromatin landscape and transcriptional blueprint of this 
homogeneous cell population. Thereby, I demonstrated that a set of H3K27me3 marked immune 
genes was rapidly transcriptionally induced upon challenge. Further, by applying a newly 
developed genome clustering algorithm, I demonstrated that these H3K27me3 positive genes 
are in a chromatin state that is distinct from the canonical Polycomb chromatin, in which 
developmental transcription factors are silenced. This state has two important properties: First, 
by demonstrating that in plasmatocytes H3K27me3 is depleted specifically at immune genes 
after activation, I showed that it is dynamically regulated in response to physiological 
stimulation. Second, by establishing that immune genes were up-regulated when H3K27me3 was 
depleted by mutating PcG proteins or histone H3, I confirmed that it is instructive in maintaining 
a silenced gene state. Therefore, I termed this novel chromatin state dynamic Polycomb 
chromatin. 
Further analysis revealed that this dynamic Polycomb chromatin state is also associated with a 
large number of other dynamically regulated genes in Drosophila plasmatocytes. Some of these 
genes were also up-regulated when H3K27me3 is depleted by genetic manipulation. Hence, I 
propose that dynamic Polycomb chromatin is a novel chromatin state that targets genes which, 
in contrast to developmental genes, are triggered by non-predetermined signaling events. 
Silencing by dynamic Polycomb chromatin thresholds such genes against aberrant gene 
activation, but permits rapid induction in physiologically relevant situations.
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4 INTRODUCTION 
4.1 Histone modifications and transcriptional regulation 
4.1.1 TRANSCRIPTION AND CHROMATIN 
Our genes carry the blueprint that make up the cells in our body. The main actors, that define the 
function of these cells are however RNAs and proteins. To produce these our genes are 
transcribed into mRNAs by RNA polymerases and translated to proteins by ribosomes. But if our 
genes are the same across all cells of our body, how can these cells be so different and carry out 
so many different functions?1-3 Therefore, factors must exist that modulate the transcription (and 
translation) of genes to achieve the appropriate activity of a gene at any given time and in any 
given cell. 
It is well established that transcription factors are one major mechanism by which transcription 
can be modulated in a temporal and context dependent manner. When activated these 
transcription factor proteins recognize specific DNA sequences which they bind triggering 
transcription of adjacent genes.4 This basic mechanism of gene control is well conserved across 
prokaryotes and eukaryotes and helps cells maintain cell states and respond to environmental 
changes.5,6 
Another crucial player in gene regulation is chromatin. It is a complex of DNA and a large number 
of proteins found in  the nucleus of eukaryotic cells.7 The smallest unit in chromatin is the 
nucleosome. It organizes 146 base pairs of DNA, which are wrapped in 1.67 superhelical turns 
around an octamer of highly conserved histone proteins – containing 2 copies of each of the core 
histones H2A, H2B, H3 and H4.8 This basic unit is then organized into higher structures by other 
proteins, including the linker histone H1, that together make up chromatin. 9 This structure aids 
in the 3D organization and storage of the large eukaryotic genomes. 
Chromatin is however much more than an inert platform that packages DNA. It is in fact heavily 
modified and varies greatly in its composition, density and modifications both across genomic 
regions and between individual cells. 10-13 
 
4.1.2 HISTONE MODIFICATIONS 
Histones in particular undergo a tremendous number of posttranslational modifications (PTMs). 
In this regard, the N-terminal tails of histones are of particular interest. While the globular core 
of the histone octamer is tightly wrapped by DNA, the long and unstructured N-terminal parts of 
the histone subunits protrude outwards and are accessible for protein-protein interactions and 
posttranslational modification. 14,15 
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Among the most studied histone PTMs are histone acetylation and histone methylation 16,17, but 
many further histone modifications like ubiquitination, phosphorylation and citrullination are 
also well documented.14,15 In fact, histone H3 alone has 5 lysines that carry well studied 
methylations and various approaches have been used to identify many more histone lysine and 
arginine residues that carry posttranslational modifications. 18,19 
Most of these histone lysine methylations can be either mono-, di- or trimethylations.18,19 These 
‘marks’ are placed by one or more methyltransferases – so called histone writers - that are often 
highly specific for the residue that they modify.20-24 The writers may either catalyze one step in 
the process of histone modification – only adding one methyl group towards mono-, di- or 
trimethylation21,22 - or perform several steps at once23. Histone methylation is very stable and is 
therefore considered critical in maintaining information across longer time spans and through 
cell divisions.25 
Histone lysine acetylation also occurs on a large number of residues. 17 Here only a single acetyl 
group is being transferred by its writer enzymes.26-28 Histone acetylation is thought to be much 
shorter lived than histone methylation, but it is of high interest because it changes the charge 
properties of the histone: By neutralizing the positive charge of the lysine being modified it 
weakens the affinity of the normally positively charged histone to the negatively charged DNA. 
Because the now less positively charged N-terminus can no longer bind adjacent DNA as 
efficiently, this change in affinity could then result in an overall decondensation of chromatin, 
allowing better access for other protein complexes that translate or replicate the DNA bound by 
the modified nucleosome.29-31 There exist however also dedicated proteins that bind to existing 
histone acetylations (readers), and it remains unclear, to what extent either the charge property 
or the or the reader binding confers the function of individual acetylations.32,33 
 
4.1.3 THE HISTONE CODE 
The advent of new genome-wide profiling methods has led to a greatly improved understanding 
of the localization of histone modifications and other proteins across the genome.  The use of 
Next generation sequencing methods in particular has allowed the localization histone 
modifications with almost single nucleosome precision.34-36 This has led to the observation that 
histone marks correlate with the transcriptional activity of associated genes and are distinctly 
located on specific genetic elements – enhancers, promotors or exons for example 37,38 Here I will 
focus on the proteins and modifications as they are described in the model system used in this 
thesis - Drosophila melanogaster. These processes are however well conserved across metazoans 
and orthologues of all enzymes can be found in mammals.39 
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The main focus in this thesis lies on Histone H3 Lysine 27 trimethylation (H3K27me3) and the 
related Histone H3 Lysine 27 dimethylation (H3K27me2). In Drosophila, both marks are processed 
by the enzyme Enhancer of Zeste (E(z))40,41 which, as part of the Polycomb repressive Complex 2 
(PRC2) places these modifications at and around non-transcribed genes. H3K27 methylation is 
therefore found both along the whole gene body – including introns and exons – but also in 
intergenic regions around silenced genes.42-44 Because of the relevance of this process in this 
thesis I will return to H3K27me3 and Polycomb later in their own chapter. 
Another mark that is frequently associated with silent (non-transcribed) chromatin but also with 
structural chromatin (e.g. telomeres and centromeres) is Histone H3 Lysine 9 trimethylation. 45 
This mark is placed, with the help of further proteins and complexes, by the enzyme Suppressor 
of Variegation 3-9 (Su(var)3-9)46 and is a hallmark of constitutive heterochromatin – a type of 
highly compacted chromatin.47 This heterochromatin is bound by specific proteins like 
Heterochromatin Protein 1 48-50 and is therefore either silent or structural.51 
Further, I interrogated a number of modifications that are frequently associated with actively 
transcribed genes. One of these is Histone H3 Lysine 9 acetylation (H3K9ac), which is placed by 
the Gcn5 Acetyltransferase as part of the SAGA complex.52,53 It is found both at active enhancers 
and around the transcriptional start sites (TSS) of active genes.54,55 Similarly distributed is the 
other histone acetylation I investigated in this thesis - Histone H3 Lysine 27 acetylation 
(H3K27ac).55 It is placed by the acetyltransferase Nejire (nej, also called dCBP).28  
Additionally, I investigated a number of methylations that are associated with actively 
transcribed genes. Histone H4 lysine 20 monomethylation (H4K20me1) is placed by PR/SET 
Domain Containing Protein 7 56,57 and is found at promotors and along the gene body of active 
genes.58,59 
Next there is a set of methylations on the tail of histone H3 which are associated with active 
transcription. I tested Histone H3 lysine 4 for both mono- and trimethylation (H3K4me1 and 
H3K4me3), which are both placed by distinct enzymes. While H3K4me1 is placed by Trithorax-
Related22 or Trithorax60 and is found at enhancers, predominantly those of active genes55, 
H3K4me3 is placed by SET Domain Containing 1 21,61 and is found around transcriptional start sites 
(TSS) of active genes. 54,55  I also assayed histone H3 lysine 36 trimethylation (H3K36me3), which 
is written by Absent, Small, or Homeotic Discs 1 (ash1) 62-64 and is found on exons of active genes, 
particularly towards the 3’ end of the gene.57,65 
Among these last writers, the enzymes that write H3K27ac, H3K4me1, H3K4me3 and H3K36me3 
are all part of a group of proteins that are called Trithorax Group proteins (TrxG) 66 which have 
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been well described to be involved in gene activation, specifically during development where 
they counteract Polycomb based repression. 66 
This large diversity of histone modifications – I limited myself to the ones reported in this thesis 
– with their specificity towards certain genes and their characteristic localization on certain 
functional genomic elements has led to the formulation of the histone code hypothesis. 67,68 It 
proposes, that the histone PTMs can fill the gap in long term transfer of transcriptional 
information and encode cell specific information that can – unlike DNA – not only be read but 
also dynamically written, thereby “considerably extending the information potential of the 
genetic (DNA) code”.67 
Therefore, considerable effort has been made to integrate a multitude of histone PTMs as well 
as additional chromatin bound proteins into a single model, proposing the existence of distinct 
chromatin states defined by the combination of histone modifications present on them. 55,69 In 
Kharchenko, et al. 55 they split the genome in 200-bp windows and used a Hidden Markov Model 
(HMM) to fit 9 different chromatin types, based on a number of ChIP-seq experiments performed 
in Drosophila cell lines. By doing this, they were able to identify chromatin types corresponding 
to genetic elements like enhancers, TSS or active gene bodies with characteristic enrichment of 
histone modifications along those elements. In Filion, et al. 69 they instead used DamID 70 to 
identify protein binding along genomic regions again using an HMM model to fit 5 chromatin 
states. These states, being based entirely on protein binding data, reflected the gene state and 
also associated with the characteristic histone modifications of that state. Both Kharchenko, et 
al. 55 and Filion, et al. 69 acknowledge however, that the number of states in their studies were 
chosen arbitrarily and were selected such that they best corresponded to their prior knowledge 
of chromatin structure and function. 
These types of studies come with a caveat however. While the presence of repressive histone 
modifications may strongly correlate with absence of transcription and the presence of active 
histone marks may be sufficient to predict of active transctiption54,55,71, these observations still 
only demonstrate a correlation of transcription and histone modifications. Therefore, they 
cannot inform about the order of events, the instructiveness of each modification and whether 
or not they might be required to maintain an active or repressed gene state or just follow as a 
consequence of that gene state.71,72 
 
4.1.4 MUTATING HISTONE POSTTRANSLATIONAL MODIFICATIONS 
In order to address the instructive role of histone posttranslational modifications in transcription 
it was necessary to manipulate these PTMs – for example preventing them to be placed – and 
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identify changes in transcription as a consequence of this manipulation. One approach to prevent 
histone marks from being placed is mutating or inhibiting the enzyme or enzymes responsible 
for writing them.21,40,60-62 Ablating histone PTMs in this fashion is achievable in a wide number of 
organism and cellular settings, it does however have a few shortcomings: The enzymes in 
question may also modify different targets73-75 or fulfil functions other than the enzymatic 
processing of posttranslational modifications, whether alone or as part of a protein complex. 60,76-
79 
Therefore, researchers have sought to also mutate the modified histone residues. This is faced 
with some challenges however. While in Saccharomyces cerevisiae it is possible to generate 
histone mutants80,81, this did not appear to vastly alter transcriptional patterns, and the question 
remained, whether this would be different in a more complex, multicellular metazoan, where 
generating such histone mutants has proved much more difficult. While in metazoans the genes 
encoding for the histones H2A, H2B, H3 and H4 are commonly found in clusters, these clusters 
are spread across several loci throughout the genome.82,83 In humans for example they are 
located on 3 different clusters across different chromosomes 82,84,85, which makes genetic 
manipulation of them difficult, if not impossible.  
The canonical histones in Drosophila are however arranged in a distinct fashion: They are 
clustered in a single locus on chromosome 2 termed the histone complex, which is a tandem 
repeat of histone gene repeat units that in turn contain  the 4 canonical core histones H2A, H2B, 
H3 and H4 as well as the linker histone H1.86 This made it possible to generate mutant animals 
and cellular mosaics deficient for canonical histones which can then be rescued by insertion of 
transgenic histone gene units.84,85 By using transgenes carrying point mutations in histones 
researchers used this Drosophila model to study the functional relevance of many histone PTMs, 
including H3K9 modifications87, H3K36 modifications65, H3K4 modifications88 and H3K27 
modifications.25,89 
When looking at the results of these histone point-mutations it becomes clear however, that 
many seem to not show the expected changes in the transcriptional output that might be 
expected by their genomic distribution or by mutations in their writers – a derepression of 
silenced genes or a silencing of transcribed genes.65,87,88 Even more, the histone mutants87,88,90 
often do not recapitulate the lethality phenotype of the writer enzyme mutants.21,91,92 This might 
just be an effect of maternal contribution – the histone mRNAs or proteins present in the embryo 
deriving from the heterozygous mother – supplying sufficient histones to continue past critical 
developmental stages93, but it might also demonstrate the further function of those write 
enzymes beyond the enzymatic function. 
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In conclusion, the histone replacement model in Drosophila, just like the mutations in histone 
writer enzymes, has its shortcomings. For each modification, one has to be wary of alternative 
modification on the same residue, for example lysine methylation and acetylation. Therefore, the 
best approach to identify the relevance of any one histone modification must be to determine 
the effects of both mutation in histone writers and histones themselves and integrate these 
findings to build a concordant model. 
 
4.1.5 POLYCOMB GROUP COMPLEXES AND HISTONE H3  LYSINE 27 TRIMETHYLATION 
One instance where the phenotypic changes and loss of repression in histone point -mutant and 
writer enzyme mutant correlated well is the H3K27me3/E(z) pair.25,89 Because of its relevance in 
this thesis I want to go into more detail about how these act, with a particular focus on my model 
system Drosophila. 
Much work on the mechanism of their gene silencing properties has focused on homeotic 
transformation, the full or partial transformation of one body part into another, and the 
misexpression of the homeobox transcription factors, particularly the subset of Hox transcription 
factors, which are critical for developmental patterning.66,94 Hox genes are a set of transcription 
factors which maintain the segmental identity along the anterior-posterior axis such that each 
region or segment is identified by exactly one of the Hox transcription factors.95 
Therefore, in Drosophila, in each segment most of the Hox genes are silenced. In this silencing 
process, Polycomb group (PcG) proteins play a critical role. The PcG proteins organize in 2 mayor 
complexes, called Polycomb repressive complex 1 (PRC1)76,96 and 2 (PRC2)23,97,98.  
PRC2 consists of Enhancer of Zeste (E(z)), a SET domain containing protein responsible for 
histone H3 lysine 27 methylation, Suppressor of Zeste 12 (su(z)12), Extra Sexcombs (esc) and 
Chromatin Assembly Factor 1, p55 subunit (Nurf55).41,99-101 In Drosophila this complex binds to 
Polycomb response elements (PREs). These are short genomic sequences characterized by their 
ability to confer silencing to adjacent reporter transgenes through Polycomb repression. 102 In 
consequence, PRC2 through the methyltransferase activity of E(z) will trimethylate histone H3 
lysine 27 around the PRE including adjacent genes. 98 
PRC1 consists of Polycomb (Pc), Polyhomeotic (Ph), Posterior Sex Combs (Psc) and Sex Combs 
Extra (Sce).103 It too binds to PREs to silence adjacent genes. 77,104 PRC1 ubiquitinates H2A at lysine 
118 through Sce’s ubiquitin ligase activity.105 However, whether this step is necessary for silencing 
is controversial.106,107  Additionally PRC1 also binds H3K27me3. Thereby PRC1 is able to compact 
the chromatin it locates to, consequently silencing genes located in the compacted 
chromatin.77,104 In summary, 3 essential steps mediate Polycomb based gene silencing: The 
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binding of PRC2, the writing of the H3K27me3 mark89 and the binding and of chromatin 
compaction by PRC177,104 
Drosophila also has a dedicated enzyme for the removal of H3K27me3 called Utx Histone 
Demethylase (Utx).108,109 Like many other Hox activating enzymes it is part of the Trithorax group 
(TrxG) of proteins. 110,111 Interestingly, the enzymatic activity of Utx is important in early 
embryonic development, but zygotic protein is sufficient for animals to complete development 
and make it to adulthood.112 However, the Utx mutant adults then rapidly die, indicating a role 
for Utx, and perhaps Polycomb, outside development (which would be completed at that stage). 
112 
 
4.1.6 POLYCOMB AND EPIGENETIC MEMORY 
Most interesting about this silencing conferred by PcG proteins is that it is self-propagating, self-
maintaining and even heritable across cell divisions.113 Both PRC1 and PRC2 can bind to 
H3K27me3 which promotes a spreading of the complex across silenced regions. 114-116 This allows 
silencing to be maintained for a few cell divisions even if the PRE, the primary recruiter of PcG 
proteins, is lost thereby promoting the stability of the silencing.25  
Importantly, PREs and by extension Polycomb group proteins appear to not discriminate 
between transcription factors with which they cooperate when silencing genes. This has been 
well described in the establishment of transcriptional patterns of Hox genes in the early embryo. 
Each Hox gene is selectively expressed along the anterior-posterior axis by a combination of 
enhancer and PREs. This patterning can also be transferred to reporter constructs using the same 
set of enhancers and PREs. Interestingly, while each set of enhancers mediate gene expression 
which closely matches just that of the Hox gene they derived from, PREs can be freely swapped 
between constructs: As long as it is sufficiently strong the PRE will maintain the transcriptional 
pattern of the enhancer and not superimpose the pattern of the gene from which the PRE 
derived.102,117-120 
Further, Polycomb group proteins confer a long-term memory to Hox genes on which they act. 
While the enhancers which initially coordinate the segmental expression of Hox genes are only 
active for a relatively short time in the early embryo, the resulting transcriptional patterns are 
maintained throughout the fly’s lifespan. 121,122 Also, this silencing memory is not tied to the 
activity of the enhancer that established it, it can act on any nearby enhancer. In one experiment 
it was shown that in a reporter construct Polycomb was able to remember the positional 
information initiated by a neighboring embryonic enhancer and transfer this information to an 
adjacent late larval enhancer when this enhancer became active many cell divisions later. 102 
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Likewise, PREs, in some instances, can maintain active transcriptional states, a feature which is 
perhaps conferred by the activity of Trithorax group proteins. 121-123 This has led to the conclusion 
that, at least for these well studied Hox and developmental PREs,  the transcriptional state that 
they confer is bistable, meaning that only fully active or repressive gene states are stable, while 
intermediates are unstable and therefore self-correct to be active or repressed.113 Mathematical 
modelling has demonstrated, that at least on a histone modification level the enzymatic 
machinery of Polycomb and Trithorax group proteins could explain much of the bistability of the 
PREs.66 
These properties have however been tested with only a small set of perhaps more extreme PREs 
that confer strong silencing to Hox genes and other developmental genes. Even among currently 
known PREs the strength with which Polycomb is able to silence adjacent genes varies broadly 124 
and likely only the stronger PREs have so far been identified. This calls into question, in how far 
the described properties of Polycomb translate to targets with less well studied or no known 
genetic control elements.113  
 
4.1.7 TOWARDS A BROADER ROLE OF SILENCING BY POLYCOMB GROUP PROTEINS 
Concluding, there is a lot of genome wide information about the distribution of histone PTMs and 
chromatin modifications that correlate well with the observed gene state. This includes the broad 
spread of histone H3 lysine 27 trimethylation, which is set by the Polycomb repressive complex 2 
and is found throughout the genome on silenced genes.55,69 
Also, Polycomb group proteins confer stable long-term memory and repression to 
developmental genes wherever it is necessary and these genes are maintained active or inactive 
according to the patterning set during early development.102,117-119,122 
 
This raises the question, how do H3K27me3 and Polycomb act on those targets which are not 
developmental in nature, but that are still targeted by H3K27me3? As Steffen and Ringrose 113 put 
it: “Hence, we propose that epigenetic memory may  be an extreme case and that a more global 
function of PREs may be to stabilize or even amplify existing gene expression states over shorter 
time frames. Whether a given PRE mediates long- or short-term and large or small effects on 
gene expression states will depend on its genomic context, the DNA sequence of the PRE, the 
expression status of the gene and the developmental context.” 
Consequently, in this thesis I wanted to address whether the same principles that were 
discovered in the developmental context also apply in a system, where gene regulation needs to 
Introduction 
 
 19 
be less terminal, but highly responsive to an external stimulus. For this I turned to the Drosophila 
immune system. 
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4.2 Drosophila immunity 
4.2.1 CELLULAR IMMUNITY IN DROSOPHILA MELANOGASTER 
Drosophila – like most animals – face the constant threat of falling prey to one of a number of 
pathogens and parasites. Therefore, like most metazoans it employs a large arsenal of immune 
response effectors, including phagocytosis (the engulfment of pathogens by dedicated immune 
cells) and humeral effectors (small molecules and peptides that directly harm intruders).  
To ensure that wounds and intruding threats can be sensed and dealt with the Drosophila 
hemolymph – the primitive arthropod equivalent to blood – contains highly specialized immune 
cells, the hemocytes. These are migratory cells that employ innate immune strategies, 
participate in tissue maintenance and wound response and are therefore functionally similar to 
the mammalian myeloid cells.125 There are 3 principle types of hemocytes that have been 
described: plasmatocytes, crystal cells and lamellocytes. 
Plasmatocytes make up the majority of all hemocytes comprising around 95% of the total 
hemocyte cell pool in larvae under non-stress conditions.126-128  Because plasmatocytes fulfill 
many of the same functions as mammalian monocytes or macrophages, they have also been 
called drosophila macrophages. 129,130 Just like macrophages, plasmatocytes are migratory, they 
can phagocytose pathogens and can transcriptionally respond to stimuli to produce 
antimicrobials and cytokines.131-133 I will return to effectors of plasmatocytes and their regulation 
later. 
Crystal cells are a relatively rare cell type, which under normal condition make up 2 -5% of all 
hemocytes in larvae.134,135 Animals lacking crystal cells are less efficient in wound healing and are 
more susceptible to dying after wounding136-138, likely because of the importance of crystal cells  
in melanization after injury.139,140 Crystal cells express two forms of Prophenoloxidase, PPO1 and 
PPO2.141 While PPO1 is readily released into the hemolymph, PPO2 is stored inside crystalline 
inclusions which give the crystal cell its name and is released in a later stage of immune 
activation.139 When prophenoloxidase is released and converted into active phenoloxidase these 
enzymes will trigger melanization, the polymerization of melanin.142,143 Animals deficient in 
crystal cells or PPO1 and PPO2 are also more susceptible to infection, potentially through the 
lack of reactive oxygen species (ROS) normally produced as part of the melanization 
cascade.139,140,144 
Lamellocytes are a highly specialized type of immune cells whose primary effector is 
encapsulation, the enclosing of dead tissue and parasites too large to be phagocytosed. They are 
larger than other hemocytes, flat and disc shaped.145 In normal healthy animals lamellocytes are 
absent. They are produced in wild-type animals after wasp parasitization, where when the 
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parasitic wasp lays its egg into a drosophila larva, this egg is recognized by plasmatocytes which 
attach to it.146 Consequently lamellocytes can be produced two different ways: On one hand, 
signaling through JAK/STAT, JNK and other signaling pathways147-150 can trigger proliferation and 
differentiation of hemocytes in the lymph gland, a hematopoietic organ in Drosophila larvae, to 
specifically produce and release lamellocytes.134,150 On the other hand the plasmatocytes bound 
to the egg can transdifferentiate to lamellocytes.151 Lamellocytes deriving from either source can 
then encapsulate the egg separating it from the host, preventing growth or spread and eventually 
killing it though melanization orchestrated by lamellocytes and crystal cells.146 
 
4.2.2 HEMATOPOIESIS IN DROSOPHILA 
Before turning back to plasmatocyte functions, I want to look at the developmental origins of 
hemocytes. Three major proliferative hubs have been described for the production of hemocytes: 
the embryo, the lymph gland and larval hematopoietic hubs. 
The earliest hemocytes are produced as early as stage 7 of embryonic development. 152-154 
Estimates have put the number of cells produced at this stage at 600-700, and while a small 
number of the generated hemocytes are crystal cells, plasmatocytes comprise around 95% of 
embryonic hemocytes.127,152  
Around the same time of embryonic development, a group of cells in the dorsal mesoderm 
separates. These will eventually become the dorsal vessel and the lymph gland.155 The lymph 
gland is perhaps the best described hematopoietic organ in drosophila, potentially because of its 
large size and the number of cells produced. It consists of three major zones: The posterior 
signaling center (PSC), the medullary zone (MZ) and the cortical zone (CZ). The CZ is the 
outermost part of the lymph gland where almost mature hemocytes reside, most of them being 
plasmatocytes and few crystal cells and lamellocytes.156,157 The MZ contains hemocyte 
progenitors which are actively dividing, maintained by proliferative signaling from the PSC, 156,158  
This complex signaling network maintains the lymph gland and it keeps increasing in cell count 
until the late 3rd instar stages of the larval development159-161 eventually reaching 3000-5000 
hemocytes.134,156,162 
In parallel, the embryonic hemocytes establish additional niches, called hematopoietic pockets, 
between the epidermis and the muscle layer of the larvae. These cells proliferate throughout the 
larval development while they are kept adherent and proliferative by the cells of the local 
microenvironment and local sensory neurons.162-164 
In non-stress situations, both the lymph gland and the hematopoietic pockets proliferate while 
releasing relatively few cells until the late 3rd instar larval stages. Around the wandering stage of 
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the 3rd instar larvae this changes and both hematopoietic niches break down releasing large 
numbers of hemocytes.162,165 While the relative contributions of both hematopoietic niches 
remains unclear, the hemocyte pool increases in this way from several hundred after 
embryogenesis to more than 5000 in early pupae stages134,163,165, reducing to 1000-2000 
hemocytes in adults.134 Adult hematopoiesis is still debated but is most likely not massively 
significant.128,166 
It is important that, even though plasmatocytes can derive from all these different hematopoietic 
sources, no clear distinction has yet been made that would indicate that plasmatocytes from 
these different sources differ in their effector functions. While many markers exist that enable 
the genetic marking hemocytes and even though these markers are not expressed with complete 
penetrance across all plasmatocytes, no subset of plasmatocytes has been described, that differs 
not in their origin, but in their ability to phagocytose, to respond to wound healing or in their 
general transcriptional programming.135,152,162,167,168   
 
4.2.3 PLASMATOCYTE EFFECTOR FUNCTIONS 
Now I want to turn back to plasmatocytes and look at how they deal with pathogens, with 
emphasis on phagocytosis, wound healing, detection of pathogens and the resulting 
transcriptional changes. 
The fact that plasmatocytes are the professional phagocyte, both responsible for the clearance 
of dead cells and pathogens has contributed to them being called Drosophila macrophages.130 
Just like in the vertebrate system phagocytosis is controlled by a set of specialized receptors and 
enhanced by opsonization. In development, because Drosophila is a holometabolous insect there 
is not only tissue modeling in the embryo but also tissue destruction and remodelin g in pupae. 
And of course phagocytosis by plasmatocytes plays an important role in both embryonic 
development152,169,170 and pupal development.171-173  These developmental phagocytic processes 
are initiated by the dedicated receptors Croquemort 174, Draper175 and Nimrod C4.176  
In pathogen clearance there is a different set of receptors for phagocytosis of bacteria and fungi. 
Both Eater133 and Nimrod C1 168 are required for phagocytosis in Drosophila larvae and adults, and 
loss of these receptors leads to an increased susceptibility to infections. 133,168 Interestingly 
Peptidoglycan Recognition Protein LC (PGRP-LC), which also has a role in NF-κB signaling, is also 
a phagocytic receptor.177 Plasmatocytes also express a set of C3/C4/C5-complement-like proteins 
called Thioester-Containing Proteins (TEPs) which opsonize bacteria and fungi. This 
opsonization further enhances the ability of plasmatocytes to phagocytose the opsonized 
pathogens.141,178,179 
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Plasmatocytes and crystal cells are also critical in injury response and wound healing. In the 
embryo any damage to the epidermis leads to an immediate response of nearby cells. First, a 
calcium wave is released and propagates from the site of infection.180 This causes the NADPH 
oxidase, Doux, to produce H2O2 which is sensed by hemocytes and attracts them to the site of 
injury.180,181 Similar processes guide the hemocyte dependent wound healing in larvae. Here, 
plasmatocytes also phagocytose damaged or dead cells and help in wound clotting. 182-184  
Hemocytes further contribute to wound clotting by the production of a number of secreted 
protein factors. One of these is Prophenoloxidase, which, as already discussed, helps 
melanization based clotting.142,143  Hemocytes also produce Hemolectin, which is a von 
Willebrand factor-like clotting protein.182,185 Further, Tiggrin, an extracellular matrix protein and 
integrin ligand is produced by hemocytes and involved in wound healing.185  
Besides their function in immunity hemocytes do also play a critical role in development. In 
addition to their role in the clearance of apoptotic cells through phagocytosis in the embryo 152 
and pupae173 that I already discussed, they also are important in extracellular matrix deposition 
and maintenance in embryo186, larvae187 and pupae171. There they facilitate the formation of the 
extracellular matrix and production of Collagen IV186, Laminin188, Triggrin189 and more, and 
disruption of such processes have been shown to lead to developmental defects in neurons 190 and 
the renal tubules.191 
Any activation either through phagocytosis, signaling from wounding or direct sensing of 
pathogens also triggers a transcriptional response in plasmatocytes. Among these genes, which 
are dynamically induced after stress or bacterial challenge are those coding for the Thioester-
Containing Proteins.141,178,179 Additionally, hemocytes, like all immune-competent tissues, 
produce anti-microbial peptides (AMPs), whose expression is controlled by NF-κB signaling and 
are specific to the pathogen.141,192 Plasmatocytes have also been reported to secrete cytokines, 
even though this field is far less well studied then the vertebrate system. Unpaired signaling by 
the proteins Unpaired1, Unpaired2 and Unpaired3, which activate JAK/STAT pathways through 
their receptor Domeless and which are closely related to vertebrate leptins, have been 
demonstrated to play a role in drosophila immunity.193 Unpaired3 for example is induced after 
infection, it signals to the fat body, Drosophila’s liver-like organ, where it induces a stress 
response.194 Unpaired3 has also been demonstrated to be important in the response to wasp 
parasitation.164 Eiger is a tumor necrosis factor (TNF) like protein195 which is upregulated after 
infection.192 It plays a role in the clearance of extracellular pathogens and mutants show reduced 
survival, are less phagocytic and produce less AMPs in response to such challenges. 196,197 Lastly, I 
want to mention the cytokine like factor Spätzle, which is also expressed in hemocytes and 
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hemolymph and is secreted in a pro-form.131,198,199 Mutants in spätzle are more susceptible to 
fungal infections.131 After immune challenge by a pathogen Spätzle is converted to its active form 
through cleavage by the Spätzle Processing Enzyme, which is also produced by hemocytes.199 It 
then binds to its receptor Toll which in turn activates NF-κB signaling200. 
 
4.2.4 NF-ΚB SIGNALING PATHWAYS IN DROSOPHILA 
Toll signaling is one of 2 NF-κB signaling pathways that have been described in Drosophila.201 In 
contrast to the mammalian system, where the Toll Like Receptors (TLRs) are pattern recognition 
receptors,202,203 Toll in Drosophila does not directly bind pathogen associated molecular patterns 
(PAMPs).204,205 Drosophila Toll signaling was discovered in the embryonic development, where its 
role is not that of protecting against pathogens, but instead is important in the dorsal ventral 
patterning.206 During embryogenesis the extracellular protein Spätzle is cleaved by the protease 
Easter from its pro form into its active form and then bind to its receptor Toll. This signaling 
defines the dorso-ventral polarity of the embryo.198,207,208 In immunity, extracellular cleavage of 
Spätzle also proceeds Toll signaling, but the actors involved in cleaving it differ. Here the cascade 
is activated by extracellular receptors recognizing either peptidoglycan from gram-positive 
bacteria, through the Peptidoglycan Recognition Proteins (PGRPs)209,210 or fungal β-glucans, 
through the Glucan Binding Proteins (GNBPs).211-213 This binding leads to the activation of the 
Spätzle Processing Enzyme, which then in turn cleaves pro- Spätzle into Spätzle.204 Just like in 
development active Spätzle will then bind to Toll, which leads to its dimerization.205,214 The 
subsequent intracellular signaling cascade closely resembles the pathways seen in the 
mammalian system.201,202,215 The dimeric Toll receptor is bound by MyD88 with its intracellular 
Toll/interleukin-1 receptor (TIR) domain, which recruits a larger protein complex. This culminates 
in the phosphorylation of the protein Cactus, its subsequent ubiquitination and degradation. 216-
218 This releases the NF-κB like transcription factors Dorsal and Dorsal-related immunity factor 
(DIF), which allows their translocation to the nucleus and activation of NF-κB target genes.219,220 
The other Drosophila NF-κB signaling pathway is called Immune Deficiency (Imd) pathway. Here 
the cell surface receptor Peptidoglycan Recognition Protein LC (PGRP-LC), which is also a 
receptor of phagocytosis, directly recognizes the peptidoglycan of gram-negative bacteria.177,221-
223 This causes the intracellular binding of the namesake of the pathway, IMD, to PGRP-LC.224,225 
IMD then recruits FADD and the caspase-8 homologue DREDD to the receptor complex.226,227 
This membrane bound complex activates the TAK1/TAB2 complex228-230, which in turn signals 
through Iκκ signalosome. Both the Imd-FADD-DREDD complex and the Iκκ signalosome then 
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contribute to the cleavage of Relish, which releases its active N-terminal part to translocate to 
the nucleus, act as NF-κB like transcription factor and activate immune genes.227,231 
Initially, a high pathway specificity for the transcription of certain AMPs in response to different 
immune challenges was described. It was observed for example that the AMP Drosomycin was 
expressed predominantly in response to gram-positive bacteria and fungi, while for example 
Diptericin was expressed in response to gram-negative bacteria.232 It was therefore thought that 
the Toll and Imd pathways could control the expression of one or the other target through its 
unique NF-κB protein. Indeed, bioinformatic analysis could identify some variants of the NF-κB 
motive which would bind Relish or Dorsal/DIF with increased affinity, but binding of the 
alternative site was still high.233 It therefore remains unclear, whether this distinction in signaling 
is entirely dependent on the NF-κB pathways, or whether further signaling pathways are 
necessary to distinguish between different types of pathogens. 
 
4.2.5 GENE REGULATION BY HISTONE MODIFICATIONS IN IMMUNITY 
The distribution and relevance of histone posttranslational modifications has not been 
extensively studied in Drosophila immunity. To my knowledge, no genome-wide data exists on 
the presence of any histone marks of any drosophila immune tissue. One of the few reports 
dealing with epigenetic regulation in immunity described the role of the transcriptional regulator 
Akirin. It was demonstrated to interact with Relish after Imd signaling which lead to the 
recruitment of the Switch/Sucrose Non-Fermentable (SWI/SNF) complex, a nucleosome 
remodeling complex.234 Knock-down of this interaction cascade lead to reduced H3K4ac after 
immune challenge, reduced expression of immune genes after immune challenge and an overall 
drop in survival of infected animals.235  
More reports are available on histone modifications in mammalian macrophages and on the role 
of H3K27me3 in mammalian innate immunity. The availability of large numbers of monocyte or 
bone marrow derived macrophages has made them a useful tool for the study of cellular 
processes in primary cells. Therefore, many genome wide profiles are available from such cells. 236 
A number of reports show the importance of epigenetic regulation in the differentiation of innate 
immune cells, demonstrating the requirement of PcG and TrxG proteins in the differentiation of 
monocytes to macrophages237 as well as in the plasticity of CD4+ T-cells.238 However, some data 
is also available on the role of H3K27me3 in gene regulation in innate immune cells. Two reports 
demonstrate a potential role of two histone H3 lysine 27 demethylases KDM6A and KDM6B, 
which are orthologs of the Drosophila Utx Histone Demethylase. One report demonstrates, that 
knock-down of KDM6A increases the production of the cytokines IL6 and IFN- in response to 
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viruses and TLR activation.239 Another report showed, that KDM6B is strongly induced after LPS 
stimulation of macrophages, but they did not investigate how this affected gene expression. 240  
Histone modifications have also been implicated in immune memory, the ability of immune cells 
to respond differently to a stimulus when encountering it for a second time, either less or more 
severe than the first time around. It was demonstrated that H3 lysine 27 is differentially 
acetylated after -glucan or LPS priming and might therefore play a role in immune memory.241 
Another study showed, that H3K27me3 was induced at a small set of promotors after stimulation 
with the cytokine IFN-, thereby acting anti-inflammatory.242 
I think that studying histone modifications in immunity is a good complementation of the long -
established study of those modifications in development. Immunity has some interesting 
features of gene regulation, that set it apart from development: Genes must be dynamically 
regulated, they should be transcriptionally silent in non-immune challenged situations, but must 
be induced rapidly after infection. The central aim of my thesis was to characterize how the 
regulation of those genes, which are just like developmental genes often silenced, but whose 
silencing can be overcome quickly, is implemented on the chromatin level.  I did so by studying 
histone modifications in general and H3K27me3 in particular  in Drosophila plasmatocytes and I 
hope that the information gained from studying such a system might also be translatable to 
similar, highly responsive signaling situations, such as neuronal gene regulation or metabolism. 
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5 RESULTS 
5.1  Transcriptional response of Drosophila hemocytes to infection 
5.1.1 THE SEPTIC INJURY MODEL IN DROSOPHILA LARVAE 
The septic injury model is a well-established model to study the immune response in 
Drosophila.243 In this model bacteria are introduced into the animal by pricking it with a sharpened 
tungsten needle covered in bacteria, which can be individual strains or mixtures of different 
bacteria and is not limited to Drosophila pathogens.  
To demonstrate that both the Imd and Toll pathways are activated by the manipulation I aimed 
to reproduce the available findings on the activation of those pathways by septic injury in 
larvae.232 Therefore, I tested wild-type Oregon R (OrR) 3rd instar wandering larvae in their 
response to the microbial challenge to the gram-negative bacterium Escherichia coli (E. coli or 
E.c.), the gram-positive Staphylococcus aureus (S. aureus or S.a.) and to sterile injury. 6 hours after 
the injury I isolated total RNA from whole larvae and subjected it to RT-qPCR determining 
expression levels of the  AMP genes Diptericin (Dpt), which is a target of the Imd pathway, and 
Drosomycin (Drs), which is regulated by the Toll pathway.232 My results demonstrate that in my 
hands, as previously reported, the expression of both AMPs is increased in all 3 treatment 
conditions (E. coli, S. aureus, Sterile injury, Figure 1A). Further, the response of Dpt is highest in 
the E. coli challenge, consistent with a predominant activation of the Imd pathway, and the 
response of Drs is highest in the S. aureus injury, indicating the preferential activation of the Toll 
pathway. 
To further characterize the transcriptional response of larvae to septic injury I challenged mutants 
of NF-B signaling pathways and measured their response. First, I tested a mutant deficient in 
the Imd pathway with a loss of function mutation in the NF-B transcription factor Relish (Rel).244 
I performed RT-qPCR against the AMPs Dpt and Drs, which are reporters of the activation of the 
Imd and Toll pathway, respectively (Figure 1B). In the RelE20 mutant, the expression of Dpt is 
strongly reduced in response to sterile injury, S. aureus challenge, and E. coli challenge. The 
response of Drs was also reduced following all 3 challenges, though to a lower extent. This 
corresponds well with previously published data.232,244 
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Figure 1: Septic injury induces an NF-B immune response in Drosophila larvae. A: Wild type OrR larvae 
were pricked with a sharpened tungsten needle, either sterilized with ethanol (sterile injury) or dipped into 
a pellet of E. coli, S. aureus, or kept untreated (cont.). Total RNA was isolated from these larvae and was 
subjected to RT-qPCR. Ct values of Drs and Dpt were normalized to rp49. One-way ANOVA p-value: Drs = 
1.62*10-5, Dpt = 7.85*10-7. B and C: Larvae from mutant background RelE20 (B) or RelE20,spz4 (C) were pricked 
with a sharpened tungsten needle, either sterilized with ethanol (ster.) or dipped into a pellet of E. coli (E.c.) 
or S. aureus (S.a.), or a mixture of E. coli and S. aureus (sept.). Total RNA was isolated from the larvae, RT-
qPCR performed and the data was normalized as in A. 
 
Next, I tested RelE20 spz4 double mutant larvae that lack signaling in both NF-B pathways.226 In 
these experiments I challenged 3rd instar wandering larvae with sterile injury or a septic injury (a 
combination of E. coli and S. aureus) and performed RT-qPCR on Dpt and Drs. The results indicate 
that both, expression of Dpt and Drs, were not induced by the challenge. (Figure 1C) 
Interestingly, while the requirement of the Imd pathway to induce Dpt and the requirement of 
spz to induce Drs was be recapitulated very well in this work, the specificity of the pathways to E. 
coli and S. aureus only reproduces partially. While the first experiment (Figure 1A) shows, as 
expected the highest response of Drs to S. aureus and the highest response of Dpt to E. coli, the 
second experiment has mixed results with regard to PAMP specificity (Figure 1B and C). 
Therefore, it is possible that other factors contribute to the transcription of specific AMPs, that 
has not been addressed currently. 
My data and the corresponding literature show, that injury alone will also cause transcriptional 
changes in the animal and its hemocytes141,243. In this thesis, however, I am interested in the 
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general mechanism of transcriptional regulation and therefore the relative contributions of 
damage-associated molecular patterns (DAMP), pathogen-associated molecular patterns 
(PAMP) and wounding response to the transcriptional response are not under investigation. 
Instead, I am aiming to achieve a maximally strong transcriptional immune response.  Hence, I 
decided to apply a septic injury model that combines a E. coli and S. aureus immune challenge.  
 
 
5.1.2 PLASMATOCYTE ISOLATION AND PURITY 
To study the plasmatocyte specific response I, therefore, adapted a method to isolate these cells 
from Drosophila. This resulted in a slightly modified version of the published protocols245 that I 
used throughout my thesis. In brief, 3rd instar wandering larvae were used for plasmatocyte 
isolation, because they have the highest hemocyte count and can be bled while avoiding the 
disruption of the gut or other organs. These larvae were bled out into a tissue culture dish 
containing Schneider’s medium as described in the methods. I also added the ROS scavenger N-
Acetyl-L-Cysteine (NAC) to block the melanization246 that disruption of the cuticula will trigger. 
The extracted hemocytes attach strongly to the tissue culture surface and can be washed 
rigorously with PBS to remove debris, bacteria and potentially remaining crystal cells. 
To test the purity of the resulting Plasmatocyte preparation I used a Drosophila line with the 
genetically encoded marker Hml-dsRed. In this line, plasmatocytes and crystal cells are marked 
by nuclear expression of dsRed.247 I isolated hemocytes from larvae of this line and the wild type 
OrR strain and analyzed them by flow cytometry to determine if residual non-fluorescent cells 
are present in my preparation (Figure 2A-C).  
Plasmatocytes were first gated by forward scatter (FSC) and side scatter (SSC) to select intact 
cells. Considerable subcellular debris was present in the preparation (Figure 2A), likely due to the 
forceful method by which the plasmatocytes are extracted. However, A clear population of intact 
cells was identified and selected. The gated single cells (Figure 2B) showed a strong separation 
between OrR and Hml-dsRed cells, with minimal overlap between plasmatocytes isolated from 
the non-fluorescent wild type strain OrR and the Hml-dsRed line (Figure 2C). This indicates that 
the gated cells were exclusively hemocytes. 
However, both plasmatocytes and crystal cells express this Hml-dsRed reporter126, so these two 
cell types are not distinguishable by this method. Therefore, I checked cells isolated from the 
Hml-dsRed line by fluorescence microscopy, where crystal cells can be identified by their distinct 
internal morphology and size.248 Consistent with flow cytometry, all cells showed dsRed 
expression with distinct nuclear localization and morphologically these cells were homogeneous 
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with no crystal cells detectable (Figure 2D). Together this demonstrates, that my adaption of the 
hemocyte isolation protocol works and produces a pure and homogeneous population of 
plasmatocytes. 
 
 
Figure 2: Plasmatocytes can be isolated readily from Drosophila larvae. A – C: Plasmatocytes were 
isolated from OrR and Hml-dsRed lines and FACS sorted. A: FSC vs SSC of all isolated cells from the Hml-
dsRed line. The gate marked “Hemocytes” marks the selection of events that are considered intact cells. 
B: FSC height vs area of all cells selected by the gate in A. Events with a high correlation in FSC height and 
area are considered single cells and selected. C: Isolated cells from OrR and Hml-dsRed lines were gated 
according to A and B. dsRed was exited with a 488nm laser and detected a 585/40nm bandpass filter. D: 
Hemocytes were isolated as described before but left to attach to a tissue culture dish and imaged by 
fluorescence microscopy. Overlay of the channels from transmission and fluorescence from excitation 
531/40 nm and detection 593/40 nm. 
 
5.1.3 RNA-SEQ TIME COURSE OF PLASMATOCYTES AFTER INFECTION 
To identify immune genes in plasmatocytes I then characterized their transcriptional response at 
various time points after immune challenge. Accordingly, I used the septic injury model 
established in 5.1.1 and challenged larvae with a combination of S. aureus and E. coli. Previous 
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reports indicated, that the immune response in whole animals is maximal at about 6 hours post-
challenge.232 In order to determine the dynamics of the transcriptional response, I decided to also 
include time points at 3 and 18 hours post-challenge. For controls, I included plasmatocytes from 
unchallenged animals and from 6 hours post sterile injury. In order to minimalize perturbance by 
factors like larval density, animal age and circadian rhythm, the closely staged 1st instar larvae 
were seeded into food tubes at fixed densities at fixed times, and plasmatocytes were also 
isolated from late 3rd instar larvae at fixed times. The different time points post infections were 
achieved by staging the time of immune challenge 3, 6 or 18 hours before the fixed plasmatocyte 
isolation time. From the challenged larvae samples of plasmatocytes were collected, RNA was 
isolated and subjected to RNA-seq. Four independent biological replicates were collected in this 
fashion for every treatment condition. The resulting data was mapped and treated as described 
in the methods section. 
First, I performed a principal component analysis (PCA) on the 1000 most variable genes in the 
transcriptome of challenged plasmatocytes acquired by RNA-seq (Figure 3A). In this analysis RNA 
samples cluster closely together according to the treatment condition from which they derive, 
indicating a high degree of reproducibility between biological replicates. The samples from 
unchallenged (control) plasmatocytes, 3h post septic injury and 6h post septic injury clearly 
cluster apart, and interestingly they are located on different tips of an imaginary triangle rather 
than being points on a straight line. This suggests that plasmatocytes do not initiate a singular 
transcriptional response that merely increases or decreases over time but in fact induce two 
distinct transcriptional programs: An early response detected after 3 hours and a late response 
detected by 6 hours. Almost half (49.71%) of the variance across all samples is explained by the 
first component of the PCA alone, and the samples from unchallenged and 3h post septic injury 
locate furthest apart on that scale, indicating that these samples are most dissimilar and the 
largest changes are to be expected between them. The other samples from challenged 
plasmatocytes (6h post septic injury, 6h post sterile injury, 18h post septic injury) also cluster 
slightly apart from the control on this dimension, but to a far lesser extent. This indicates that the 
early response that was observed at 3h post septic injury is much reduced at later time points. 
Component 2 of the PCA did not show a strong separation according to conditions. There is only 
a tendency for all challenged conditions to slightly separate from the control in this dimension. 
However, I could not find any interfering variables like date of sample preparation, order of 
sample preparation, RNA yield, RNA integrity or technical parameters of the RNA-seq library 
preparation and sequencing that explains the variance across this or any other dimension. 
Therefore, it might simply represent true biological variance that needs to be expected from 
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biological systems. Dimension 3 explains 10.2% of all variance that was observed and strongly 
separates the control from both the 6h post septic injury and the 6h post sterile injury. 
Interestingly, the 3h sample does only vary very little across this dimension, indicating that this is 
a distinct late response that is different from that observed at 3h post septic injury. The 18h 
sample is positioned in-between the 6h samples and the control, which indicates a return to the 
ground state after clearance of the bacteria. Dimensions 4 and 5 explain 7.45% and 2.83% of the 
variance respectively but do not yield any biological information and were, therefore, not shown. 
Another interesting observation is the overlap of the samples from 6h post sterile injury and 6h 
post septic injury. These plasmatocyte samples seem to be very similar, even though my initial 
whole larvae experiments at the same time points (Figure 1A) demonstrate that the septic injury 
induces an overall stronger response than sterile injury in whole larvae. It is possible, however, 
that plasmatocytes respond transcriptionally different than the whole animal, where the 
predominant source of AMP transcripts will be the fat body.131 Plasmatocytes migrate to the 
wound, where they may encounter and respond to bacteria that leak in from the wound even 
after injury with a sterile needle. Alternatively, they may mount an anticipatory response at 6h 
post-challenge. In summary, at 6h post septic injury plasmatocytes seem to distinguish little 
between the high bacterial load introduced by septic injury and an injury with a sterile needle. 
The findings from the PCA can be corroborated by identifying differentially expressed genes. For 
this, I filtered for genes that are represented with at least 1 read mapped to them per 1 million 
total reads in any 4 samples, regardless of which treatment group they belong to. This left me 
with data for 7586 out of the 17737 genes annotated in BDGP Drosophila genome assembly 6.91. 
Filtering genes in such a fashion is useful because changes in genes with lower read count are not 
likely to reach significance, but their presence during testing increases p-value thresholds during 
false discovery rate correction. Therefore, I will apply this filtering in all RNA-seq experiments in 
this thesis before testing for differential expression. On this gene set, I applied pair-wise 
comparisons of conditions using edgeRs glm approach and aimed to identify genes with a log2 
fold change in expression greater than 1 (LFC > 1) and a false discovery corrected p-value smaller 
than 0.05. First, I compared the 6h post sterile injury and the 6h post septic injury samples. 
Consistent with the PCA analysis there are very few differences between the two samples, and 
no genes reach the significance threshold outlined before. 
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Figure 3: Septic injury induces a multi-component transcriptional response in plasmatocytes. A: PCA 
of RNA-seq from immune challenged plasmatocytes, septic injury indicates a combination of S. aureus and 
E. coli. Gene level read counts were stabilized by applying a regularized logarithmic transformation 
(DESeq2), then PCA was performed on the 1000 most variant genes. B-D: Volcano plots of all detected 
genes for the comparisons 3h post septic injury vs. control (B), 6h post septic injury vs. control (C) and 18h 
post septic injury vs. control (D). P-values are plotted log transform against the Log2 fold change (LFC). P-
values were calculated by a glm negative binomial approach (edgeR) and significant genes were selected 
with a cut-off false discovery rate corrected p-value = 0.05 and LFC = 1 (marked by vertical dashed lines). 
The most outlying genes are marked by gene name, and genes with immune GO terms among the labeled 
genes are labeled in red. 
 
Subsequently, I determined how plasmatocytes transcriptionally responded to septic injury at 
various time points after the challenge. I, therefore, compared the septic injury samples from 3h, 
6h, and 18h post challenge to the unchallenged control samples and determined log2 fold 
changes, p-values, and differential expression. At 3h after septic injury (Figure 3B), a large 
number of genes were differentially expressed (705 genes are up-regulated, 6098 are not 
significantly differentially expressed, 783 are down-regulated). While a larger number of genes 
were down-regulated than up-regulated, the most strongly regulated genes, with the largest fold 
Results 
 
 34 
change, were up-regulated. Among them are many genes that are associated with at least one 
immune gene ontology (GO) term. Furthermore, when comparing the volcano plots from 3h post 
septic injury vs. control (Figure 3B) to the ones from 6h and 18h post septic injury vs. control 
(Figure 3C-D) it is apparent that the number of differentially expressed genes was far greater at 
3h post-challenge then at any other time point. This observation is well consistent with the PCA. 
At the same time, the extent of up-regulation in the most strongly up-regulated genes is similar 
in all comparisons, hence the immune response at 6h or 18h post septic injury is not simply a 
weaker induction of the same response. At 6h post septic injury (Figure 3C) I detected a smaller 
number of regulated genes compared to the 3h time point (141 genes are up-regulated, 7373 are 
not significantly differentially expressed, 72 are down-regulated). Here, very few genes were 
down-regulated, and those that were do not show a large fold change. On the other hand, a 
number of genes were up-regulated with large fold changes, and among them are many genes 
with annotated immune GO terms (marked with red text labels in the volcano plots), specifically 
the AMPs of the diptericin, attacin, and cecropin groups and the receptors from the peptidoglycan 
recognition protein group. At 18h after septic injury (Figure 3D) no down-regulated genes were 
detected (50 genes are up-regulated, 7536 are not significantly differentially expressed, 0 are 
down-regulated). As for the comparisons of 3h and 6h post septic injury, a large number of 
immune-type genes were among the up-regulated genes. The overall smaller number of 
differentially expressed genes indicates that plasmatocytes at this stage were returning to a 
“resting” state, normally observed in unchallenged animals. However, a number of genes were 
still up-regulated with high significance, and their fold change was not necessarily smaller than 
at either 3h or 6h post-challenge. Together, this demonstrates that the transcriptional response 
of plasmatocytes to septic injury is a two-component response, in which early at 3h post septic 
injury, a large number of genes is differentially regulated, followed by a later response at 6h post 
septic injury, where specific immune genes are highly expressed. 
To identify at the trajectory of individual genes and their reproducibility across the 4 replicates in 
each condition I selected a set of relevant genes by choosing the genes with the highest variance 
among all genes that were differentially expressed in plasmatocytes at 6h post septic injury when 
compared to control conditions. These genes I normalized for their mean and standard deviation 
of expression by applying a gene-wise z-score transformation on the regularized logarithmic read 
counts. These values were plotted in a heatmap (Figure 4), such that each column represents one 
plasmatocyte sample and each row represents a gene, sorted by hierarchical clustering. On the 
gene level, several clusters are discernible, indicated by colors next to the gene names: Some 
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genes are generally up-regulated during infection (in the upper part of the heatmap in Figure 4) 
and some are generally down-regulated (which are in the lower part of the same heatmap).  
In the uppermost cluster is a set of genes that includes TEP2 and the AMPs DptB, Mtk and Drs, 
which are up-regulated at 3h and 6h after the septic injury to about the same extent. Below is the 
cluster marked in orange which includes the cecropins and 2 attacins that is most strongly up-
regulated at 3h after septic injury, but also highly expressed at 6h in septic and sterile injury.  
The clusters marked in purple and magenta include genes that are more highly expressed at 6h 
and 18h post-challenge than in either 3h post septic injury or control. Among the genes in the 
yellow cluster that are generally down-regulated, there is a set of Nimrod phagocytosis receptors, 
but unfortunately, no data exist whether these specific Nimrod subtypes are required for 
developmental phagocytosis or phagocytosis of pathogens. 
On the pattern of individual samples a few interesting observations can be made, both in the 
heatmap of differentially expressed genes (Figure 4) and the dendrogram of hierarchical 
clustering of those samples (Figure 5). The samples from 6h post septic injury and sterile injury 
are very similar, with the 3h sample being somewhat similar and the control sample being most 
dissimilar. The 18h post septic injury clusters in several places, which is also apparent from the 
heatmap, where there seems to be 2 distinct types of samples in the 18h group. Potentially some 
variance in how quickly the challenge was be resolved resulted in these differences. Judging by 
the heatmap this difference may, in fact, derive from only a subset of genes among the genes 
that were up-regulated at 3h and 6h, with 4 genes in the magenta cluster, among which is AttC, 
being strikingly different between the 18h samples 1 and 4 and the 18h samples 2 and 3. The 
genes that were down-regulated at 3h and 6h are, however, consistently returned to control 
levels in all the 18h samples. 
Therefore, individual genes, including different AMPs, can be identified, which are most strongly 
regulated at different times post septic injury and thereby group the plasmatocyte samples into 
3 principle transcriptional states: Unchallenged, 3h post septic injury and 6h post septic injury.  
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Figure 4: Plasmatocyte immune genes are regulated in a characteristic temporal fashion. Genes were 
selected by choosing among all genes up-regulated in 6h post septic injury the genes with the highest 
variance across all samples. Regularized logarithmic transformed (DESeq2) gene read counts were 
normalized by z-score transformation and genes were sorted by row-wise hierarchical clustering (indicated 
by colors on the left). For the tiles, blue indicates genes that are in that sample more highly expressed than 
in the mean, while red indicates gene expression lower than the mean.  
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Figure 5: Plasmatocyte transcriptional immune responses cluster by their post-challenge time. The z-
score transformed gene counts from Figure 4 were clustered by hierarchical clustering and plotted as a 
dendrogram, such that the heights represent the Euclidian distances of samples. Labels c: control, 3h: 3h 
post septic injury, 6h: 6h post septic injury, s: 6h post sterile injury, 18h: 18h septic injury. 
 
To better understand the functional consequences these transcriptional changes have for 
plasmatocyte function, I identified the enrichment of gene ontology (GO) terms by applying the 
algorithm from goseq as implemented in edgeRs goana module. 
GO-terms relating to immunity are enriched at 3h and 6h after septic injury but only some remain 
enriched by 18h after septic injury. This observation is consistent with an immune response of 
plasmatocytes that returns to a ‘resting’ state within 18h after the challenge. Generally, the effect 
sizes of the enrichments are higher in the 6h samples, potentially because fewer genes that are 
not annotated as immune effectors are differentially regulated at these time points. However, 
immune-related GO-terms are enriched amongst genes that are differentially expressed 
between 3h and 6h after septic injury. This underlines that the immune response changes from 
an early to a late response.  Interestingly, genes that are involved in general metabolic processes 
and more specifically carbohydrate derivative metabolic processes are enriched among the 
down-regulated genes both, at 3h and 6h after septic injury. This suggests a change in the 
metabolic state of plasmatocytes alongside their immune response.  Down-regulation of 
glycolysis is contradictory to the Warburg-effect observed in macrophages after infection249, but 
it would be necessary to measure enzymatic activity in glycolysis to determine if and how the 
transcriptional changes in plasmatocytes actually affect their metabolic activity.  
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Figure 6: Specific functional programs are sequentially induced in plasmatocytes after septic injury 
challenge. GO-term enrichment was performed using the goana module implemented in edgeR. Rows are 
GO modules that reached significance, while columns are individual comparisons and, where not otherwise 
noted, the challenged plasmatocyte samples were compared to the RNA-seq of control plasmatocytes. 
The effect size is (b/n)/(B/N) where b is the number of genes that are regulated and carry the GO-term, n is 
the number of genes regulated in that direction, B is the total number of genes with that GO-term, and N 
is the total number of genes in the comparison. GO-terms are sorted by manual selection to reflect 
common groups of gene functions. 
 
Further, a set of terms related to ion transport, specifically metal ions and cations, appears to be 
enriched among up-regulated genes at 3h, 6h, and 18h after septic injury. These could relate to 
calcium signaling, which is important in wound healing180 or be related to antimicrobial activity, 
which can be mediated by ion transporter.250 Further, a number of GO modules that relate to cell 
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to cell signaling and cell migration is enriched am genes up-regulated at 3h post-challenge. This 
is likely related to the signaling and the migratory response of plasmatocytes. 181 Interestingly, 
the genes out of this group are no longer enriched in regulated genes later than 3h post-
challenge, which suggests that they are part of an early and transient response. Finally, the genes 
in terms relating to pigmentation, which are enriched among up-regulated genes at 3h and 6h 
post-challenge fulfill a dual role: Because both pigmentation and immunity use melanin, the 
genes contained in these terms here are likely to be related to melanization for clotting or 
antimicrobial ROS production.142-144 It is important to note that also based on GO-term 
enrichment the septic injury condition at 6h after challenge was not readily distinguishable from 
injury with a sterile needle at the same time point. Still, the GO-term analysis clearly shows that 
plasmatocytes show a complex biological response in the septic injury model that is dominated 
by a pattern of immune response mechanisms. 
In summary, I characterized the transcriptional response of plasmatocytes at various stages of an 
immune response. There are only 3 other whole transcriptome studies on Drosophila 
plasmatocytes like cells that I am aware of, all of which used microarrays. Irving, et al. 141 analyzed 
the transcriptional pattern in various mutants affecting hemocyte hematopoiesis, Johansson, et 
al. 192 tested the response of the hemocytes like mbn-2 cell line to PAMPs and Woodcock, et al. 
251 investigated the effect of diet on adult hemocytes. Therefore, to my knowledge, I generated 
the first RNA-seq data sets on primary Drosophila plasmatocytes and their transcriptional 
regulation in immunity. Additionally, I showed that there are distinct transcriptional patterns at 
3h post-challenge and 6h post-challenge, indicating that there is a two-step response, early and 
late. Furthermore, I showed that the response is highly reproducible and although complex, 
dominated by genes that have been annotated with immune functions.  
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5.2 ChIP-seq on unchallenged Drosophila plasmatocytes 
5.2.1 CHIP-SEQ SAMPLE DESCRIPTION 
To establish the regulation of gene expression by histone posttranslational modifications in 
Drosophila plasmatocytes I further established a detailed profile of the relevant histone 
modifications targets from those cells. Therefore, I isolated plasmatocytes from unchallenged 
Drosophila larvae, prepared cross-linked chromatin from them and subjected it to chromatin 
immunoprecipitation (ChIP).  
On average after washing, I recovered approximately 1000-2000 plasmatocytes from each larva. 
Given that most ChIP protocols work in excess of 1 million cells, it was not feasible to optimize 
ChIP protocols for each of the 10 targets in this study using plasmatocytes. Therefore, I used 
chromatin from the S2R+ Drosophila cell line, from which larger quantities of chromatin can be 
prepared easily, to optimize ChIP protocols. This chromatin was sheared, immunoprecipitated 
and enrichment was determined by qPCR for known or predicted targets (data not shown). 
After optimizing my protocols to work with approximately 105 cells I performed ChIP experiments 
on chromatin from plasmatocytes for all targets. To control for chromatin accessibility, genome 
duplication or deletions and for potential problems in the data processing pipeline, I held a 
matching input sample back whenever a ChIP experiment was performed. As is standard in ChIP-
seq252, 2 replicates were prepared for each ChIP target, the immunoprecipitated DNA was tested 
by qPCR for enrichment in predicted regions and consequently made into libraries and sequenced 
(see Table 9 for libraries). The resulting sequencing reads were mapped to the Drosophila BDGP 
dm6 genome assembly and treated as described in the methods. 
To visualize the processed data in a genome browser, I merged the replicates and calculated 
bigwig coverage files using 25 bp bins. An example of the resulting profiles is shown in Figure 7. 
The genomic region shown here is the area around the even skipped (eve) locus. The eve locus is 
controlled by a set of enhancers, that mediate a highly specific expression pattern in the 
embryo253  and is silent in larval plasmatocytes, according to the expression analysis in this study. 
In Figure 7 I colored the tracks according to the correlation that has been ascribed to the 
corresponding histone modification: Modifications that mark active chromatin (active marks) in 
green and modifications that mark repressed chromatin (repressive marks) in red. While many 
regions carry some active marks, the chromatin region around the eve locus is devoid of all of 
them. In this genomic region, the repressive marks H3K9me3 and H3K27me3 as well as the 
‘combined’ H3K27me2/me3 mark (detected by using an antibody recognizing both H3K27me2 
and H3K27me3) show enrichment. Interestingly, it appears that the input in these regions is 
slightly reduced, but it is still well detected. For genes outside the eve domain, there are a number 
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of peaks and short regions enriched for active marks. First of all, RNA polymerase II has a strong 
peak as well as a trailing signal along the gene body on genes that are transcribed. This has been 
described as its characteristic distribution, where the initial peak indicates stalled RNA 
Polymerase II and the tail reflects progressing transcription.254  
 
 
Figure 7: Genome profiles of ChIP-seq from unchallenged plasmatocytes are concordant with 
previously published observations. Mapped ChIP-seq reads from 2 replicates for each IP target were 
mapped on dm6.91 and ChIP coverage was calculated using 25 base pair bins. The resulting profiles were 
visualized using IGV. Here, I show the profiles around the eve locus. Green tracks label histone marks that 
are associated with active transcription, while red tracks label repressive marks. Additionally, the blue 
profile shows log2 coverage of RNA-seq from unchallenged plasmatocytes. The bottom panel shows gene 
spans of genes annotated in the genome assembly dm6. 
 
H3K4me3 peaks are located directly after the transcriptional start site (TSS) of active genes, 
centered slightly after the stalled RNA polymerase II peak, a distribution which is well described 
for H3K4me3.54 The competing H3K4me1, on the other hand, is located at positions further away 
from these H3K4me3 TSS peaks and also locates to introns of active genes. It is mostly restricted 
to active genes and the literature suggests that these regions act as enhancers.22 The lysine 
acetylations H3K9ac and H3K27ac appear to be enriched on both H3K4me1 and H3K4me3 
positive regions, but while H3K9ac seems to be preferentially present at H3K4me3 peaks, 
H3K27ac seems to be more evenly enriched among both of the tested H3 lysine 4 marks. 
H3K36me3 is enriched on active genes at regions downstream of the TSS while being absent from 
long introns like the one in Mef2, which corresponds well with the described enrichment for 
H3K36me3 at the 3’ exons of active genes.20 H4K20me1 is present along the complete gene body 
of active genes both on introns and exons. However, the background in this ChIP is higher than 
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in other ChIPs, with a signal being visible even in the silenced eve locus. In short, the ChIP-seq 
profiles show a distribution concordant with previous publications55, which indicates that 
modified genomic regions were successfully enriched. 
Additionally, I controlled that signals that I find for my ChIP-seq experiments reproduce. 
Therefore, I checked the correlation between the ChIP replicate pairs. To do this I followed the 
standard Deeptools pipeline255: The genome was divided into 10 kb bins and read counts were 
quantified for those bins. Then, the Pearson correlation coefficients for those counts were 
calculated and plotted as a hierarchically clustered heatmap (Figure 8). The label after the ChIP 
target (e.g. CHxxx or Kxxx) identifies the experimental group of the ChIP (see Table 9). 
Pairwise Pearson correlation coefficients show that the replicates reproduce very well, and all 
ChIPs have a Pearson’s r between r = 0.99 and r = 1. The input samples correlate to a lesser extent, 
but this is likely because there is little true signal in these tracks and most differences between 
samples will be random fluctuations in read sampling. The Input samples from the experiment 
K3772 are somewhat more dissimilar to the other inputs, which might stem from the lower 
sequencing depth in those samples.  
Beyond reproducibility within replicates, this analysis reveals correlations (or anti-correlations) in 
the genome-wide distribution of different histone marks and therefore allows to group them into 
co-occurring clusters. H4K20me1 clusters most closely with input and not well with other histone 
marks, an observation that could be caused by the poor ChIP enrichment achieved with the 
monoclonal antibody used in this sample.  
In contrast, the three repressive marks H3K9me3, H3K27me2/me3 and H3K27me3 cluster well 
together. Interestingly, H3K27me3 does not correlate very well with H3K27me2/me3, which 
recapitulates the results of the raw data tracks (Figure 7). Therefore, some additional signal must 
derive from H3K27me2, which, based on the better correlation with the input samples and the 
profile I described before, appears to be spread more broadly across the genome than H3K27me3. 
Similar to the repressive marks active histone marks cluster together. The acetylations H3K27ac 
and H3K9ac correlate very strongly, but they also correlate with the other TSS associated marks 
H3K4me3 and RNA PolII as well as the enhancer mark H3K4me1. Interestingly, RNA polymerase 
II most strongly correlates with marks close to the TSS and enhancers, which demonstrates that 
most polymerase is in either stalled states254 or involved in the production of enhancer activity 
related transcripts (eRNAs).256 Far less correlation exists between RNA PolII and H3K36me3, 
which is consistent with H3K36me3 being deposited during transcriptional elongation and 
therefore enriched towards gene 3’ ends. Further, even though they locate to different parts of 
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genes H3K36me3 best correlates with H3K4me3, which is likely reflecting the cooperation of their 
writer enzymes in TrxG complexes.66  
 
 
Figure 8: ChIP-seq samples correlate by replication and genomic proximity. Mapped reads from each 
individual ChIP-seq replicate were binned using 10kb windows. Pairwise Pearson correlation coefficients 
of the resulting read counts were calculated using Deeptools. Samples were sorted using hierarchical 
clustering and visualized as a heatmap. Colors indicate the correlation according to the scale on the right. 
 
Underlining their assignment into active and repressive marks both classes of marks lack 
correlation and in part even anti-correlate. These small correlation coefficients seem to be similar 
across all different active ChIP targets, and the strongest anti-correlation to active marks is 
observed with the canonical gene repression mark H3K27me3. This unbiased anti-correlation of 
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repressive marks with active marks indicates, that repressive marks, unlike active marks, do not 
target individual parts of genes, but spread over entire silenced domains. 
In summary, the high pairwise correlation of replicates demonstrates, that histone modifications 
were reproducibly enriched, and the degree of correlation between different marks well reflects 
their described genomic proximity. 
As an alternative way to assess cross-sample variation and clustering observable in the ChIP-seq 
experiments, I performed a PCA analysis on the ChIPs by using 10 kb bins to quantify read counts 
and calculating the PCA rotations using the 1000 most variable bins across all samples.  The 
loadings of the resulting first three principle components were plotted (Figure 9A). The replicates 
cluster well together, further supporting that the replication was successful. Similar to the results 
from Pearson correlation there are 3 major groups, with the active marks clustering towards the 
top left, the inputs in the bottom center and the repressive marks spreading towards the bottom 
right. The active gene marks separate from the input samples across principle component 1 (PC1), 
and this component explains 44% of all sample variance. It is, however, important to mention 
that I assayed a larger number of active marks and any common variance in these samples , 
therefore, has a greater impact on the overall data matrix than the smaller number of repressive 
marks. Consequently, a higher fraction of variance does not automatically imply a higher degree 
of dissimilarity between input and active marks than between input and repressive marks. 
The clustering of the active marks reproduces some observations that were made from the 
Pearson correlation coefficient heatmap (Figure 8). The two acetylations H3K9ac and H3K27ac 
cluster closely together, furthest away from the input. RNA polymerase II and H3K4me3 cluster 
close to these, while H3K4me1 is slightly more distant from the acetylations. Interestingly, 
H3K36me3 in this analysis is closest to H3K4me1 and not to H3K4me3 both along PC1 and PC2, 
which is in contrast to the correlation-based analysis. H3K4me1 is, too, placed by a TrxG 
member66, but normally locates to enhancers. As with the correlation analysis, H4K20me1 is 
much closer to input than any other active histone mark. Further, it is the only active histone mark 
that is distinguished from input almost exclusively by PC2 and not by PC1.  
Along this PC2, 33.4% of all sample variance is explained, and this component distinguishes both 
active marks (to the left) and repressive marks (to the right). Strikingly, the repressive mark that 
is most distant from the input and thereby most distant from active marks along PC2 is 
H3K27me3. This reflects the instructive role of H3K27me3s in silencing97 and the less broad, more 
localized enrichment observed for it when compared to the other silencing marks. 
H3K27me2/me3 is close to the input samples, perhaps reflecting its broad genome distribution, 
while H3K9me3 is located in between H3K27me2/me3 and H3K27me3.  
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The third dimension of the PCA explains very little of the variance (only 7%) and only the input 
samples vary strongly along it. Active marks do however also separate from repressive marks, 
which are along this dimension most distant from the input. Therefore, this component likely 
recapitulates the generally poorer recovery of repressed chromatin regions in the input (Figure 
7). 
 
 
Figure 9: Principle component analysis of ChIP-seq samples separates active and repressive marks. 
Reads from all samples were counted using 10 kb genomic bins and the 1000 most variable bins were 
selected. The resulting counts were subjected to principal component analysis. A: Visualization of the first 
3 components of the PCA with colors indicating the different antibody targets. B: Percent of total sample 
variance explained by the first 10 components. 
 
The further PCA components encode even less of the total variance (Figure 9B) and no clear 
patterns that explain the separation along these dimensions were identified. Therefore, they 
were not plotted, limiting the PCA shown here to explaining 84.4% of all sample variance. In 
short, PCA well separates active and repressive histone marks, and the degree of separation 
reflects their mutual exclusiveness. 
This PCA analysis comes with 2 caveats which I want to shortly address. First, the bins used for 
the PCA were selected for their high variance across all samples. While this is helpful to exclude 
excessive noise from the analysis, it might also limit the analysis to the more extreme bins, like 
regions around Hox genes or ribosomal genes. Second, the large size of the bins (10 kb) , while 
also facilitating a stable, noise-free signal, may cause marks with a rather sharp distribution like 
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H3K4me3, which locates exclusively to TSS, to be captured poorly by this approach. This second 
point further extends to the correlation heatmap (Figure 8). 
To quantify genome-wide localization of histone modifications on genes I therefore determined 
averaged signal intensity of these modifications along genes. Hence, I calculated log2 ratios of 
each ChIP-target over input in 25 bp genomic bins, normalized to the library size.  
To be able to compare genes of different lengths I scaled the gene length of all genes to 10kb 
from transcriptional start site (TSS) to transcriptional end site (TES) and adjusted the signal 
tracks accordingly. Regions before the TSS and after the TES were added unscaled. The resulting 
gene-level profiles were separated into 2 groups using k-means clustering and the average signal 
intensity along the genes in each cluster was plotted (Figure 10A). Here, k-means clustering 
produces 2 groups that appear to be split into the genes with more repressive marks (in red and 
orange) and more active marks (in purple and black). Therefore, I labeled the 2 cluster groups as 
active genes and repressed genes.  
Among the active genes, one striking feature is the depletion of all histone mark signals around 
the TSS. Instead, a strong peak of RNA PolII signaling is present in this position, which 
corresponds to a loss of nucleosomes in these positions.257 The RNA polymerase II signal then 
trails out towards the TES. H3K36me3, on the other hand, is steadily increasing downstream of 
the TSS and only reaches its maximum slightly before the TES, consistent with prior 
observations.20  
The repressive marks are lowest around the TSS of active genes and remain low throughout the 
gene body. On inactive genes,  the repressive marks are much more prominent than active marks 
and show very little variation across the gene body, with only a slight enrichment towards the 
middle of the gene. Here, depletion of signal around the TSS is almost absent, perhaps only 
deriving from a minor subpopulation of sporadically transcribed genes. H3K27me3 is the most 
strongly enriched repressive mark on inactive genes. This may recapitulate its characterized role 
in gene repression, but an effect of antibody strength might also explain part of the difference.  
Subsequently, I addressed the distribution of marks around the TSS, which is a hotspot for several 
highly localized marks. Here, a scaling of genomic regions was not necessary. After selecting 
appropriate histone PTMs to investigate, the data was otherwise processed as described above, 
using the same k-means method to separate active and inactive genes.  
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Figure 10: Histone marks distribute along genes concordantly with previous reports. Log2 ratios of 25 
bp coverage files for each ChIP target were calculated as ChIP-seq over input, both normalized to the total 
read count in that library.  The resulting coverage files were quantified using Deeptools. A: A selection of 
marks was quantified by scaling all gene regions from the transcriptional start site (TSS) to the 
transcriptional end site (TES) to 10 kb and determining coverage. B: A selection of marks was quantified in 
a fixed window around the TSS. A and B: Genes were then split into 2 groups using k-means clustering and 
profiles were plotted. 
 
Consistent with depletion of nucleosomes at the TSS I observe a lower signal of histone marks 
directly at the TSS of active genes. On active genes the RNA polymerase II signal is centered 
directly at the TSS, given the resolution of the ChIP, this likely reflects the previously described 
stalling of polymerase.254 H3K27ac, H3K9ac, and H3K4me3 signals peak directly after the TSS 
with a shoulder towards the 3’ region. H3K4me3 is most strongly localized towards the region 
directly downstream of the TSS, while the peaks for both acetylations are broader and also more 
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prominent upstream of the TSS. This reflects well the described distributions of these marks, with 
H3K4me3 enriched just around the TSS, while both H3K9ac and H3K27ac are present both at the 
TSS as well as at active enhancers and therefore more distant from the TSS.55 H3K4me1 on the 
other hand is less enriched around the TSS both with regard to the sharpness of the distribution 
peak as well as the overall enrichment over inactive genes. This pattern fits well with the 
observation that that H3K4me1 is predominantly found at enhancers, which are not located at 
any fixed point relative to the TSS. In general, all these active marks are strongly depleted in 
inactive genes and are spread more evenly across the genomic region than in active genes. 
Together, the histone modifications show both a distribution across individual genes as well as a 
concordant separation along gene groups which well reflects established histone modification 
descriptions.55 
In summary, I was able to establish a ChIP-seq protocol from primary plasmatocytes. This is to 
my knowledge the first ChIP from primary hemocytes and the first ChIP from any major 
Drosophila immune tissue. Further, the observed distributions of histone modifications are highly 
consistent with those that have previously been described for Drosophila, both with regard to 
their preference for active or repressed genes and to their localization on specific genomic 
elements, like TSS, enhancers or gene bodies. Interestingly, among the datasets which I 
generated H3K27me3 was most discordant with active gene marks, being both most enriched on 
inactive genes and most anti-correlated with active marks.  
 
5.2.2 MULTIDIMENSIONAL BINOMIAL EXPECTATION-MAXIMIZATION MODELS 
The strong anti-correlation to active marks raised the question of whether the H3K27me3 
enrichment is based on only a small number of genes, such as Hox genes which are strongly 
targeted by H3K27me3 and permanently repressed, or if inactive genes, in general, are targeted 
by H3K27me3. Therefore, I developed an approach to quantify and categorize the enrichment of 
H3K27me3 (and histone modifications in general) on genomic regions or genes. I especially 
addressed whether I could detect one or multiple states of H3K27me3 enriched chromatin  and 
how this explains the co-variance with gene state: There might be either a small set of highly 
H3K27me3 positive genes, or a larger set of intermediately enriched, or both. 
Many algorithms have been proposed previously to detect such ChIP enriched regions, each with 
slightly different underlying mathematical models and their own advantages and 
disadvantages.258,259 Perhaps best known and most used is Model-based Analysis of ChIP-Seq 
(MACS)260, which identifies regions of interest by characteristic peak shifts between strands and 
estimates enrichment by ratios of sequencing depths using Poisson models. Many further 
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algorithms based on such Poisson models have been developed, including SPP261 and SICER262. 
Others have proposed different models, like the bivariate HMM models implemented in 
histoneHMM263.  
One interesting approach is implemented in normR, which uses expectation-maximization (EM) 
based fitting of binomial models to identify enriched regions.264,265 This implementation worked 
very robustly in my hands and has some advantages that the authors discuss: By modeling both 
foreground (enriched or signal) and background (non-enriched or noise) regions simultaneously, 
high sensitivities can be reached even with weak enrichment. Further, the count-based modeling 
reflects very well the additional uncertainty for shallow coverages of genomic regions. Last, the 
underlying model allows simultaneous fitting of more than 2 models to reflect chromatin states 
with different levels of enrichment in a ChIP-target or to determine differential enrichment 
between 2 ChIP-seq experiments. There are however additional interesting features that I 
noticed, which are not implemented in the normR package, but which are, in principle, supported 
by the underlying mathematics: First, unlike the normR implementation, genomic regions 
analyzed for enrichment do not have to be of fixed width but are flexible. While normR suggests 
500 bp bins, the binomial model can also be applied to gene-level data. This is justified as long as 
the tracks for input and ChIP are similarly smooth across the whole region as they are across small 
bins, which is to say that the true ChIP signal is not localized to small peaks within the larger 
region of interest and therefore much of the region is in fact actually be background. Such 
uniform coverage is highly likely for H3K27me3 (also see Figure 10) and may, in fact, be valid for 
further histone marks. The second interesting property of binomial EM is that the model which is 
implemented in normR as a single dimension model or, in other words, requires exactly 1 ChIP 
and 1 input data set, can be extended to more dimensions. Such a multidimensional binomial 
expectation-maximization algorithm can be used to fit background and foreground components 
simultaneous across two or more replicates of a ChIP. In this case, each dimension or pair of ChIP 
and input is connected to the other replicates by the assignment to a component like background 
or foreground, while the parameters (or binomial probabilities) of the distributions in that 
dimensions may differ between different ChIPs. This approach is interesting, because ChIP 
replicates may produce different enrichments of signal to noise simply because of technical 
differences resulting for example from differences in the washing during the Immuno-
precipitation. These differences would be measurable, but not biologically relevant. Therefore, 
building a model that captures this information is interesting to improve on the classic approach 
to handle replicates, which is to merge samples for peak calling (which might bias the results to 
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more strongly consider 1 replicate over the other) or to call peaks separately and identify 
overlapping enriched regions (which might strongly underestimate the likelihood of enrichment). 
I, therefore, decided to rebuild the binomial expectation maximization (EM) algorithm 
implemented in normR from the ground up to implement the possibility to hand over both, 
manually selected bins and to use any number of replicates when desired.  In order to 
demonstrate the modifications made to the EM algorithm here, I first want to recapitulate the 
general math for the one dimensional (one sample pair) case. Figure 11 demonstrates the 
binomial model in the simplest case: Just one pair of input and ChIP, to which exactly one 
background (noise) and one enriched (signal) component should be fitted. In this case, after 
splitting the genome into bins using the desired method (fixed width, genes, etc.) the reads from 
ChIP and Input are counted in that region and throw them in an “urn” to draw from. Such a 
drawing process follows a binomial distribution: 
p(𝑠𝑖 , 𝑟𝑖|𝜃𝑗) =  (
𝑠𝑖 + 𝑟𝑖
𝑠𝑖
) 𝜃𝑗
𝑠𝑖 (1 − 𝜃𝑗 )
𝑟𝑖  (1) 
With 𝑖 = 1, … , 𝑁 the number of bins chosen, 𝑠𝑖 and 𝑟𝑖   the number of reads in the i-th ChIP or 
input bin respectively, and 𝜃𝑗 the probability of “drawing” a ChIP read. In the simple two-
component model j can be 1 (background) or 2 (enriched) and 𝜃𝑗  is the same for every bin in the 
genome which belongs to component j. Here, therefore exactly 2 types of urns exist to draw reads 
from. However, the information whether a genomic region or bin is truly enriched is hidden and 
figuring out the assignment to the background or enriched “urn” is exactly the purpose of ChIP-
seq peak calling. 
Therefore, we must find a way to determine what is a good combination of estimates for both 
the binomial probabilities j and the assignments of the bins. For ease of notation, I will call the 
true (unknown) assignment of the i-th bin to a component 𝑧𝑖 ,𝑗 , which is 1 if the i-th bin is in 
component j and else 0. Then the likelihood function can be derived from the binomial probability 
(1)  
ℒ(𝑠𝑖 , 𝑟𝑖|𝜃𝑗 , 𝑧𝑖 ,𝑗 , 𝜋𝑗) =  ∏ ∏ [(
𝑠𝑖 + 𝑟𝑖
𝑠𝑖
) 𝜃𝑗
𝑠𝑖 (1 − 𝜃𝑗 )
𝑟𝑖 𝜋𝑗 ]
𝑧𝑖,𝑗
𝑚
𝑗
𝑁
𝑖
 (2) 
where 𝜋𝑗  is the fraction of bins belonging to component 𝑗  and 𝑗 = 1, … , 𝑚  the number of 
components (or different urns) used. Now a model can be found that contains the unknown 
parameters 𝜃𝑗 , 𝑧𝑖,𝑗  and 𝜋𝑗  such that it maximizes the likelihood function (2). This approach is also 
called maximum likelihood estimation and is useful, because it finds the best possible model, 
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given the mathematical assumptions, that explains the observed data. However, given the large 
number of unobserved variables 𝑧𝑖,𝑗  the likelihood function cannot be maximized directly. 
 
 
Figure 11: An urn model can be used to represent ChIP-seq enrichment. General representation of how 
the binomial model works for ChIP-seq. The reads are counted in bins (separated by white lines) for both 
the Input track (black, r) and the ChIP track (red, s). The resulting read counts of both samples can be 
considered as resulting from draws from an urn. Enriched regions have a higher ratio of red “balls” (reads) 
to black “balls” (reads) than background regions, which results in a higher probability of drawing ChIP reads 
from the enriched region “urn”.  
 
This is where the EM approach steps in. First, the likelihood function is log-transformed (2). 
Because the logarithm is a monotonically increasing function, any maximum on the log-
likelihood function is also a maximum of the likelihood function. For the log-likelihood, we find 
the simpler equation 
ℓ(𝑠𝑖 , 𝑟𝑖|𝜃𝑗 , 𝑧𝑖,𝑗 , 𝜋𝑗)  = log ∏ ∏ [(
𝑠𝑖 + 𝑟𝑖
𝑠𝑖
) 𝜃𝑗
𝑠𝑖 (1 − 𝜃𝑗 )
𝑟𝑖 𝜋𝑗 ]
𝑧𝑖,𝑗
𝑚
𝑗
𝑁
𝑖
= ∑ ∑ 𝑧𝑖,𝑗
𝑚
𝑗
𝑁
𝑖
 [log (
𝑠𝑖 + 𝑟𝑖
𝑠𝑖
) +  𝑠𝑖 log 𝜃𝑗 +  𝑟𝑖 log(1 − 𝜃𝑗 ) + log 𝜋𝑗 ] 
(3) 
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For the expectation-maximization algorithm 𝑧𝑖,𝑗  is replaced by the expected value for 𝑧𝑖,𝑗  
𝐸[𝑧𝑖,𝑗 |𝑠𝑖 , 𝑟𝑖 , 𝜃𝑗 , 𝜋𝑗 ] =  𝐸𝑖,𝑗, which results in the expected value of the likelihood function given the 
current set of parameters: 
J(ϑ|ϑ(𝑡)) = ∑  𝑞(𝑧|𝑥, 𝜃) log 𝑝(𝑥, 𝑧|𝜃)
𝑧
= 
=  ∑ ∑ 𝐸𝑖,𝑗
𝑚
𝑗
𝑁
𝑖
[𝑙𝑜𝑔 ((
𝑠𝑖 + 𝑟𝑖
𝑠𝑖
)) +  𝑠𝑖  𝑙𝑜𝑔(𝜃𝑗 ) +  𝑟𝑖  𝑙𝑜𝑔((1 − 𝜃𝑗 )) +  𝑙𝑜𝑔(𝜋𝑗 )] 
(4) 
Now the EM algorithm optimizes the likelihood as follows: The model is initialized with a random 
selection of 𝜃𝑗  and 𝜋𝑗  from the space of possible parameters. Then, the function is iteratively 
optimized by performing 
E-step: 𝐸𝑖,𝑗 = 𝑝(𝑧𝑖,𝑗|𝑠𝑖 , 𝑟𝑖 , 𝜃𝑗 , 𝜋𝑗) for each 𝑖 
M-step: Set 𝜃𝑗 =  arg max𝜃𝑗
J(ϑ|ϑ(𝑡)) for each 𝑗 
This process is continued iteratively until the change in the expected value of the likelihood 
function (4) drops below a chosen threshold. As such the EM algorithm can be considered a 
gradient ascend in which we iteratively maximize J with respect to 𝐸𝑖,𝑗  and to the parameters 𝜃𝑗  
and 𝜋𝑗 . Others have demonstrated that such iterative accent at least converges to a local 
stationary point in J , such a point can however also be a saddle point or, rarely, a local 
minimum.266,267 Most often, however, for well-behaved likelihood functions this will find at least 
a local maximum.267 In order to maximize the chances of finding a global maximum, the EM-
algorithm can impute a set of estimates several times from a different set of randomly chosen 
starting parameters. When these converged to their local maxima, the results which had the 
highest likelihood can be chosen ((2) or (3)) as the best model to explain the data. 
Therefore, in the t-th iteration of the algorithm, we calculate the E-step with fixed 𝜃𝑗  and 𝜋𝑗: 
𝐸𝑖,𝑗
(𝑡)
=  
𝜃𝑗
𝑠𝑖 (1 − 𝜃𝑗 )
𝑟𝑖 𝜋𝑗
∑ 𝜃𝑘
𝑠𝑖 (1 − 𝜃𝑘 )𝑟𝑖 𝜋𝑘
𝑚
𝑘
=  
𝛼𝑖,𝑗
∑ 𝛼𝑖,𝑘
𝑚
𝑘
 
 
(5) 
and then maximize the parameter 𝜃𝑘
(𝑡)
 while keeping the 𝐸𝑖,𝑗  fixed in the M-step: 
∂J(ϑ|ϑ(𝑡))
∂𝜃𝑘
=  ∑ 𝐸𝑖,𝑘 [ 
𝑠𝑖
𝜃𝑘
+  
𝑟𝑖
(1 − 𝜃𝑘 )
]
𝑁
𝑖
 (6) 
Which solves to 
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𝜃𝑘
(𝑡)
=  
∑ 𝐸𝑖,𝑗 𝑠𝑖
𝑁
𝑖
∑ 𝐸𝑖,𝑗 (𝑠𝑖
𝑁
𝑖 +  𝑟𝑖 )
 
 
(7) 
In a similar fashion, we can optimize for 𝜋𝑗: 
𝜋𝑘
(𝑡)
=  
∑ 𝐸𝑖,𝑗
𝑁
𝑖
∑ ∑ 𝐸𝑖,𝑗
𝑚
𝑗
𝑁
𝑖
=  
∑ 𝐸𝑖,𝑗
𝑁
𝑖
𝑁
 (8) 
This is the algorithm as it is implemented in normR.264 When reimplemented in this fashion, it can 
address the first point made above: By applying it to non-fixed-width genomic intervals enriched 
genes can directly be identified, always under the assumption that the resulting ratio of ChIP and 
input reads still follow a binomial distribution. But the second objective has not yet been 
addressed: I want to transform the likelihood function in such a way, that multiple pairs of ChIP 
and input can be used for model building at once, ideally without being computationally too 
intensive.  
Previously in (1), natural numbers were used in the binomial probabilities for the number of reads 
from ChIP 𝑠  and the number of reads from input 𝑟. Now in the modified binomial probability 
function for the larger number of ChIP input pairs that there are 𝑑 of such pairs (I will call them 𝑑 
dimensions). For the i-th genomic bin the numbers  𝑠𝑖  and 𝑟𝑖  can then be transformed into 
vectors 𝒔𝑖 and 𝒓𝑖 such that 𝒔𝑖 , 𝒓𝑖  ∈  ℕ
𝑑  and the probabilities 𝜃𝑗  into vectors 𝜽𝑗  ∈  ℝ
𝑑. We can 
then find: 
p(𝒔𝑖 , 𝒓𝑖|𝜽𝑗) =  ∏ (
𝑠𝑖,𝑙 + 𝑟𝑖,𝑙
𝑠𝑖,𝑙
)𝜃𝑗,𝑙
𝑠𝑖,𝑙 (1 − 𝜃𝑗,𝑙 )
𝑟𝑖,𝑙
𝑑
𝑙
 (9) 
with 𝑙 = 1, … , 𝑑 being the individual dimensions or pairs of samples. Such a probability function 
is still well normalized since for any vector 𝐜 ∈ ℕ𝑑  it is true that for the sum over all tuples of 𝒔, 𝒓 
such that 𝒔 + 𝒓 = 𝒄 
∑ p(𝒔, 𝒓|𝜽)
(𝒔,𝒓)∶ 𝒔+𝒓=𝒄
=  1 (10) 
Therefore, the earlier likelihood function (2) can be modified by accounting for the multi-
dimensional case: 
ℒ(𝒔𝑖 , 𝒓𝑖|𝜽𝑗 , 𝑧𝑗 , 𝜋𝑗) =  ∏ ∏ ∏ [(
𝑠𝑖,𝑙 + 𝑟𝑖 ,𝑙
𝑠𝑖,𝑙
) 𝜃𝑗,𝑙
𝑠𝑖,𝑙 (1 − 𝜃𝑗,𝑙 )
𝑟𝑖,𝑙 𝜋𝑗]
𝑧𝑖,𝑗𝑑
𝑙
𝑚
𝑗
𝑁
𝑖
 (11) 
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One could apply the brute force approach of finding solutions to every parameter by adding the 
additional index 𝑙, but this makes computation inefficient for higher-dimensional cases. Here, 
some matrix notation can help save a lot of time. By using the representations: 
𝑹, 𝑺 ∈  ℕ𝑁𝑥𝑑 =  [
𝑠1,1 ⋯ 𝑠1,𝑑
⋮ ⋱ ⋮
𝑠𝑁,1 ⋯ 𝑠𝑁,𝑑
] ,   𝚯 ∈  ℝ𝑑𝑥𝑚 =  [
𝜃1,1 ⋯ 𝜃1,𝑚
⋮ ⋱ ⋮
𝜃𝑑,1 ⋯ 𝜃𝑑 ,𝑚
] , 
𝐄 ∈  ℝ𝑁𝑥𝑚 =  [
𝐸1,1 ⋯ 𝐸1,𝑚
⋮ ⋱ ⋮
𝐸𝑁,1 ⋯ 𝐸𝑁,𝑚
] ,      𝚷 ∈  ℝ𝑁𝑥𝑚 =  [
𝜋1 ⋯ 𝜋𝑚
⋮ ⋱ ⋮
𝜋1 ⋯ 𝜋𝑚
] 
we can find the following simplifications. For the E-step we use 
log 𝚨 = (log 𝛼𝑖,𝑗 ) =  𝑺 × log 𝚯 + 𝑹 × log(𝐉 − 𝚯) + log 𝚷 (12) 
with the 𝐉 being the matrix of ones. From there we adapt from (5): 
𝐸𝑖,𝑗
(𝑡)
=  
𝛼𝑖 ,𝑗
∑ 𝛼𝑖 ,𝑘
𝑚
𝑘
  
We then turn to the M-step. The calculation of  𝜋𝑗  is described in (8) and requires no 
modifications, since the number of dimensions 𝑑  does not apply to this parameter. For the 
binomial probabilities 𝜃𝑗,𝑙  we calculate 
log 𝚯 = (log 𝜃𝑗,𝑙 ) = log(𝑺 × 𝑬
𝑇 )  −  log((𝑺 + 𝑹)  ×  𝑬𝑇)  (13) 
Using formulas (12) and (5) for the E-step and formulas (8) and (13) for the M-step, the EM-
algorithm can then be applied to find the maximum likelihood estimators (MLEs) of the binomial 
probabilities 𝜃𝑗,𝑙  as well as the probabilities 𝐸𝑖,𝑗  with which each genomic region 𝑖 belongs to a 
component 𝑗. Consequently, I implemented this multidimensional binomial EM as an R function 
(see source code in Code Snippet 1). It can be used by calling the function 
BinomEMwrapperParallel from EMcalc.R using the parameters N, which is the matrix of the total 
number of reads in each bin 𝑵 = 𝑹 + 𝑺 ∈  ℕ𝑁𝑥𝑑 , S, which is the number of reads in the ChIP 
sample 𝑺 ∈  ℕ𝑁𝑥𝑑 , and k, which is the number of components 𝑚  which I will later also call 
clusters or states. Further, the number of attempted imputations can be specified (it defaults to 
10), that is, how many random starting parameters should be tried for the optimization. I found 
that most starting parameters will arrive at the same MLEs, but on highly complex samples that 
could contain a larger number of local maxima, it might be useful to increase this further. 
Additionally, the tolerance can be specified, which will determine at what change of likelihood 
between iteration steps the algorithm will consider the estimates to have converged. A 
maximum number of iterations was also implemented, which serves as an escape, should the 
Results 
 
 55 
algorithm ever diverge, though I have never observed this. Last, to increase speed, the function 
was made multithreading capable. The multithreading, in this case, is simply implemented by 
running each imputation as a separate thread, which means that for ideal performance the 
number of threads should be adjusted to the number of imputations to be tried. 
Each imputation starts by randomly sampling 𝚯 =  𝜃𝑗,𝑙  𝜖 [0,1] and 𝜋𝑗  𝜖 [0,1]. Then the iterative 
improvement of the parameters starts: First, in the E-step, the expectations are calculated 
according to formulas (12) and (5), then in the M-step the maximum likelihood estimator of the 
parameters 𝜃𝑗,𝑙  and 𝜋𝑗  are calculated according to (8) and (13). Now the improvement in the log 
likelihood (see (11)) needs to be calculated to determine if the model has converged. Because the 
log-likelihood is essentially  
log ℒ(𝒔𝑖 , 𝒓𝑖|𝜽𝑗 , 𝑧𝑗 , 𝜋𝑗) =  ∑ log 𝛼𝑖 ,𝑗
𝑖,𝑗
+ 𝑑 ∑ log (
𝑠𝑖,𝑙 + 𝑟𝑖 ,𝑙
𝑠𝑖,𝑙
)
𝑖 ,𝑙
  (14) 
the difference in log-likelihood between iterations t and t+1 are easily found by 
∆𝑡,𝑡+1 log ℒ(𝒔𝑖 , 𝒓𝑖|𝜽𝑗 , 𝑧𝑗 , 𝜋𝑗) =  ∑ log 𝛼𝑖,𝑗
𝑡+1
𝑖,𝑗
−  ∑ log 𝛼𝑖,𝑗
𝑡
𝑖,𝑗
 (15) 
which can be derived from (12). Once that difference is smaller than the set threshold the model 
is considered converged and saved. 
After all imputations are done all resulting models are compared for their log-likelihood and the 
model with the largest likelihood is chosen as the best model to explain the data. Last, each of 
the bins on which ChIP and input reads were counted is assigned to one of the components 𝑗 by 
choosing that component with the highest expectation in the final best model. The function then 
returns this assignment, along with all other model parameters like the final parameters 𝜃𝑗,𝑙  and 
𝜋𝑗, and the expectations 𝐸𝑖,𝑗. 
The EM algorithm described here, therefore, improves on the algorithm implemented in the 
normR264 package in several ways. First, I can apply it to any count data from genomic bins, both 
using a selection of genomic bins and using bins of different widths. This would have been 
possible with the normR package too but would have required the calling of private functions that 
are not meant to be called by the user. More importantly, however, the model is expanded to 
work with any number of ChIP and input pairs. This can, for example, be used to more accurately 
call p-values when using ChIPs with replicates. If 𝜃𝐵  is the binomial probability of a background 
(or noise) component in the normR264 package, they suggest to calculate the p-value for the null 
hypothesis that the bin 𝑖 derives from the background component as  
𝑝 =  ∑ (
z + 𝑟𝑖
z
) 𝜃𝐵
z(1 − 𝜃𝐵 )
𝑟𝑖
𝑠𝑖+𝑟𝑖
𝑧>𝑠𝑖
 (16) 
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Helmuth, et al. 264 suggest to handle replicates by simply summing the counts for input and ChIP, 
but this will lose a lot of information contained in the replication and therefore misrepresent the 
p-value. In contrast, with my implementation the p-value can instead be calculated by fitting 
multidimensional models and finding: 
𝑝 =  ∑ ∏ (
𝑠𝑖,𝑙 + 𝑟𝑖 ,𝑙
𝑠𝑖,𝑙
)𝜃𝑗,𝑙
𝑠𝑖,𝑙 (1 − 𝜃𝑗,𝑙 )
𝑟𝑖,𝑙
𝑑
𝑙
𝑠𝑖+𝑟𝑖
𝑧𝑙>𝑠𝑖,𝑙
 (17) 
using the vector forms of 𝒔𝒊 and 𝒓𝒊 and summing over all 𝒛 such that every 𝒛𝒍 is larger than 𝒔𝒊,𝒍.  
The EM model can however also be used for other purposes than calculating more accurate p -
values: It can be used with a set of different ChIPs on different targets, thereby finding categories 
of bins with co-varying binomial probabilities. 
In summary, I modified existing methods to fit binomial mixture models through an expectation-
maximization algorithm, such that it can be used to handle replication. This algorithm can also 
be used to fit models to larger ChIP-seq data collections to predict principle chromatin states. 
 
5.2.3 HISTONE PTM CHROMATIN STATE MODELS BY EM 
To verify the functionality of my newly implemented algorithm I applied it to the ChIP data I 
generated from Drosophila plasmatocytes. First, I showed that the algorithm can identify 
different types of H3K27me3 enrichment on genes. Because H3K27me3 is distributed almost 
evenly across genes both in the active and silenced gene subgroups (Figure 10) I can use each 
gene span as a region of interest and count the total number reads from both ChIP and input 
replicates overlapping with each of these gene regions. I can then use those counts in the EM 
model and call different components or clusters. Initially, I set the number of EM clusters to 3 
since that well explained the distribution of signal shown in Figure 7, where there are 3 types: 
H3K27me3 low genes which are transcribed, H3K27me3 medium genes which are non-
transcribed and H3K27me3 high state genes which are non-transcribed developmental genes. 
The EM algorithm then processed the number of ChIP and input reads and grouped the genes 
into 3 different components based on their probability to derive from the fitted binomial 
distributions.  
To better visualize the results, I will first introduce one definition I will use throughout my thesis: 
I here define the enrichment for each gene as the expected value of the binomial probability for 
gene 𝑖: 
𝐸𝑛𝑟𝑖𝑐ℎ𝑚𝑒𝑛𝑡(𝑔𝑒𝑛𝑒𝑖 ) =  
𝑠𝑖
𝑠𝑖 + 𝑟𝑖
=  
# 𝑟𝑒𝑎𝑑𝑠 𝑖𝑛 𝐶ℎ𝐼𝑃 𝑎𝑡 𝑔𝑒𝑛𝑒𝑖
# 𝑟𝑒𝑎𝑑𝑠 𝑖𝑛 𝐶ℎ𝐼𝑃 𝑎𝑛𝑑 𝑖𝑛𝑝𝑢𝑡 𝑎𝑡 𝑔𝑒𝑛𝑒𝑖
 
 
(18) 
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where the number of reads is normalized to the total number of reads generated from the 
respective library. This definition of enrichment slightly differs from the usual definition of 
enrichment which is the log ration of ChIP over input, but has some advantages: First, it works 
well even when a library was only sequenced shallow, such that a number of bins have zero reads 
overlapping with them. When using the log-ratio, if either input or ChIP is zero over a bin, the log 
ratio cannot be calculated correctly for that bin. Therefore, when using log ratios, pseudo-counts 
often have to be added to prevent zero values. With my definition of enrichment, this is only a 
problem if both ChIP and input are zero (in which case the analysis of that bin likely makes no 
sense). Second, my definition of enrichment works very well with the concept of binomial 
models, because the value I find is also the maximum likelihood estimator for the binomial 
probability of that isolated genomic region. Last, the profiles generated by calculating 
enrichment as in (18) are overall similar and it will for any non-zero pair of input and ChIP reads 
produce the same rank of a bin as the log ration method. 
 
𝑠1
𝑠1 +  𝑟1
>
𝑠2
𝑠2 + 𝑟2
 ⇒  
𝑠1
𝑟1
>
𝑠2
𝑟2
 
 
(19) 
Further, there are some interesting properties in this way of calculating the enrichment, as it is 
always between 0 and 1, and 0 will mean exactly no reads in the ChIP sample, while 1 will mean 
no reads in the input. Because of these advantages, I will use (18) throughout my thesis to 
calculate enrichment. 
After applying the EM algorithm to the H3K27me3 data I plotted the enrichment of the two 
replicates of H3K27me3 ChIP-seq I performed from Drosophila plasmatocytes, normalized over 
the matching input sample (Figure 12). In the scatter plot, each dot represents a single gene with 
its corresponding enrichment in each replicate. Using this analysis, the two samples correlate 
very well on a gene level (r = 0.988, p-value < 2.2e-16), similar to what I observed previously when 
applying 10 kb bins for sample correlation (Figure 8).  
Above the scatter plot there is a histogram of the binned frequencies that were observed in 
replicate A, and the histogram is, therefore, a projection of the data from the scatterplot. Each 
gene was colored according to the component it was assigned to by the EM algorithm, and I will 
refer to these components as states. This new EM-based method of clustering worked well, as is 
apparent by the distinct regions into which all genes of a state fall. From the histogram, it is clear 
that the 2 peaks that can be observed in the enrichment plot are each covered by a different st ate, 
where the low state (green) covers the genes with the lowest levels of H3K27me3, while the 
medium state (orange) coverers H3K27me3 intermediate genes. Further, the genes that are in-
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between these peaks are split around the middle, such that genes below this (soft) threshold are 
assigned to the low state, while genes with higher enrichment belong to the medium state. The 
high state (purple) marks the genes with very high H3K27me3 levels, which represent only a 
minor population among all genes. 
 
 
Figure 12: Gene level H3K27me3 EM-clustering produces three distinct gene states. Gene level read 
counts of H3K27me3 ChIP-seq samples and corresponding input samples were clustered into 3 groups 
using a binomial EM-clustering. Enrichment (ChIP / ChIP + Input) was calculated for each replicate ChIP 
input pair. Lower panel shows the correlation of this gene-level enrichment between the two replicates 
and each dot is a gene. Genes were colored by their EM-state. The top panel is a projection of replicate A 
into a histogram. 
 
So, what does this state assignment mean in biological terms for the respective genes? The low 
state with its very low H3K27me3 signal is well explained by the absence of H3K27me3 from 
actively transcribed genes. The H3K27me3 high state predominantly contains developmental 
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genes, like the Hox genes and e.g. eve, that I used as an example in Figure 7.  Therefore, the state 
seems likely to represent stably repressed genes, for which PcG proteins and strong PREs are 
instrumental.76,89,95 The remaining H3K27me3 medium state apparently defines non-expressed 
genes which are not targets of strong PREs but represent an intermediate case. The question 
remains though, if the targeting of these genes by PcG proteins and the placement of H3K27me3 
is functionally relevant at these genes, or if it is merely incidental. In short, EM clustering predicts 
a three-state model for H3K27me3 levels, which recapitulates the established Polycomb 
chromatin state and H3K27me3 low state, but also adds an H3K27me3 medium state, that is 
clearly distinct from the other two states. 
To investigate whether a combination of histone modifications helps to infer more about the 
different H3K27me3 states, I applied the algorithm to the complete data set of plasmatocyte 
ChIP-seq runs. In this case, given the much more diverse distribution of the signals for the 
different targets (see Figure 8 and Figure 10) than in H3K27me3 alone, using gene wide signals is 
no longer an option. Therefore, I instead divided the genome into 200 bp bins and counted the 
reads overlapping with each of these bins for each pair of ChIP replicate and its matching input. 
This generates tracks for 20 ChIPs, 2 replicates of each ChIP of RNA-PolII, H3K4me1, H3K4me3, 
H3K9ac, H3K9me3, H3K27me3, H3K27me2/me3, H3K27ac, H3K36me3, and H4K20me1. Further, 
because not all ChIPs were done at the same time, I have 8 different input samples, each 
belonging to a different set of ChIPs. This genome-wide fixed bin width data was then applied to 
the EM algorithm in much the same way as the gene level H3K27me3 data was before. In contrast 
to the gene level H3K27me3 analysis however, EM analysis on the whole set of marks generates 
clusters that are characterized simultaneously by the enrichment levels of multiple marks. 
Therefore, a clear ChIP background cluster might not appear. This is due to the disjoint , or non-
correlating presence, of histone marks: Where H3K27me3 is maximal, H3K36me3 is minimal 
(which is to say it is at its background level) and the other ways around. The clusters, therefore, 
are more likely to represent different chromatin states, each with a set of histone modifications, 
that are enriched over their background level, and others that are not enriched. Here, I tried 
several different component numbers, but settled on 7 clusters (later called states), because this 
number of states seemed to best explain the data. As others have mentioned55,69, there is no clear 
way to determine the optimal number of states to fit, and any choice must be to some degree 
arbitrary. 
First, I tested if the histone mark enrichments observed in the resulting 7 states argue for a 
chromatin state model. Consequently, I separated the bins according to their assignment by the 
EM algorithm and calculated the enrichment in each bin according to (18). I then formed the 
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mean of those enrichments from each bin first by the state to which they belong and then by the 
histone modification targeted in the immuno-precipitation. The resulting data were 
hierarchically clustered across columns and rows and plotted as a heatmap (Figure 13A). This 
heatmap shows a clear separation of the different histone marks. The left 3 states (states 3, 1 and 
5) are depleted of active marks (which are towards the top of the heatmap) but have increased 
levels of H3K27me3, H3K27me2/me3 and H3K9me3. These states are therefore likely to represent 
repressed chromatin states. The right 3 states (states 6, 4 and 7) on the other hand are strongly 
depleted in all repressive marks, but they are all enriched in at least one of the active histone 
modifications. State 2 in the middle appears to represent more of a transitory type of chromatin, 
though the comparably higher levels of active marks seem to indicate some type of active 
chromatin. 
By comparing each chromatin state to published data, the underlying biological terms can be 
identified. The rightmost state 7 is very strongly enriched in H3K4me3 and H3K9ac, but RNA 
polymerase II and H3K27ac are also high. It seems therefore likely that this state represents active 
TSS, where H3K4me3 enrichment has been well described.268 In state 4 many similar marks are 
characteristic, but instead of H3K4me3, I find a strong enrichment of H3K4me1. This suggests 
that these regions represent active enhancers.22 State 6 has a different pattern of enriched marks 
and here H3K36me3 is by far the most enriched, while RNA polymerase II is intermediately 
enriched. This is consistent with regions of transcript elongation on active genes.20 At the same 
time state 6 also has somewhat increased levels of H3K4me1 and H3K27ac which indicates the 
presence of some enhancers in the regions covered by this state. The intermediate state 2 is not 
strongly enriched in any one mark. I do however observe only low levels of H3K9me3 and 
H3K27me3, while H3K4me1 and RNA polymerase II are still above background levels. Therefore, 
it seems most likely that these are weakly bound enhancer regions, where both H3K4me122 and 
RNA PolII are present.256 The 3 repressive states cluster on the left. Among them, state 5 is 
strikingly high in H3K27me3 and H3K9me3, but not the highest in H3K27me2/me3. This likely 
indicates that in these regions all histone residues of H3K27 are fully methylated and no 
H3K27me2 is left. Such high levels of H3K27me3 would be expected from silenced developmental 
genes like eve (which I have shown in Figure 7) or the Hox genes. Therefore state 5 probably 
identifies those genomic regions which are most strongly targeted by PcG proteins.43 State 1, on 
the other hand, is also high in H3K9me3, but much lower in H3K27me3 and instead high in 
H3K27me2/me3. This high levels of H3K9me3 without the strong histone H3 lysine 27 
trimethylation indicates that this state represents structural heterochromatic regions like 
centromeres and telomeres or transposons.269 Last, in state 3 all repressive marks are present, 
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with a slight enrichment of both H3K27me3 and H3K27me2/me3 over H3K9me3. These genomic 
state therefore likely corresponds to the H3K27me3 intermediate state, which I previously 
identified on a gene level (Figure 12). It is also interesting, that the lower levels of H3K27me3 are 
not complemented by increased levels of H3K27me2/me3, which is highest in state 1. Therefore, 
this state is not one of high H3K27me2 with intermittent H3K27me3, but instead a H3K27me3 
positive chromatin state. Importantly, none of the active marks is any higher here than in the 
other 2 repressive state 1 and 5. This indicates that these chromatin regions do indeed represent 
repressive chromatin states and not mere intermediates between active and repressive states.  
The resulting states also vary greatly in their size (Figure 13B). Most of the 200 bp genomic bins 
appear to fall into state 3, while other states like state 7 or state 5 have far fewer elements. 
Perhaps this corroborates earlier observations from Figure 7 and Figure 10: Some of the marks 
like H3K4me3 are highly localized to only a very small parts of the genome (in the case of 
H3K4me3 only to TSS of active genes) while other marks like H3K9me3 or H3K27me2/me3 are 
broadly spread and can be found in many regions, both on silenced genes, on intergenic regions 
and on structural heterochromatin.  
 
Figure 13: Genome-wide EM-clustering produces a seven-state chromatin model. Genome-wide read 
counts were quantified in 200 bp bins for ChIP and input samples. A binomial EM-model was used to cluster 
the resulting counts into 7 different components (states). A: Average enrichment of different ChIP signals 
in each state of the EM model, where rows correspond to ChIP targets and columns to EM states. Rows 
and columns are sorted by hierarchical clustering. B: The fraction of 200 bp bin in each component (state) 
representing the percentage of the genome bins belonging to each chromatin state. 
 
Indeed, state 7, which is likely localized at TSS of active genes, accounts for the smallest fraction 
of the genome. The states for elongating transcription (state 6) and for enhancers (4 and 2) 
account for a larger part of the genome. State 1, which appears to be structural/constitutive 
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heterochromatin makes up only 14% of the genome, which is somewhat smaller than published 
data of total heterochromatin content in Drosophila.270,271 It is important to consider that short-
read sequencing approaches like Illumina sequencing are notoriously bad at covering these 
regions because of their repetitive nature, and the common reference assemblies are therefore 
missing much of the centromeric and telomeric regions.272  Interestingly, of the two H3K27me3 
targeted states, states 5 and 3, state 5 only covers a small fraction of the genome, which is 
consistent with it accounting for the relatively few key developmental genes strongly targeted 
by PcG proteins, while state 3 is by far the biggest of all states. Two factors might contribute to 
the spread of this state: First, I showed that the silencing marks are not localized exclusively to 
TSS, enhancers or gene body (Figure 7 and Figure 10) but spread across both genes and intergenic 
regions, and second, it appears that many genes fall in this intermediate category represented 
by state 3 (Figure 12). 
In summary, the chromatin states defined here corroborate the established roles that marks have 
and correlate well with published models. A clear distinction is that this new EM model defines 
an additional repressed state where previous models proposed only a single H3K27me3 positive 
state.  
 
 
Figure 14: Chromatin states separate by their function in PCA. ChIP-seq signal was processed into bins 
as in Figure 13 and states were determined by EM. The same bins were then subjected to PCA. A: The 
enrichment in bin level read counts were subjected to PCA and from this analysis points were randomly 
sampled to plot. The first 3 dimensions of the PCA are plotted, where each point represents a bin. Bins are 
colored according to the EM-cluster into which they fall. B: Percentage of variance explained by each 
component of the PCA from A. 
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In order to test for the robustness of my chromatin state model, I tested whether PCA, would 
allow similar state separation. I first calculated the enrichment according to (18) from the signal 
that was detected in each ChIP across all 200 bp bins and which was also used to build the EM 
model. The resulting data matrix, in which each column represents a genomic bin and the 
enrichments in the individual ChIP replicates represents the rows or features, was then used to 
calculate the PCA rotations. From the rotation matrix, in order to prevent overcrowding the plot 
with 687743 data points, I randomly sampled 3000 bins for the final PCA plot (Figure 14A). The 
individual bins which represent dots in the PCA were then colored according to the chromatin 
state to which they were assigned during EM clustering. By the separation of the colors I can show 
that these mathematically different approaches of reducing data complexity are well concordant 
in their separation of genomic bins. 
Along the principal component 1 (PC1), which by itself explains 53.5% of all the variance observed 
across the genomic bins, the active chromatin state (states 4, 6 and 7) to the right separate from 
the repressive states (states 1, 3 and 5) to the left. The state 2 which appeared intermediate in my 
earlier analysis is also in between the 2 groups here. Further, the states 4 and 7, which I proposed 
to be enhancers and TSS respectively, separate along the PC2 from the state 6, which are the 
H3K36me3 positive 3’ end of active genes. Among the later principal components, I find that PC3 
separates chromatin state 4 from the bulk of the other states. Interestingly chromatin state 2 
slightly co-varies along PC3 with state 4, which is concordant with my previous hypothesis that 
state 2 represents a slightly less active type of enhancer chromatin. The last component that 
yields any separation of states is component 4, which slightly separates EM state 7 from the other 
state. Together these four components account for 79.4% of the variance (Figure 14B). 
Interestingly the repressive states 1, 3 and 5 do not separate well along either of the principal 
components and in the PCA the transition between their locations is fluent. It is not clear, 
whether this represents true biology (it is possible that these chromatin states are facets of a 
continuum), or if the large discrepancy in active marks (7 in total) and repressive marks (3 
different histone modifications) are responsible for the poor performance of the PCA in the 
separation in repressive states.  In summary, the PCA supports the EM-based chromatin state 
model by demonstrating that principal components can separate the predicted chromatin states 
in an unbiased fashion. 
To characterize how genes associate with chromatin states I counted genes by their overlap with 
the 7 chromatin states from the EM model. Genes were classified as being in a given chromatin 
state if any of its exons had any overlap with a chromatin state. Using this definition I do expect 
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genes to overlap with several chromatin states: Given for example that chromatin state 7 should 
be at the TSS of active gene and state 6 at 3’ ends of active genes, I expect most active genes 
contain both of these states at once. The overlap of genes with states is quantified in Figure 15. 
 
 
Figure 15: Chromatin states are distinct in their relative gene content. All genes from genome assembly 
dm6.91 were checked for overlap with chromatin state states of bins from the binomial EM model. Any 
overlap of 1 or more bp caused the gene to count towards overlapping with that state. A: Absolute number 
of genes overlapping with each state. B: Fraction of bins in a state that overlap with a gene. 
 
This overlap of genes and states (Figure 15A) only partially reflects what may be expected based 
on previous chromatin state models. Chromatin states 6 and 7, which should overlap with the 3’ 
exons and 1st exon of active genes respectively, are indeed associated with a large number of 
genes. At the same time, state 2 and 4, which appear to represent enhancers, also seem to 
overlap with exons, but a lower number of them. Compared to previous reports it also seems 
surprising, that state 1 should overlap with so many genes since it represents heterochromatin, 
which is supposed to be gene-poor.273 In fact, here it appears that state 1 (heterochromatin) 
overlaps with more genes than state 5 (Polycomb chromatin), even though the latter’s primary 
function is gene silencing. To solve these discrepancies, I calculated gene density, which I define 
as the fraction of all bins in a chromatin state that overlap with any exon by at least 1 bp ( Figure 
15B). Based on gene density the chromatin states fit much better with the published data.  States 
6 and 7 are very gene (exon) dense, while state 1 is by far the least gene dense of the chromatin 
states. Further, chromatin states 3 and 5 are similarly low in gene density, likely because 
repressive chromatin marks like H3K27me3 spreads also to intergenic regions, unlike active 
marks in chromatin states 6 and 7. In addition, it has to be taken into account that intros are not 
counted towards this gene density, which likely affects chromatin state 5: many Hox genes are 
very rich in long introns, a feature which is otherwise uncommon in Drosophila, in which most 
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genes only have short or no introns.274 Chromatin state 3, which was not previously identified in 
chromatin state models, is of particular interest with regard to gene density. This state is low in 
gene density, but it also covers a large part of the genome (Figure 13). It, therefore, overlaps with 
more than 8000 genes. The results from RNA-seq of plasmatocytes showed that about 9300 
genes were not detectable at a level useful for statistical inference, which means that the number 
of genes in the repressive state 3 is by no means excessive. Only a small fraction of the non-
transcribed genes from plasmatocytes are known to be PRE based PcG targets275,276, which 
should fall into state 5, and the remainder of silent genes must, therefore, fall into another 
repressive chromatin state. This also matches my observations on the H3K27me3 gene states, 
where many genes appear to be in the H3K27me3 intermediate category (Figure 12, medium 
state). Together, gene density across different chromatin states reflects observations for the 
prior description of the states. Importantly, the novel H3K27me3 intermediate chromatin state 3 
has similar gene density to the H3K27me3 high chromatin state 5 but covers a far larger number 
of genes. 
 
 
Figure 16: Repressive chromatin state overlap in a fraction of genes. A: Gene overlap of genes with 
chromatin state based on gene expression. Genes overlap was determined as in Figure 15A. Then RNA-seq 
expression levels were determined and any gene which is not at least covered by 1 read per million in any 
4 samples in the RNA-seq is called RNA-seq low. B: Venn diagram of genes overlapping with either of the 
repressive states 1, 3 or 5. Genes overlaps are determined as in Figure 15. 
 
Subsequently, I tested whether the overlap of a given gene with a distinct chromat in state is a 
good predictor of its transcriptional activity. Accordingly, I compared the EM clustering results to 
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the RNA-seq data from unchallenged plasmatocytes (Chapter 5.1.3). I, therefore, separated the 
genes scored in Figure 15A by their RNA seq read counts as, ‘high’ in RNA-seq counts if it had at 
least 1 read mapped to it per 1 million sequenced reads, and ‘low’ if it had less than that ( Figure 
16A). All 3 repressive states state 1, 3 and 5 overlap with a large number of low read count genes 
and only a small number of high read count genes. At the same time the active chromatin states 
4, 6 and 7 show the reverse and overlap predominantly with high read count genes. State 2 is 
intermediate, overlapping to about the same extent with high and low read count genes. 
Additionally, the number of low read count genes, even when only considering the repressive 
states 1, 3 and 5, exceeds the total number of inactive genes of 9294. When summing up the 
number of genes from the RNA-seq low group from states 1, 3 and 5 I find that they add up to 
10504 genes. However, as mentioned before, genes can overlap with several states. Therefore, 
when investigating the role of the individual chromatin states in gene repression, it is important 
to be aware of this non-unique assignment. To visualize the overlap in the assignment of genes 
to chromatin states, I generated a Venn diagram of all genes that overlap with any of the 
repressive chromatin states 1, 3 or 5 (Figure 16B). Clearly, most genes that overlap with states 1 
or 5 also overlap with state 3. Perhaps, this demonstrates that state 3 is to some extent a default 
state of repression, which is therefore found in inactive genes everywhere, even if those genes 
are additionally targeted by mechanisms that establish the other repressive states 1 or 5. In short, 
chromatin states 1, 3 and 5 are all repressive chromatin states, but their association with genes is 
not mutually exclusive. 
To visualize the local chromatin state distribution I reproduced the profiles of the eve locus 
(Figure 7) but annotated the assignment of individual bins from the EM-model (Figure 17A). The 
chromatin state 5 (lime green) does indeed span the whole eve locus, as I predicted from the 
enrichment of H3K27me3. Around the locus, there are active genes, which have distinct 
chromatin states at the TSS (state 7, brown), enhancers (marked by H3K4me1, state 4, magenta) 
and the 3’ gene body (state 6, yellow). To the right of the eve locus Pka-R2 is marked as belonging 
to chromatin state 3, which is well reflected by the presence of intermediate H3K27me3 levels as 
well as the absence of almost all active histone marks (except perhaps two small peaks of 
H3K4me1).  
Results 
 
 67 
 
Figure 17: Chromatin states distribute across genes concordantly with the marks enriched in them. A: 
Genome profiles were produced as in Figure 7, but an additional track for the EM-clusters was added 
between polyA RNA and Gene annotation. B: Frequency of chromatin states relative to TSS. For all TSS 
the state assignment of the adjacent 10 bins upstream and downstream (= 2000 bp upstream and 
downstream) was determined and plotted as relative frequency over the number of total TSS. 
 
This representation is however only a snapshot from a small genomic region. Therefore, I 
determined genome-wide the frequency of individual chromatin state assignments within the 21 
adjacent bins centered around the TSS assignments (Figure 17B). The results show that also 
genome-wide the chromatin state assignments reflect the topology of active and repressed 
genes, with a pattern similar to the relative frequencies of ChIP targets around gene 
transcriptional start sites (Figure 10). Among the states that I determined to relate to active 
chromatin, state 7 has a major peak right after the TSS, with a minor peak slightly 5’ of it, 
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consistent with the high levels of H3K4me3 in that state (Figure 10). State 6, on the other hand, 
is enriched further downstream of the TSS, reflecting the tendency of H3K36me3 to be enriched 
on 3’ ends of genes. State 6 is also enriched far upstream of the TSS, but this is likely to reflect 
signal deriving from adjacent genes.  
Particularly interesting is the distribution of states 2 and 4, both of which I assumed to be 
enhancer chromatin states. These states seem to be most frequent directly 5’ to the TSS, which 
is marginally different from the position of H3K4me1 I described earlier (Figure 10) and perhaps 
more closely resembles the location of a mixture of RNA polymerase II and H3K4me1. This 
proximity to the TSS possibly reflects a mixture of promoter and enhancer chromatin states close 
to the TSS others have reported.277  
The repressive states of states 1, 3 and 5, on the other hand, show very little preference with 
regard to their distribution and are almost constant in their frequency around the TSS with only 
a slight decrease directly at the TSS. This is very similar to the distribution of repressive marks 
that I described earlier (Figure 10). In the mean frequency of all repressive states across all bins 
around the TSS repressive state 3 is much more frequent than the state 1 or 5, but this reflects 
the overall abundance of these states (Figure 13). Together, this shows that the distribution of 
chromatin states reflects the distribution of histone marks which they are enriched for. 
In summary, using the binomial expectation-maximization algorithm, I implemented a novel 
approach to define chromatin states. After validating this algorithm based on published 
observations I conclude that the EM-based chromatin state model works comparably well to prior 
HMM-based models55,69 while producing a mathematical model that is based on count based 
probability distributions found in ChIP-seq. Using this new approach, I was able to identify a 
previously not characterized repressive chromatin state, identified by the repressive of 
H3K27me3 at levels below those observed for developmentally regulated and stably repressed 
PcG chromatin. I reproduced this observation using a gene-based EM clustering approach, which 
further supports that two distinct H3K27me3 dominated chromatin states exist in Drosophila 
plasmatocytes. From here on, I will call the states derived from the 3 state gene-level H3K27me3 
model H3K27me3 high, medium and low states and the 7 states from the combined ChIP-seq data 
chromatin states 1-7. 
 
5.2.4 PLASMATOCYTE CHROMATIN STATES AND INFECTION REGULATED GENES 
After determining both, a set of immune regulated genes and chromatin states in plasmatocytes, 
I tested which chromatin landscape is characteristic for inactive but still inducible genes. 
Therefore, I used the gene classifications based on the overlap with chromatin states (Figure 15) 
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and on the H3K27me3 gene state (Figure 12) and then applied them to the differential expression 
analysis from the plasmatocyte 3h, 6h and 18h post septic injury comparisons to control (Figure 
3). First I tested enrichment of these states by applying the FRY algorithm implemented in limma, 
which is a fast approximation of the rotation based ROAST algorithm also implemented in 
limma.278,279  
 
 
Figure 18: Plasmatocyte immune induced genes are enriched for repressive chromatin states. A: 
Differentially regulated genes in 3h, 6h, and 18h post septic injury plasmatocytes were tested for 
enrichment of overlapping chromatin states (Figure 15) and H3K27me3 level (Figure 12) using the limma 
fry algorithm. The color indicates if they were enriched among up- or down-regulated genes, size is the 
effect size (the relative fraction of genes overlapping with that state), and transparency the p-value. B: 
Gene set enrichment (GSEA) style plot of enrichment of genes overlapping chromatin state 3 (green) or 
falling into the H3K27me3 medium state (orange). Genes are ranked by fold change. Bottom panel: Log2 
fold change over gene rank. Top panel: Density of genes positive for the feature. Middle: GSEA score by 
gene rank. P-value determined by gene permutation: Overlapping chromatin state 3: p < 1*10-5, H3K27me3 
medium state: p < 1*10-5. 
 
Figure 18A shows the enrichment that was observed for all the chromatin states and gene-based 
H3K27me3 levels, respectively, at the different time points after challenge. As with the GO-term 
analysis earlier, the size of the circle indicates the enrichment of the respective chromatin states 
Results 
 
 70 
assignment, while the color indicates the directionality of the change and the transparency 
indicates the p-value of the chromatin states enrichment.  
Both, chromatin state 4 and H3K27me3 high state groups are absent because they were not 
enriched in any of the comparisons. The data clearly indicates that chromatin states associated 
with active genes (chromatin states 6 and 7 as well as the H3K27me3 low state) are enriched 
among down-regulated genes, while up-regulated genes are enriched for repressive chromatin 
states (chromatin states 1,3 and 5 and H3K27me3 medium state genes). Further, all modules tend 
to have both smaller effect sizes and smaller p-values in the 3h post septic injury over control 
comparison than in the other comparisons. Likely the large number in overall differentially 
expressed genes in the 3h post septic injury comparison factors into this observation.  
Interestingly, at 3h and to a much lesser extent at 18h post-challenge genes overlapping 
chromatin state 1 are enrichment. This enrichment is however smaller than the enrichment 
observed for the genes overlapping with the other 2 repressive chromatin states. Further, genes 
overlapping chromatin state 5 seems to have the strongest effect size at each of the time points, 
while genes overlapping chromatin state 3 have the smallest p-value. This may, in fact, be 
explained by some statistical properties relating to this enrichment analysis. First, the effect size 
is inversely correlated with the number of elements in the gene category. Since there are far 
fewer genes overlapping either chromatin state 1 or 5, their effect size is naturally larger. At the 
same time, a larger number of elements tend to produce smaller p-values, which explains why 
the genes overlapping with chromatin state 3 produce smaller p-values than those overlapping 
chromatin state 1 or 5. Beyond the statistical details of the enrichment analysis, it is important to 
recall that in my model genes can be assigned to multiple chromatin states simultaneously, in 
other words, there is no ‘majority vote’ that assigns a gene solely to the predominant chromatin 
state  (Figure 16). Many genes overlapping with chromatin state 1 and 5 also overlap with 
chromatin state 3. Therefore the chromatin state assigned to some genes might actually not 
reflect the predominant chromatin state found at the respective gene. However, this does not 
apply to gene-level states of H3K27me3 (Figure 12), which is assigned uniquely for each gene. It 
is interesting, that in the gene enrichment analysis for up-regulated genes, of the 3-state 
H3K27me3 model only H3K27me3 medium state genes are overrepresented. The H3K27me3 high 
state is absent because no genes out of this group are differentially regulated. The comparison 
of gene-level enrichments for H3K27me3 with the bin signal levels showed H3K27me3 high state 
genes best correspond to chromatin state 5 (Figure 13). This suggests that the genes assigned to 
chromatin state 5 and up-regulated upon infection are likely those where this chromatin state is 
not the predominant one.  Importantly, both the chromatin state-based as well as H3K27me3 
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gene level-based analysis show that genes located in H3K27me3 modified chromatin are enriched 
among the genes up-regulated upon immune challenge.  
To ensure that these observations are not an artifact of the gene enrichment analysis method I 
tested if this enrichment is also found with an alternative analysis approach. Therefore I 
implemented a modified Gene Set Enrichment Analysis (GSEA)280, a tool that is frequently used 
to test for gene module enrichment and visualize the results. Here genes are ranked by a ranking 
statistic, for which I chose the log2 fold change. Then a gene rank wise enrichment score is 
calculated by walking down the ranked gene list and increasing the score, if the gene that is met 
belonged to the category of interest, and else decreasing it. The maximum enrichment score can 
then be used for permutation-based statistical testing. Figure 18B shows the GSEA for genes 
overlapping with chromatin state 3 (green) and H3K27me3 medium state genes (orange). The 
bottom panel shows the ranking statistic (the log2 fold change), while the top panel shows the 
density of genes that are assigned to the category of interest at that gene rank (overlapping with 
chromatin state 3 or H3K27me3 medium state). The middle panel shows the enrichment score 
derived from the analysis of this density as discussed above. Both terms, overlapping with 
chromatin state 3 and H3K27me3 medium state, show strong enrichment among genes with a 
high log-fold change, and both reach enrichment scores of greater than 0.3. To test the 
significance of these findings, I applied gene-wise permutation to them. For neither gene set a 
higher gene set enrichment score was found after 100.000 permutations, resulting in  p < 1*10-5 
for both sets. 
This underscores that the H3K27me3 intermediate chromatin, with H3K27me3 levels lower than 
that of developmental genes, but clearly above background, marks inactive but inducible genes. 
This observation is in contrast to the hypothesis that H3K27me3 leads to stable repression of 
targeted loci.25,281 
To quantify H3K27me3 enrichment levels at immune regulated genes I categorized the RNA-seq 
data set into up-regulated, not significantly different, down-regulated, or not expressed genes 
and compared these to H3K27me3 enrichment (as calculated by (18)). As described earlier, I 
defined genes not expressed if their read count appeared insufficient for statistical inference, that 
is to say, if they had less than 1 read mapped to them per 1 million reads in a sample. Differential 
expression was defined by both a false discovery rate corrected p-value < 0.05 and a log2 fold 
change > 1 (or < -1). I calculated gene-level enrichment of H3K27me3 according to (18), formed 
the mean between replicates and plotted this enrichment for all genes (Figure 19). Figure 19A 
recapitulates that for 6h post septic injury over control H3K27me3 intermediate genes are 
overrepresentation. Both down-regulated genes and genes which are not differentially 
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expressed contain almost exclusively H3K27me3 low genes, which based on the earlier gene-level 
EM chromatin state (Figure 12) have an enrichment of less than 0.4. There are however slightly 
higher levels of H3K27me3 in the down-regulated gene group (p = 0.0045, Wilcoxon rank-sum 
test). The box-plots demonstrate that up-regulated genes are much higher than not differentially 
expressed genes in H3K27me3 enrichment (p < 2.2*10-16, Wilcoxon rank-sum test). The 
underlying distribution (violin plots) suggests, however, that this is due to a mixture of H3K27me3 
negative genes and H3K27me3 positive genes. Among up-regulated genes there is also a number 
of H3K27me3 low genes (enrichment < 0.4). There is however a second population, a large 
fraction of which falls into the category of genes with enrichments between 0.4 and 0.75, which 
are the H3K27me3 medium state genes (compare Figure 12). Therefore, up-regulated genes still 
are much lower in H3K27me3 enrichment than not expressed (p < 2.2*10-16, Wilcoxon rank-sum 
test), where a large fraction of genes are in the H3K27me3 medium state or H3K27me3 high state 
(all with enrichment > 0.4). In summary, a set of H3K27me3 positive genes is up-regulated in 
plasmatocytes after septic injury, with a stronger enrichment for such genes at later time points 
post septic injury. 
I was also interested in how this enrichment behaves quantitively over time, in other words what 
the relationship between unchallenged plasmatocyte H3K27me3 levels and the dynamics of gene 
expression after immune challenge is. I showed earlier (Figure 18A) that at 3h post septic injury, 
the p-value of H3K27me3 positive gene enrichment was smaller than at either 6h or 18h after 
septic injury, while the effect size was larger at both 6h and 18h than at 3h after septic injury. I, 
therefore, selected from each comparison (3h, 6h and 18h post septic injury vs control) the up -
regulated genes and calculated their H3K27me3 enrichment. Interestingly, H3K27me3 
enrichment is higher at later time points (3h vs 6h p = 3.4*10-14, 6h vs 18h p = 0.0013, Wilcoxon 
rank-sum test) (Figure 19B). This means that genes that are up-regulated early after infection 
rarely come from H3K27me3 marked chromatin but genes that are up-regulated later or stay on 
longer are more likely to come from an H3K27me3 positive chromatin state. There is a clear 
bimodal distribution in the H3K27me3 enrichment levels, with both H3K27me3 low (enrichment 
< 0.4) and H3K27me3 medium state (enrichment > 0.4 and < 0.75) genes being present in all 
conditions. In fact, the change in H3K27me3 enrichment levels seems to derive from a shift in 
ratios between H3K27me3 low and H3K27me3 medium state genes. It is, therefore, important to 
consider the vastly different total number of up-regulated genes (3h: 1311 genes, 6h: 187 genes, 
18h 56 genes). Hence, it is not clear from this observation alone, whether H3K27me3 positive 
genes are up-regulated later, H3K27me3 negative genes are down-regulated earlier, or if another 
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effect is the cause of the observation that the fraction of H3K27me3 intermediate genes increases 
over time. 
 
Figure 19: H3K27me3 levels are increased in immune induced genes. H3K27me3 enrichment was 
calculated for all genes using the mean enrichment from both replicates. Genes were grouped into 
categories based on their differential expression in plasmatocytes after challenge. A: Genes were grouped 
by their expression at 6h post septic injury when compared to control, either down-regulated (Down), not 
significantly differentially expressed or up-regulated (Up). Not expressed marks genes that were filtered 
by their low expression and have less than 1 read per million mapped to them. n: number of genes in that 
group. Mann-Whitney U test: Up vs not differentially expressed p < 2.2*10-16, Up vs Not expressed p < 
2.2*10-16, Down vs not differentially expressed p = 0.0045. B: For each time point of septic injury, up-
regulated genes at that time when compared to control were selected and plotted as described for A. 
Mann-Whitney U test: 3h vs 6h p = 3.4*10-14, 6h vs 18h p = 0.0013. 
 
Consequently, I took all genes which were up-regulated at 6h post septic injury and split them 
based on their gene-level assignment to H3K27me3 (high + medium vs. low) or based on their 
chromatin state assignment (state 3 vs. all other states). From these genes, I plotted the log2 fold 
changes over time when compared to the unchallenged control (Figure 20). Interestingly, for 
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neither grouping based on H3K27me3 nor on overlap with chromatin state 3, there appears to be 
much of a difference in the overall shape of the response between H3K27me3 positive and 
negative genes. Both groups are increased in expression immediately at 3h, stay at similar levels 
through 6h and then decrease slightly towards 18h.  
 
 
Figure 20: Genes in repressive chromatin states are not delayed in their transcriptional response. Log2 
fold changes for all genes which are up-regulated at 6h post septic injury is plotted as time course, grouped 
by their A: H3K27me3 level or B: their overlap with the H3K27me3 intermediate chromatin state 3. Orange 
genes fall in the respective category, while gray genes do not. Background traces are time courses of 
individual genes, foreground points show mean and standard deviation. (H3K27me3 high vs low, 3h: p = 
6.5*10-12, 6h: p = 2.6*10-15, 3h: p = 5.8*10-11; Overlapping chromatin state 3 vs Not, 3h: p = 2.9*10-10, 6h: p 
= 4.6*10-11, 3h: p = 2.4*10-8, Wilcoxon rank-sum test) 
 
The magnitude of the fold change on the other hand is much greater for the H3K27me3 positive 
genes at all time points and for all comparisons (H3K27me3 high vs low, Figure 20B, 3h: 
p = 6.5*10—12, 6h: p = 2.6*10-15, 3h: p = 5.8*10-11; Overlapping Chromatin state 3 vs Not, Figure 
20A, 3h: p = 2.9*10-10, 6h: p = 4.6*10-11, 3h: p = 2.4*10-8, Wilcoxon rank-sum test). Hence, 
H3K27me3 positive genes do not respond delayed when compared to H3K27me3 negative genes. 
Neither do they return to a base level significantly faster. Together, this indicates that H3K27me3 
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positive genes are not slower in responding when compared to H3K27me3 low genes, but their 
response may be stronger than that of H3K27me3 low genes. 
In summary, I have shown that H3K27me3 positive genes are up-regulated in plasmatocytes after 
immune challenge. These inducible genes fall into an H3K27me3 intermediate category, that is 
distinct from the H3K27me3 high category which includes for example stably repressed 
developmental genes and a H3K27me3 depleted category which includes actively transcribed 
genes. These H3K27me3 positive immune regulated genes are a subset of all immune regulated 
genes, they are robustly induced after immune activation and are not delayed in their 
transcriptional response. Therefore, I hypothesized that H3K27me3 is targeted to immune genes 
to prevent their aberrant transcription and thereby acts as an immune regulator in Drosophila. 
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5.3 Differential ChIP-seq of challenged plasmatocytes 
5.3.1 CHIP-SEQ OF 6H POST SEPTIC INJURY PLASMATOCYTES 
The mere presence of H3K27me3 at immune inducible gene loci does not prove that H3K27me3 
acts as a suppressor of transcription at these genes. However, if it did act to suppress 
transcription at these genes then it should be removed to allow their transcriptional activation.  
Therefore, I used ChIP-seq to test for differences in histone modifications after immune 
challenge. Because ChIP-seq required a larger number of cells than RNA-seq, here I only tested 
one time point at the 6h after septic injury. This 6h time point has been widely used in the 
literature as a time point to identify transcriptional changes after challenge.205,225,232 Further, the 
RNA-seq of plasmatocytes revealed a significant number of H3K27me3 positive genes 
differentially expressed at this time point. Therefore, I collected cross-linked chromatin samples 
from plasmatocytes 6h post septic injury and performed ChIP-seq on them with antibodies 
directed against H3K27me3 and H3K27ac. It seemed plausible that H3K27me3 might be 
accompanied by a gain of H3K27ac, because H3K27ac is a mark found at actively transcribed 
genes and because this modification is mutually exclusive and therefore competing with 
H3K27me3.42 As described for the earlier ChIP-seq the samples were checked for general 
enrichment by qPCR and ChIP-seq libraries were prepared from them. These libraries were then 
sequenced and mapped to the BDGP dm6 reference genome exactly the same way as all ChIP 
samples from unchallenged plasmatocytes. 
I expect that, while there will be treatment depended changes in histone modifications, they are 
likely to be minor compared to the overall ChIP-seq signal given that the plasmatocytes are 
neither transdifferentiated nor have they changed in any other fundamental way. Additionally, 
all histone modifications have a characteristic distribution, that does not change fundamentally 
even when comparing ChIP-seq from entirely different cells. I therefore expected, that the 
samples of the same type (H3K27me3, H3K27ac or input) are very similar not only between 
replicates but also between unchallenged and 6h post septic injury samples. 
Hence, I first applied PCA to check for sample similarity. Accordingly, I split the genome into 10 
kb bins and quantified the signal by counting reads that fall into them. I then picked the 1000 
most variant bins and applied PCA, which is plotted in Figure 21. 
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Figure 21: ChIP-seq from plasmatocytes cluster primarily by the histone modification and not the 
treatment. The genome was split into bins of 10 kb and reads falling into each bin were counted. The 
resulting counts were subjected to principal component analysis. A: Visualization of the first 3 components 
of the PCA. Colors indicate antibody targets, shapes indicate plasmatocyte treatments. B: Percent of total 
sample variance explained by the first 10 components. 
 
When plotting the first 3 components of the PCA (Figure 21A) indeed all samples cluster 
according to the antibody target (H3K27me3 in yellow, H3K27ac in green, input in purple) rather 
than according to treatment condition (unchallenged control as a circle and 6h post septic injury 
as a square). This suggests that the changes in signal introduced by the septic injury only make 
up a minor part in the overall signal and that the plasmatocyte specific chromatin landscape is 
still the main cause of the observed ChIP enrichment. Further, similar to unchallenged 
plasmatocytes, the active mark H3K27ac, and the repressive mark H3K27me3 separate strongly 
along the principal component 1, which explains 55.8% of the total sample variance, while the 
input sample lies in between the two. Interestingly, component 2, which explains 33% of sample 
variance separates both ChIP samples from the input, which likely represent regions where 
neither of the modifications are enriched. When I compare for each of the ChIP targets the 
sequencing results derived from control plasmatocytes to 6h post septic injury plasmatocytes 
they cluster slightly apart, an observation which is perhaps most pronounced in the H3K27me3 
ChIP, where the distance between the two control samples and the two septic injury samples is 
largest. There is also an interesting directionality of change: In H3K27me3 the septic injury 
samples are slightly closer to the input samples than the control samples, while the H3K27ac 
samples show the reverse effect. This may be a first indication, that H3K27me3 is lost in some 
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regions, corresponding to a greater similarity to the modifications free like input, while H3K27ac 
is increased in distance to input, indicating a gain of the signal. Therefore, ChIP-seq samples of 
unchallenged and 6h post septic injury plasmatocytes cluster closely together by the immune-
precipitation target and only separate weakly by the treatment. 
Hence, I analyzed the changes in the ChIP signal as well as the location of those changes with 
regard to the genes of interest, which are immune induced genes. One of the established 
procedures to check for differences between ChIP-seq samples employs MACS2258,260. Here the 
identification of differentially targeted regions is done in several steps. First , all regions with 
higher than background enrichment are identified across all conditions of the ChIP -seq samples 
in a step named peak calling. Given the broader binding of histone modifications I here used the 
MACS2 broad peak algorithm. Then those peak regions which differ in signal intensity are 
identified by determining the probability of the read counts in peak regions deriving from the 
same Poisson model across the different treatment conditions. I applied this pipeline for both 
H3K27me3 and H3K27ac separately. Then I used these peak calls to identify differentially 
targeted genes, which I defined as any gene that overlaps with at least 1 bp with a differential 
peak region of that ChIP-seq target.  
In addition, I applied a differential binomial EM approach based on the algorithm proposed in the 
normR package264. Here, instead of calling the probabilities of ChIP over input as described in 
Figure 9, I identify different populations as if the reads were drawn from urns containing mixed 
reads from the control and septic injury ChIP-seq runs. From these enriched regions, I can identify 
genes with differential histone modifications by identifying overlap of differentially modified 
regions and genes. 
At first, I tested this pipeline on the set of H3K27me3 ChIP-seq data sets (Figure 22). Using MACS2 
a large number of broad peak regions can be identified in the control plasmatocyte samples 
(12756 peaks, Figure 22A), of which only a small fraction (1210 peaks) contains regions that are 
differentially modified. This is in line with the fact many H3K27me3 positive genes are not related 
to immune function and should be unaffected by the septic injury challenge. It is interesting that 
all of the H3K27me3 peak regions which are changed between control and septic injury conditions 
have lower levels of H3K27me3 after septic injury, while none show increased levels. This is 
exactly what I would expect, if H3K27me3 is a regulator of immune gene transcription since the 
loss of H3K27me3 would enable increased transcription of the overlapping genes. At the same 
time, there is no reason to believe that down-regulation of genes would immediately result in 
H3K27me3 modification of those genes, which explains why no regions were found to be 
increased in H3K27me3 after septic injury. 
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Figure 22: H3K27me3 peaks are reduced in H3K27me3 in plasmatocytes at 6h post septic injury. 
Differentially bound regions for H3K27me3 were calculated using MACS2 and a differential EM approach. 
A: Donut plot of all peaks called in non-challenged plasmatocyte H3K27me3 sample using MACS2. Colors 
indicate change between6h post septic injury and unchallenged plasmatocytes. B: Venn diagram of genes 
overlapping MACS2 H3K27me3 differential peaks (MACS2), EM model H3K27me3 differential peaks (EM) 
and genes differential expressed at 6h and high in H3K27me3 
 
I then compared how these changes relate to the genes I found differentially expressed after 
septic injury. I therefore plotted three sets of genes in a Venn diagram: (1) Genes identified by 
MACS2 to be in regions that change H3K27me3 enrichment, (2) genes identified by the binomial 
EM algorithm to be in regions that change H3K27me3 enrichment and (3) genes which were both 
differentially expressed at 6h after septic injury as well as H3K27me3 positive (Figure 22B). First, 
the overlap between MACS2 and EM with regard to identifying genes that gain or lose H3K27me3 
is good. The binomial EM algorithm is calling more genes increased in H3K27me3 but covers more 
than two-thirds of all genes called by MACS2. More importantly, however, between both 
algorithms, they cover 75 out of the 84 genes that are H3K27me3 positive and up-regulated at 6h 
post septic injury. This high level of overlap occurs in spite of the fact, that I applied stringent false 
discovery rate corrected p-value thresholds, which means there is likely a number of false 
negatives for both RNA-seq and ChIP-seq changes. Therefore, the observed overlap between 
differentially expressed genes and gene regions that loose H3K27me3 supports well the 
hypothesis that H3K27me3 is lost at these genes in plasmatocytes after immune activation. 
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Additionally, I applied the same analysis to the H3K27ac samples. Using the same MACS2 peak 
calling approach as described for H3K27me3, I find that H3K27ac is increased in many of the peak 
regions at 6h post septic injury when compared to control plasmatocytes (Figure 23A). Here, 545 
peak regions gain H3K27ac enrichment and only 10 peak regions are decreased in enrichment. 
This is in contrast the H3K27me3 ChIP-seq results and therefore well complements the data on 
H3K27me3 loss and gene up-regulation. 
 
Figure 23: H3K27ac peaks are increased in H3K27ac in plasmatocytes at 6h post septic injury. 
Differentially bound regions for H3K27ac were calculated using MACS2 and a differential EM approach. A: 
Donut plot of all peaks called in non-challenged plasmatocyte H3K27ac sample using MACS2. Colors 
indicate change between 6h post septic injury and unchallenged plasmatocytes. B: Venn diagram of genes 
overlapping MACS2 H3K27ac differential peaks (MACS2), EM model H3K27ac differential peaks (EM) and 
genes differential expressed at 6h and high in H3K27me3 
 
Subsequently, I identified genes associated with differentially called H3K27ac peaks by the 
MACS2 and the binomial EM algorithms and plotted their overlap with genes that were 
H3K27me3 positive and up-regulated at 6h after septic injury in a Venn diagram (Figure 23B). 
Compared to H3K27me3, for H3K27ac the different groups overlap less well. The MACS2 and EM 
algorithms only show a less than half overlap. Further, they together only cover 56 out of the 84 
H3K27me3 positive immune induced genes. However, an increase in H3K27ac may very well also 
be unrelated to the loss of H3K27me3 I observed. While it is true that H3K27ac can act as a 
competitor for trimethylation at histone H3 lysine 27, it may also be placed by completely 
unrelated mechanisms, perhaps on genes that are differentially regulated, but not necessarily 
repressed by H3K27me3 in unchallenged plasmatocytes. Additionally, there is no reason to 
believe that H3K27ac is actively required to induce transcription of H3K27me3 positive genes, and 
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it may either be established with some delay or not at all.  Last, H3K27ac is found both, 3’ to the 
TSS and at enhancers and regulatory elements, but whether the role of H3K27ac is the same at 
every location is not yet clear. Together, this indicates that H3K27ac is induced at a number of 
genes in plasmatocytes after septic injury, but this increase is not restricted to genes in 
H3K27me3 positive gene states. 
Therefore, I checked if this overlap of differentially modified regions and differentially expressed 
genes is also represented in the enrichment of differentially modified genes among up-regulated 
genes at 6h post septic injury. Here, to visualize the data, I used the same gene set enrichment 
analysis algorithm I described before (Figure 18): Genes are sorted based on a ranking statistic 
(here the log2 fold change) and then a rank level enrichment score is calculated by walking down 
the list and adding or subtracting from the score, depending on what type of gene is met. This 
analysis I applied to the 4 differential ChIP-seq gene sets: Genes called differential by either the 
MACS2 or the EM algorithm for either H3K27me3 or H3K27ac (Figure 24).  
 
 
Figure 24: Genes with differential H3K27me3 and H3K27ac are enriched among immune induced genes 
in plasmatocytes. Genes overlapping differential peaks in H3K27me3 (A) or H3K27ac (B) were determined 
by either MACS2 or differential EM. Gene set enrichment was then performed for those gene groups using 
the 6h post septic injury RNA-seq. Bottom panels: Log2 fold change of 6h post septic injury vs. control over 
gene rank. Top panels: Density of genes positive for the feature. Middle: GSEA score by gene rank. P-values 
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by fry algorithm: H3K27me3 differential by MACS2 p = 0.0088, EM p = 0.0118. H3K27ac differential by 
MACS2 p = 0.0005, EM p = 0.0006. P-values by GSEA permutation: all p < 1*10-5 
 
For the H3K27me3 data set (Figure 24A), the top panel shows the density of genes which were 
called as differential by either algorithm based on the gene rank, while the middle panel shows 
the rank-based gene set enrichment score. Both MACS2 and EM show a good enrichment among 
the up-regulated genes, such that permutation-based p-values are low (p < 1*10-5 for both 
comparisons). Further, the enrichment for the gene set that includes genes identified by MACS2 
is enriched slightly more, perhaps representing the overall smaller number of genes in this set 
when compared to the set identified by the EM algorithm (also see Figure 22B). Concordantly, 
applying the fry algorithm I find p-values of p = 0.0088 for MACS2 and p = 0.0118 for EM 
differential peak enrichment. For the H3K27ac differential genes, there is a similarly significant 
enrichment (Figure 24B). Here there is a strong enrichment among up-regulated genes with 
enrichment scores even larger than the ones observed for H3K27me3. Permutation-based p-
values are small (p < 1*10-5 for both comparisons), as were p values calculated by the fry algorithm 
(enrichment for genes that overlap with regions called differential by MACS2: p = 0.0005, or EM: 
p = 0.0006). Therefore, genes with differential H3K27me3 peaks and with differential H3K27ac 
peaks are enriched among genes that are up-regulated at 6h post septic injury in plasmatocytes. 
It should also be possible to directly compare signals of ChIP-seq quantitively, much in the same 
way that it is done in ChIP-qPCR experiments. Therefore, I characterized the samples better to 
identify what data transformations are necessary. First, I determined Pearson correlation 
coefficients of samples in the same way I did for the ChIPs from unchallenged plasmatocyte. I 
divided the genome into 10 kb bins, counted overlapping reads and calculated Pearson 
correlation coefficients. These were sorted by hierarchical clustering and plotted as a heatmap 
(Figure 25A). 
Similar to before (see Figure 8), the data sets correlate well between replicates, with correlation 
coefficients ranging between r = 0.98 and r = 1. ChIP-seq of different targets do not produce good 
correlation, with H3K27me3 and H3K27ac being very dissimilar, as I described for the ChIP -seq 
from unchallenged plasmatocytes. Further information can be gained by comparing the 
correlation coefficients of 6h post septic injury (infected) and control (resting) samples for the 
same antibody. For all samples (even the input) replicates of the same condition correlate slightly 
better than the different treatment conditions. This is likely indicative of those regions which are 
differentially modified between unchallenged and 6h post septic injury plasmatocytes. 
Particularly for H3K27me3 the two samples from 6h post septic injury plasmatocytes correlate 
slightly better with each other than they do with the control samples.  Given that my previous 
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results revealed clear signal differences between 6h post septic injury and control samples, I 
wondered if technical factors of the ChIP-seq affect the samples and partially hide the true signal. 
 
 
Figure 25: ChIP-seq replicates comparison shows low-level technical variance across samples. A: 
Mapped reads from each individual ChIP-seq replicate were binned using 10kb windows. Pairwise Pearson 
correlation coefficients of the resulting read counts were calculated using Deeptools. Samples were sorted 
using hierarchical clustering and visualized as a heatmap. B: ChIP fingerprint plot. Evenness of coverage 
was determined by calculating the cumulative fraction of reads that are contained in each quantile of 
genomic bins. 
 
Therefore I generated fingerprint profiles282 from the H3K27me3 ChIP-seq samples. To do this, 
the genome is divided into small bins (in this case 25 bp) and the read count is determined for 
each bin. Then the bins are sorted based on their read count in ascending order and the 
cumulative sum of the values is calculated. The resulting profiles can then be used to infer about 
the enrichment of the ChIP-seq: In ideal input samples, this profile would essentially be a diagonal 
line, since every bin is covered by the same number of reads, and therefore the cumulative 
fraction of reads at every bin is just the cumulative fraction of bins. This ideal input is impossible, 
because of random fluctuations in read counts and DNA copy number variations between 
Drosophila lab strains and the reference genome assemblies of BDGP dm6. For ChIP samples on 
the other hand, in the most extreme case, the profile would be zero for most of the fraction of 
bins, since they are not precipitated due to the lack of a given histone modification, and the 
profile would then quickly rise to 1 in the last few bins which are regions that actually carry that 
histone PTM. At the same time, ChIP samples always have background from non-specific 
precipitation, and some modifications are broadly spread across the genome. Therefore, any true 
ChIP profile will be somewhere in between this ideal input and the ideal ChIP. Figure 25B shows 
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these fingerprint profiles for H3K27me3 and input samples. The input samples are much closer to 
the diagonal than the H3K27me3, which is expected to have many enriched regions across the 
genome. But while all inputs and all H3K27me3 ChIPs run very close together, at least one of the 
H3K27me3 samples is slightly offset. This cannot be explained by biology differences, since most 
genomic regions should be unaffected by the septic injury, and even more, replicates should 
definitely not differ in their enrichment. It seems therefore likely, that there is a difference 
between immune-precipitations of the same histone target which derive from effects of slightly 
more rigorous washing steps, or slight changes in the ratios of antibody to chromatin, or other 
technical variations. Hence. these differences are not biologically meaningful and should, 
therefore, be normalized before further data analysis. 
Indeed, when comparing the enrichment using 25 bp bins of the two replicates of unchallenged 
plasmatocytes H3K27me3 ChIP (Figure 26A), there is a bias in the distribution such that replicate 
B produces higher values for the same bins. The bin-wise enrichment values from this analysis 
are distributed in a banana-like shape, indicating that in replicate B the immunoprecipitation was 
more efficient in precipitating genomic regions with intermediate enrichment, relatively to the 
precipitation of both H3K27me3 low and high regions. 
Since this distortion was not biologically meaningful but interferes with quantification, I decided 
to normalize the data using a quantile normalization approach. These quantile normalization 
methods have been well studied and used extensively in microarray-based genome analysis, 
where they are applied to filter out technical variations caused for example by differences in 
labeling efficiencies.283,284 These technical variations in microarray signals are very similar to the 
ones I observed for my ChIP-seq replicates, so I applied a quantile normalization algorithm. This 
algorithm follows 3 steps: First, the genomic bins from each replicate are separately sorted based 
entirely on their read count value, irrespective of that bins genomic position. Then to each bin , 
the mean of all bins at the same sorted rank across replicates is assigned. Last the list is sorted 
back according to the genomic position of the bin. The exact code can be seen at  Code Snippet 
3. There are however some assumptions that need to be justified in order for quantile 
normalization to be appropriate. First, it assumes that the total abundance of H3K27me3 is the 
same. Since quantile normalization assigns each bin the row-wise mean, that also means that the 
sum of all bins, which is equivalent to the total signal across all the genome, will appear to be the 
same between all samples. Here I think this approximation is warranted. Because only a small 
subset of genes is changed in response to the septic injury, this would likely only cause a minor 
perturbance in the total levels of H3K27me3 in the plasmatocytes. This is also demonstrated by 
the fact that the majority of H3K27me3 peak regions are unchanged (Figure 22A). Second, in 
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sparse distributions, outliers will be affected to a much greater extend by changes. This is a large 
concern in microarrays, where few genes like for example Actin genes represent a significant 
fraction of the total mRNA. Here I used the H3K27me3 enrichment, which I calculated according 
to (18). Since in this definition all observed values must be between 0 and 1, which puts both an 
upper and lower limit to enrichment and prevents extreme values, the risk that quantile 
normalization would here cause distortions in ChIP-seq enrichment is minimal. 
 
 
Figure 26: Quantile normalization eliminates technical variance in ChIP-seq replicates. A: H3K27me3 
enrichment was calculated for 25 bp genomic bins of both replicates of H3K27me3 in unchallenged 
plasmatocytes. The outlines show point density, the diagonal line shows a 1:1 correlation (ideal model). B: 
The Enrichment of A was processed by a quantile normalization algorithm. 
 
When applying this quantile normalization to the previously ‘banana’ shaped distribution of 
H3K27me3 enrichment of unchallenged plasmatocyte replicates, the signal is afterwards 
distributed along the diagonal, as I would expect from replicates of the same plasmatocyte 
condition (Figure 26B). At the same time, many important features are conserved: The data is 
still distributed in a  trimodal fashion which has two major peaks at small and medium values and 
a minor peak at large enrichment values. Also, the diameter of the distribution orthogonal to the 
diagonal is unchanged, indicating that I only adjusted for technical biases, but did not suppress 
biological signal or variance. Hence, I applied this quantile normalization to both the H3K27me3 
and H3K27ac enrichment data between the 4 samples targeting the same antigen and used this 
data for all following comparisons of differential ChIP-seq. 
First, I applied the normalized data to visualize ChIP-seq signals. Accordingly, I quantile 
normalized the 25 bp window ChIP tracks and loaded them into IGV. In addition, I calculated the 
difference between the control and 6h post septic injury tracks of both H3K27me3 and H3K27ac, 
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to more easily identify regions with an increase or decrease in signal. Two examples from these 
tracks are shown in Figure 27.  
  
 
Figure 27: Select immune induced genes are reduced in H3K27me3 and increased in H3K27ac post 
immune challenge. Enrichments from unchallenged (resting) and 6h post septic injury (infected) 
plasmatocytes for ChIPs of H3K27me3 and H3K27ac were quantile normalized and averaged. Addition ally, 
signal differences were calculated and colored red for regions with a lower signal in the septic injury and 
green for those with a higher signal. The resulting tracks and their differences were visualized using IGV on 
two loci. A: Genome track around the Cecropin cluster. B: Genome track around PGRP-SC2. 
 
The top panel shows a genomic region around the Cecropin gene cluster, a group of AMPs that 
are differentially regulated in plasmatocytes at 6h after septic injury (compare Figure 3C and 
Figure 4). I visualized three data tracks for both H3K27me3 and H3K27ac: First, the quantile 
normalized signal track from unchallenged plasmatocytes, then the same from 6h post septic 
injury plasmatocytes, and last the difference of the two tracks. Here H3K27me3 is indeed reduced 
at a region around these AMPs. From the difference track it is clear that this difference is 
restricted to a small number of genes in the AMP cluster, and does not globally affect H3K27me3 
levels, which would indicate a technical artifact of ChIP-seq or normalization. At the same time, 
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H3K27ac is strongly increased on the same locus but does not appear changed much at 
neighboring regions. It is possible, that AMPs might be a special case, both because of their short 
coding sequences and because of their arrangement in clusters. PGRP-SC2, on the other hand, is 
a pattern recognition receptor that is induced in plasmatocytes after septic injury (compare 
Figure 3C and Figure 4) and it is shown as an example of a non-AMP immune gene. As for the 
Cecropin gene cluster, there is a strong difference in H3K27me3 at the PGRP-SC2 locus located in 
the middle of the shown genomic region, which is more restricted to the gene body compared to 
the Cecropin genes. Another difference to the AMP cluster is the topology of the gain in H3K27ac 
signal: For PGRP-SC2 this gain appears to be spread to regions further outside the gene body, 
making the region of H3K27ac gain much larger than that of H3K27me3 loss. These changes are 
overall restricted to the genes of interest and do not globally affect all genes in the region.  
Together these two examples demonstrate that after quantile normalization the differences 
predicted by peak calling are well visible on the level of individual genes. 
Whereas this way of data representation is very intuitive, information about replication, which is 
useful to determine the reproducibility of the effect, is lost. Therefore, I calculated the quantile 
normalized gene-level H3K27me3 enrichment of each genes that was up-regulated at 6h post 
septic injury. Of those genes I selected ones that either overlapped with the repressive chromatin 
state 3, or were H3K27me3 positive according to the H3K27me3 gene state (Figure 12 and Figure 
13). I plotted the resulting values as a z-score normalized heatmap (Figure 28). In this heatmap of 
H3K27me3 differences, columns represent samples, with both ChIP-seq samples from 
unchallenged plasmatocytes to the left and both post septic injury samples to the right. Further, 
I grouped genes, which are individual rows, first based on if they either overlapped chromatin 
state 3 or were H3K27me3 positive or both and then sorted them by hierarchical clustering.  
Overall, the two control samples to the left have a lot more blue heatmap tiles than the septic 
injury samples, indicating an overall higher level of H3K27me3 level on genes in these samples.  
In this heatmap, there are very few genes that are only in H3K27me3 positive state, but the 
treatment well predicts the H3K27me3 enrichment, with both control replicates being higher in 
H3K27me3 for all genes, while the septic injury ChIP-seq samples are always lower. For the genes 
that only overlapping chromatin state 3, on the other hand, there are replicates that are lower for 
H3K27me3 in the control sample than in the septic injury samples. However, it is important to 
remember that chromatin state assignments are not exclusive, and it is possible that these genes 
are incorrectly assigned to repressive chromatin states.  
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Figure 28: A small number of genes show discordant H3K27me3 regulation at 6h post septic injury. 
Quantile normalized enrichment of H3K27me3 was calculated on a gene level for both unchallenged 
(control) replicates and for both 6h post septic injury replicates. Genes that were up-regulated at 6h post 
septic injury by RNA-seq were filtered for genes that are H3K27me3 positive (higher than the background) 
or overlapping with chromatin state 3. The gene-level H3K27me3 enrichment signal was z-score 
transformed and plotted as a heatmap. 
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For the genes that are both in an H3K27me3 positive gene state and overlapping with the 
chromatin state 3 the vast majority of genes lose H3K27me3 after septic injury, with at least one 
of the septic injury samples showing a strong loss of H3K27me3. Specifically, these are the genes 
in the middle of the heatmap, and they include many well-characterized immune genes including 
AMPs from Diptericin, Attacin and Cecropin clusters, TEPs and PGRPs. 
In summary, this demonstrates that across all H3K27me3 positive immune induced genes, most 
of them reproducibly loose H3K27me3 after immune challenge, but a small number of genes 
responds discordantly 
Therefore, I characterized population-level histone modifications changes in greater detail. For 
H3K27me3 I used the same quantile normalized gene-level enrichment applied to each of the 
H3K27me3 ChIP-seq experiments that were generated for the heatmap. For H3K27ac, some 
modifications are necessary: As shown earlier, H3K27ac is restricted mostly to regions around the 
transcriptional start site (TSS, see Figure 10). Therefore, if I calculated the enrichment on a gene 
level, this enrichment would be a mix of H3K27ac positive region at the start of the gene and 
H3K27ac negative regions towards the 3’ end. This would, therefore, mean that the signal would 
differ not only based on the height of the signal (which is the intention) but also by the length of 
the gene (which is not correct). Hence, I restricted the analysis to the TSS of each gene by 
counting reads for 500 bp downstream of all potential TSS of each gene, calculating their 
enrichment and for each gene choosing the one TSS that had the highest enrichment (which is, 
therefore, the most likely site from which a gene product is transcribed). 
Using these H3K27me3 and H3K27ac enrichment sets I calculated some population statistics. 
First, I generated 4 categories by dividing either genes that were in a H3K27me3 positive gene 
state (Figure 12) or that overlapped with chromatin state 3 (Figure 13) and then further dividing 
genes into those that were up-regulated at 6h post septic injury in plasmatocytes (later just called 
up-regulated) and those that were not up-regulated. To identify a confidence interval of 
H3K27me3 and H3K27ac enrichment for each category I applied bootstrapping285: From each 
group, many random samples are drawn and the mean is calculated each time. By repeating this 
many times, it is easy to find the interval in which 95% of all calculated means lie, giving a good 
estimator for the 95% confidence interval of the population mean. In this way, I calculated means 
and confidence intervals for all samples and groups and plotted them in Figure 29. 
For both, H3K27me3 positive genes (left panel) and genes that overlap chromatin state 3 (right 
panel) among up-regulated genes, H3K27me3 enrichment is reduced in both ChIP-seq replicates 
from 6h post septic injury plasmatocytes (Figure 29A). At the same time, this loss of H3K27me3 
does not appear to be true for the not up-regulated genes. Indeed, if I use the gene-wise mean of 
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the replicates and calculate p-values applying a paired Wilcoxon signed-rank test I find that for 
up-regulated and H3K27me3 positive genes p = 9.56*10-10 and for up-regulated and overlapping 
chromatin state 3 genes p = 1.436*10-07. Therefore, genes that are targeted by H3K27me3 and are 
up-regulated at 6h post septic injury in plasmatocytes are reduced in H3K27me3 after the septic 
injury.  
 
 
Figure 29: H3K27me3 is reduced and H3K27ac increased across immune induced genes in 
plasmatocytes after immune challenge. Genes that were either classified as H3K27me3 positive or 
overlapping with chromatin state 3 were grouped based on their differential expression as up-regulated or 
not up-regulated. Gene level enrichment (A) or TSS enrichment (B) of each ChIP sample for either 
H3K27me3 (A) or H3K27ac (B) was calculated and the resulting values were plotted as mean ± 
bootstrapped 95% confidence interval. Wilcoxon signed-rank test for the means of replicates: H3K27me3 
positive up-regulated: (A): p = 9.56*10-10; (B): p = 1.364*10-10; Overlapping chromatin state 3: (A): p = 1.436* 
10-07; (B): p = 2.035*10-11  
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The reverse seems to be true for H3K27ac at the TSS (Figure 29B). Here genes that are up-
regulated at 6h post septic injury have increased levels of H3K27ac at 6h post septic injury. This 
gain, too, is highly significant and using a paired rank-based Wilcoxon signed-rank test I find that 
the increase in H3K27ac for up-regulated and H3K27me3 positive genes has p = 1.364*10-10 and 
for up-regulated and overlapping chromatin state 3 genes has p = 2.035*10-11. At the same time, 
the small increase observed for H3K27me3 positive not up-regulated genes only has p = 0.1907. 
Hence, the same group of genes that was reduced in H3K27me3 after septic injury also has a 
mean increase in H3K27ac. Together, population statistics, therefore, support the observation, 
that in plasmatocytes H3K27me3 is lost on immune regulated genes, while at the same time 
H3K27ac is increased at those genes. 
With regard to the mean changes in H3K27me3 (Figure 29A), it might be objected that the 
changes are only small, and it might be questioned whether these changes affect transcription. 
However, there is very little data on how H3K27me3 levels affect transcription quantitively. 
Therefore, it is difficult to say whether the observed changes in H3K27me3 are comparable to the 
changes that are to be expected based on the transcriptional fold changes. For that reason, I used 
a linear model to predict the loss in H3K27me3 quantitively. As a basis for the model, I applied my 
data sets of transcription and histone modification profiles from unchallenged plasmatocytes. I 
reasoned that, if distinct levels of H3K27me3 at one individual gene were associated with distinct 
levels of transcriptional output of that gene, this will to some degree translates to all genes, such 
that H3K27me3 levels will correlate with transcriptional output. This assumption is likely vastly 
oversimplified, as it does not consider the effects of transcription factors, other histone 
modifications, or gene intrinsic properties. But even if a model does not fully explain the data 
variance it could be a good estimator to compare to the magnitude of transcriptional and 
H3K27me3 changes observed in plasmatocytes after challenge. To build this model I first selected 
only those genes which are expressed with at least 1 read mapped to them. The read counts from 
unchallenged plasmatocytes of these selected genes were transformed into tags per million 
(TPM), which normalizes gene-level read counts for both gene length and sequencing depth. I 
then extracted 2 groups from these genes: First, all genes that do not overlap with any of the 
repressive chromatin states 1, 3 or 5, and second, all genes that overlapped with repressive 
chromatin state 3. For these genes, I then compared the average TPM to the mean H3K27me3 
enrichment of ChIP-seq from unchallenged plasmatocytes. These correlations are plotted in 
Figure 30. The top panel here shows the correlation between H3K27me3 and log2 TPM for all 
genes that do not overlap any of the repressive chromatin states, where every dot is an individual 
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gene and the blue line is a linear model of their relation. Here, genes are expressed at different 
levels mostly independent of their H3K27me3 levels. Therefore, even though all genes lie very 
close to the linear least-squares model, it does not appear to predict a lot of the change. Pearson 
correlation coefficients are r = -0.075, with p = 2.96*10-9, which means there is only a weak (but 
significant) anticorrelation between expression strength and H3K27me3 levels in this gene group. 
 
Figure 30: H3K27me3 enrichment and expression strength correlate in individual chromatin states. 
Gene level expression strength as log2 TPM compared to H3K27me3 enrichment. Genes were grouped into 
genes that do not overlap a repressive chromatin state (chromatin states 1, 3 and 5) and those genes that 
overlap chromatin state 3 and have any RNA-seq reads mapped to them. Blue lines show linear models. 
Not overlapping repressive chromatin states: r = -0.075, p = 2.96*10-9, Overlapping chromatin state 3: r = -
0.556, p < 2.2*10-16. 
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This correlation is much stronger when I analyze those expressed genes which overlap with 
chromatin state 3 (Figure 30, lower panel). Even though there are much fewer data points in this 
group, there is a clear anticorrelation observable, which has a correlation coefficient of r = -0.556 
with p < 2.2*10-16. This Pearson’s r of -0.556 demonstrates that there is  a lot of variance in the 
data that is not explained by the model. But as I discussed above, this model is extremely 
reductionist, and given the strong statistical significance, it may still be useful to explain the trend 
in data correlation. Therefore, I extracted the underlying least-squares linear model which is: 
𝐻3𝐾27𝑚𝑒3 𝐸𝑛𝑟𝑖𝑐ℎ𝑚𝑒𝑛𝑡 = −0.028 ∗ 𝑙𝑜𝑔2(𝑇𝑃𝑀) +  0.505 (20) 
 
This model can then be applied to the results of the RNA -seq of the 6h post septic injury 
plasmatocytes compared to unchallenged plasmatocytes, where H3K27me3 changes can be 
predicted by calculating 
 
∆𝐻3𝐾27𝑚𝑒3 𝐸𝑛𝑟𝑖𝑐ℎ𝑚𝑒𝑛𝑡  = −0.028 ∗ 𝑙𝑜𝑔2𝐹𝐶  (21) 
 
By applying this model to predict gene-level changes in H3K27me3 based on the log2 fold changes 
from the RNA-seq, the magnitude of observed changes in H3K27me3 can be compared 
quantitatively to the model predictions. 
Hence, I took all genes that were differentially expressed at 6h post septic injury when compared 
to unchallenged plasmatocytes and calculated their predicted change in H3K27me3 enrichment 
using (21). Then, I split genes into H3K27me3 positive or negative genes. From these comparisons 
of predicted and observed and plot them against each other (Figure 31). 
In this comparison of predicted and observed H3K27me3 changes RNA-seq log2 fold changes 
predict H3K27me3 changes well for H3K27me3 positive genes, but not for H3K27me3 negative 
genes. The 181 H3K27me3 negative genes (green) are overall very close to zero on both observed 
and predicted changes. This is well consistent with the earlier observation that H3K27me3 
negative genes have, on average, a smaller log2 fold change (compare Figure 20). Additionally, 
all genes in this H3K27me3 negative category appear scattered without a clear trend in the 
observed H3K27me3 changes, which is well reflected in the Pearson correlation coefficient r = 
0.054, p = 0.468. Therefore, there seems to be no correlation between the observed H3K27me3 
change and the transcriptional changes for H3K27me3 low genes. For the 87 H3K27me3 positive 
genes (orange) there is a clear positive correlation, such that larger observed differences in 
H3K27me3 are reflected in larger predicted changes, based on the linear model from (21). Indeed, 
I find correlation coefficients of r = 0.508 with p = 5.1*10-7. Importantly, the magnitude of the 
change for observed and predicted H3K27me3 changes seem well comparable. Therefore, in 
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plasmatocytes fold expression changes quantitively predict the loss of H3K27me3 at H3K27me3 
positive genes which are up-regulated at 6h post septic injury, but the same is not true for 
H3K27me3 negative genes. 
 
 
 
Figure 31: Transcriptional changes post immune challenge predict H3K27me3 loss in repressed genes, 
but not in active genes. Gene level log-fold changes in plasmatocytes at 6h post septic injury when 
compared to unchallenged cells were used to predict changes in H3K27me3 enrichment levels using (21). 
Corresponding changes of observed values were calculated from the differential ChIP-seq of H3K27me3 
between 6h post septic injury and control. Genes were grouped by their unchallenged H3K27me3 levels 
and plotted. Lines show linear models   95% confidence interval. H3K27me3 negative: r = 0.054, p = 0.468; 
H3K27me3 positive: r = 0.508, p = 5.1*10-7. 
 
In summary, when performing differential ChIP-seq on plasmatocytes comparing 6h post septic 
injury cells to unchallenged cells, both H3K27me3 and H3K27ac are differentially modified, such 
that H3K27me3 is lost in a number of regions, while H3K27ac is increased in differentially 
modified regions. This change is tied to genes that are also differentially expressed after septic 
injury in plasmatocytes (Figure 24) and for H3K27me3, this change is specific to H3K27me3 
positive differentially regulated genes (Figure 22, Figure 23 and Figure 31). In consequence, this 
raises the question, whether the removal of H3K27me3 is a consequence of gene transcription, or 
if it is instructive in this process, as I proposed. 
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5.4 Mosaics of H3K27me3 depletion mutants 
So far, I showed that a set of immune induced genes is decorated with the repressive histone 
modification H3K27me3 and that this mark is removed upon their transcriptional activation 
following an immune challenge. Therefore, I speculated that the modification of H3K27me3 at 
these loci is functionally relevant to suppress gene activation in unchallenged plasmatocytes. My 
approach to address this hypothesis was to genetically remove or reduce the modification 
H3K27me3 in plasmatocytes and assay transcriptional changes in immune genes. If H3K27me3 is 
indeed instructive in suppressing immune signaling, which may constantly be activated for 
example due to the presence of a microflora, I expect a transcriptional induction of immune genes 
after diminishing the level of H3K27me3 modification in the same way that removal of H3K27me3 
releases the silencing of epigenetically silenced developmental genes89.   
Here, I can apply the power of the Drosophila model: As I discussed in the introduction, in 
Drosophila I can not only mutate those enzymes (writers) that place a histone modification, but I 
can also mutate histones directly, something that is impossible in any other metazoan. 85 Because 
mutations in proteins of the PRC2 which writes H3K27me3 as well as mutations in histone H3 
lysine 27 are early larval lethal I generated genetic mosaics of these mutations in order to 
manipulate plasmatocytes at late larval stages.40,41 Therefore I want to shortly introduce these 
systems, starting with the histone mutation system. In Drosophila, histone genes are organized 
in histone gene units (HisGUs), short sequences that contain each a single copy of the core 
histone genes H2A, H2B, H3, and H4 as well as the linker histone H1. All copies of the HisGU are 
located in a single locus in the Drosophila genome, which is located on chromosome 2L proximal 
to the centromere and called the histone locus. This arrangement in a single locus allowed 
researches in previous work to delete the entire region of the histone locus by using the DrosDel 
system, and the resulting deletion is called ∆HisC.85 Homozygous ∆HisC animals are arrested early 
in embryonic development, but this arrest can by rescued by supplying at least 12 wild type HisGU 
copies in transgene, which allows flies to complete development into adulthood. 93 These 
transgene copies also provide a useful system to study histone mutants: By supplying 12 copies 
of HisGU, which carry mutant versions of a histone, the importance of for example one amino 
acid of a histone can test the. This was done in this thesis, where I used a previously published fly 
line that carries HisGU copies with a H3K27R mutation, that is histone H3 lysine 27 is mutated to an 
arginine.89 Homozygous ∆HisC animals who are rescued using these mutant HisGU-H3K27R copies 
do however die during early larval development89 and can therefore not be used here, where 
animals need to complete larval development. This is where the genetic mosaic system is useful. 
In principle, this system allows for the generation of animals that carry genetically different cells, 
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for example both wild type and mutant cells, similar to chimeric animals that have been used in 
other model organisms.286 While many techniques have been established to generate such 
genetic mosaics287 in this thesis I use exclusively the FLP-FRT mitotic recombination 
technique.288,289 Because the way in which I use this system to induce mutants in histones or 
mutants in PRC2 genes differs slightly I want to discuss them separately, starting with the histone 
mutant case.  
The general strategy for generating histone mutant cells is outlined in Figure 32.  
 
 
Figure 32: Description of the genetic system used for inducing histone mutant mosaics. Mosaics are 
induced from a parent cell (left) heterozygous for both ∆HisC and GFP. Under normal circumstances, when 
this cell undergoes mitosis, 2 identical daughter cells are produced. If FLP mediated FRT recombination is 
induced, instead two different cells, each homozygous for either ∆HisC or GFP are generated. The ∆HisC is 
rescued by transgenic histone gene unit copies. 
 
Initially, the parent cell (Figure 32, left) carries FRT recombination sites on both homologous 
chromosomal arms 2L, distal to which one chromosome carries the histone locus deletion ∆HisC 
while the other chromosome is marked by a GFP controlled by the constitutive Ubiquitin 
promotor. This cell is therefore only heterozygous for the ∆HisC deletion and as such whole 
animals with this genetic makeup are viable. At the same time, all cells are homozygous carriers 
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of the transgenic histone gene units (HisGUs), which will later ‘rescue’ histone locus deficient 
cells. If FRT mediated recombination is not induced, the cell will undergo regular S-phase DNA 
replication and the sister chromatids will separate during mitosis to form 2 genetically identical 
daughter cells (Figure 32, top). 
However, if the expression of the recombinase FLP is triggered, which is in this system is 
accomplished by heat shock mediated induction of a transgene, this recombinase will 
sporadically cause recombination between the FRT sites of the homologous 2L chromosomal 
arms in G2 cells (Figure 32, bottom middle). In that case, there is a chance that when sister 
chromatids separate during mitosis, one of the sister chromatids has exchanged the part distal 
to the FRT recombination site with that of the homologous chromosome. This can lead to 
daughter cells that are homozygous for either ∆HisC or GFP (Figure 32 bottom right). Because the 
∆HisC homozygous cells lose all GFP expression they can be distinguished from all other cells. At 
the same time, the transgenic HisGU copies which were present in all parent cells are still present 
in the mutant ∆HisC cells. But since the cell now lacks any endogenous source of histone, if 
supplied with mutant HisGU copies (which here are HisGU H3K27R) this cell will, therefore, be a 
histone mutant. 
While this exact system has previously been used to generate mosaics in other Drosophila organs, 
for example, wing discs89, no one had tested whether and at which rate mutant plasmatocytes 
can be generated in such a fashion. Therefore, in a first test run, I used larvae with the ∆HisC 
mosaic system (Figure 32) which carried either no transgenic HisGU, 12 wild type HisGU or 12 
HisGU H3K27R. I heat-shocked these larvae for 1 hour at 1st and 2nd larval stages, and then extracted 
and FACS sorted plasmatocytes from 3rd instar wandering larvae. I gated the plasmatocytes as 
described in Figure 2, first for FSC vs. SSC and then for single cells. For the resulting cells, I plotted 
their GFP levels as a histogram (Figure 33). Similar to previously published data89,93 only 0.07% of 
cells are GFP negative for animals that are not rescued by histone gene units, indicating that 
plasmatocytes which lack histones are unable to proliferate, while both animals with 12 wild type 
HisGU and 12 HisGU H3K27R produce GFP negative mutant plasmatocytes at 9.59% and 8.51% 
respectively, demonstrating that both ‘rescues’ allow plasmatocyte proliferation. Therefore, 
plasmatocytes from these genetic mosaics can be used for RNA-seq, sorting GFP negative 
plasmatocytes from 12 HisGU H3K27R mosaics as mutant cells and GFP negative plasmatocytes 
from 12 wild type HisGU mosaics as matched control cells.  
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Figure 33: Histone mutant plasmatocytes can be induced as genetic mosaics. Mosaics of plasmatocytes 
without rescue (orange), with 12x wild-type histone gene unit rescue (blue) or with a 12 histone gene unit 
H3K27R rescue (red) were FACS sorted. Plasmatocytes were otherwise gated like in Figure 2. GFP negative 
cells: no His TG: 0.07%; H3wt: 9.59%; H3K27R: 8.51%. 
 
 
As I discussed in the introduction, mutating only the histone residue which is modified has 
shortcomings, since it makes it difficult to distinguish contributions of different histone 
modifications that occur on the residue (for example H3K27me3 vs. H3K27ac). Therefore, I 
additionally generated mutants in PRC2, the complex that places H3K27me3 but which has no 
function in acetylating H3K27.  
Hence, I applied a similar mosaic system to generate mutants in the PRC2 components Enhancer 
of zeste (E(z)) and Suppressor of zeste 12 (Su(z)12), that is none the less different in some key points 
that I want to mention. E(z) and Su(z)12 are both located on chromosome 3L. Here I used the 2 
mutant alleles E(z)731 and Su(z)124, which are both premature STOP codon mutants generated by 
ethyl methanesulfonate mutagenesis40,290. For both, E(z) and Su(z)12, I used previously 
established chromosomes on which the mutant alleles are located distal to an FRT site, similar to 
the arrangement in the ∆HisC case (Figure 34). However, on corresponding homologous 
chromosome I this time used a transgene in which GAL80 is controlled by the ubiquitous Tubulin 
promotor. GAL80 is a transcriptional repressor of the Saccharomyces cerevisiae transcriptional 
activator GAL4, which is frequently used as part of the GAL4/UAS system in Drosophila. The 
function of the GAL80 repressor in this system is to repress the expression of UAS-GFP transgene 
(on the X chromosome) through inhibiting Tubulin-GAL4 which is ubiquitously expressed from 
another transgene on the X chromosome. Therefore, the parent cell is here a GFP negative cell 
that is heterozygous for either E(z)731 or Su(z)124 (Figure 34, left). 
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Figure 34: Genetic mosaics used for generating E(z) and Su(z)12 mutants using MARCM. Mosaics are 
induced from a parent cell (left) heterozygous for either mutant E(z) or Su(z)12 (mut) and a ubiquitously 
expressed version of the transcriptional repressor Gal80. Under normal circumstances, when this cell 
undergoes mitosis, 2 identical daughter cells are produced. If FLP mediated FRT recombination is induced, 
instead 2 different cells, each homozygous for either mutant E(z)/Su(z)12 (mut) or Gal80 are generated. In 
cells lacking Gal80, the transcriptional activator Gal4 can trigger GFP transcription. 
 
Now mosaics are induced in just the same way as discussed before. If no FLP is expressed, 
daughter cells each receive one of the sister chromatids and are heterozygous for both GAL80 
and the PRC2 mutation (Figure 34, top). If, however, an FLP mediated FRT recombination occurs, 
mitotic separation of sister chromatids can lead to 2 daughter cells which are each either 
homozygous for the Gal80 transgene or for the PRC2 mutation. Since the PRC2 mutants no 
longer express Gal80, Gal4 can now activate GFP expression in these cells, turning them GFP 
positive. This system is called MARCM (mosaic analysis with a repressible cell marker). 291 In this 
case that leads to two key differences: First, the PRC2 mutant cells are GFP positive, while the 
histone mutants are GFP negative. Second, because the Gal4/uas system strongly amplifies the 
signal, the brightness of the mutant cells with MARCM is much greater than with the direct GFP 
construct. This was the main reason why I chose the MARCM system for the analysis of PRC2 
Results 
 
 100 
mutants since none of the available GFP transgenes from the alternative system generated 
signals bright enough to detect and separate cells by FACS.  
Similar to the protocol I used in the histone mutation mosaics, I took larvae which carried the 
MARCM transgenes, and either the E(z) or the Su(z)12 mutation, heat-shocked them twice, once 
each in 1st and 2nd instar larval stages, to induce FLP-FRT mediated recombination, and extracted 
plasmatocytes from wandering 3rd instar larvae. I first tested the efficiency of the system in 
plasmatocytes by FACS (Figure 35A). Here I show results from mosaics induced in E(z) and Su(z)12 
lines compared to the wild type OrR strain. There is a GFP positive population that is only visible 
in those genotypes that carry the MARCM system. In the example shown I found about 11.5% 
mutant cells for the Su(z)124 mutation and 14.5% mutant cells for the E(z)731 mutation. Further, I 
checked the resulting changes in histone modifications, specifically in H3K27me3 and H3K27ac. 
Therefore in 3 independent experiments, I extracted plasmatocyte mosaics of E(z)731 and Su(z)124 
from wandering stage larvae, left them to attach to a cell culture dish, fixed and stained them 
with DAPI and antibodies against either H3K27me3 or H3K27ac and imaged them on a confocal 
microscope. Representative images of this are shown in Figure 35C-D. Afterwards, I build a 
custom ImageJ script to identify cells and quantify their signals for GFP, DAPI and the antibody 
(either H3K27me3 or H3K27ac).  
I then normalized the fluorescence signals to the DAPI intensity for each cell, identified GFP 
positive cells by using a manual cut-off and analyzed the resulting intensities for H3K27me3 and 
H3K27ac (Figure 35B). Here, H3K27me3 levels are dramatically reduced in both E(z)731 and Su(z)124 
mutants (Figure 35B, right panel, both E(z)731 and Su(z)124: p < 2.2*10-16 by Wilcoxon rank-sum 
test). This is also apparent in the example of E(z)731 mutants with H3K27me3 staining (Figure 35C): 
GFP positive mutant cells (outlined in magenta in each of the channels) are almost depleted for 
H3K27me3 signal (rightmost panel, red), while GFP negative cells (outlined in yellow) have a 
homogeneously high signal. Interestingly, E(z)731 and Su(z)124 mutants appear to compensate the 
loss of H3K27me3 with an increase of H3K27ac: For both mutants there is an increase in H3K27ac 
signal in GFP positive cells (Figure 35B, left panel, both E(z)731 and Su(z)124 have p < 2.2*10-16 by 
Wilcoxon rank-sum test). This is also seen in the representative image of E(z)731 plasmatocytes 
(Figure 35D), where GFP positive cells (outlined in magenta) have an elevated H3K27ac antibody 
staining. While the loss of H3K27me3 after mutation of either E(z) or Su(z)12 is well described and 
expected by their enzymatic role in this modification40,41,97, the origin of the increase in H3K27ac 
is not clear. It is possible that, in the absence of H3K27me3, the histone H3 lysine 27 
acetyltransferase nej is able to modify nucleosomes more frequently, but on the other hand it is 
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also possible that due to a loss of PRC mediated repression a number of additional genes become 
active, which increases the total number of genes targeted by H3K27ac.  
 
Figure 35: E(z) and Su(z)12 MARCM mosaics can be induced in plasmatocytes and are reduced in 
H3K27me3. A: Representative FACS plot of MARCM mosaics in plasmatocytes from OrR (blue), Su(z)124 
(orange) and E(z)731 (red). Plasmatocytes were otherwise gated as in Figure 2. GFP positive cells: Su(z)12: 
11.5%; E(z): 14.5%; OrR(wt): 0.08%. B: Quantification of plasmatocyte histone mutant immunostainings. 3 
independent experiments like C and D were performed for each genotype and cells were counted from 5-
10 separate images. Number of plasmatocytes (as GFP+/GFP-): E(z)-H3K27ac: 148/1068; E(z)-H3K27me3: 
144/940; Su(z)12-H3K27ac: 100/1008; Su(z)12-H3K27me3: 134/1381. Wilcoxon rank-sum test p-values: all p 
< 2.2*10-16. C-D: Examples of Immunofluorescence of plasmatocyte mosaics of E(z). MARCM mosaics of 
Su(z)124 and E(z)731 were stain with antibodies against H3K27me3 and H3K27ac. C: Representative image 
of H3K27me3 staining in E(z)731. Green is GFP, blue is DAPI, red is anti-H3K27me3. Yellow outlines are GFP- 
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cells, magenta outlines are GFP+. D: Representative image of H3K27ac staining in E(z)731. Green is GFP, blue 
is DAPI, red is anti-H3K27ac. Yellow outlines are GFP- cells, magenta are GFP+. 
 
 
In summary, I showed that using FLP-FRT based mitotic mosaics I can generate mutant 
plasmatocytes that are either H3K27R or null mutant of E(z) or Su(z)12. These mutant 
plasmatocytes can therefore be used to study the role that these factors have in the 
transcriptional landscape of plasmatocytes. 
 
5.4.1 RNA-SEQ OF PRC2 MUTANT AND H3K27R  PLASMATOCYTES 
Hence, I isolated H3K27R, E(z)731 and Su(z)124 mutant plasmatocytes from the genetic mosaic 
animals outlined above for RNA-seq by FACS sorting. Additionally, I generated genetically 
closely matching control samples for each of the mutant cell populations. As a control for H3K27R 
plasmatocytes, I generated mosaic plasmatocytes that are homozygous for ∆HisC, but are 
rescued by 12 wild type copies of HisGU instead of 12 HisGU H3K27R. For both, E(z)731 and Su(z)124 
I chose to collect GFP negative cells as internal control along with the respective GFP positive 
mutant cells. These cells are at least heterozygous for E(z) or Su(z)12 and therefore act like wild 
type.40,290 After sorting the plasmatocytes as described (Figure 33, Figure 35A) I got 2000 to 7000 
mutant cells from each sample (see Table 8). For that reason, I decided to increase the number 
of replicates in this RNA-seq experiment to account for the larger variance that is to be expected 
when preparing libraries from smaller cell numbers or lower RNA amounts.292 In total I generated 
5 replicates for both ∆HisC; 12x HisGU-H3K27R and ∆HisC; 12x HisGU-H3wt, and 6 replicates for 
E(z)731 and Su(z)124 and their matching GFP negative plasmatocytes. From the RNA isolated from 
these plasmatocytes libraries were prepared and sequenced (see Table 8). For shortness I will 
refer to the ∆HisC; 12x HisGU-H3K27R, E(z)731 and Su(z)124 mutants together  as H3K27me3 
depletion mutants 
After mapping the sequencing data and performing a quality control test, I applied PCA to 
identify sample groups. Therefore, I determined gene-level read counts and performed PCA on 
the regularized log-transformed read counts of the 1000 most variable genes across all samples. 
From this PCA I plotted the first 3 components (Figure 36A). Here, I colored the histone mutants 
and matching controls in blue, Su(z)12 mutants and controls in red and E(z) mutants and controls 
in green. Further, the darker colors identify mutant samples, while the lighter colors are the 
matching controls. In this PCA along the first 2 dimensions the samples vary according to the 
sample group (∆HisC, E(z) or Su(z)12) but not based on if the sample was mutant or wild type. 
Specifically, along PC1, which explains 60% of all sample variance, histone mutant constructs 
Results 
 
 103 
separate strongly from both E(z) and Su(z)12 samples, indicating a high degree of dissimilarity. It 
is not quite clear what the origin of these differences are. These samples have very different 
genetic backgrounds, the samples were generated at different times and library preparation 
methods differed (see material and methods and Table 8). This should however not prevent a 
direct comparison of ∆HisC animals rescued with either 12 HisGUwt to 12 HisGU H3K27R, since they 
do not differ along either PC1 or PC2. Interestingly, along PC2, which explains 11.5% of all 
variance, the samples from E(z) and Su(z)12 genetic backgrounds differ, irrespective of whether 
they belong to the mutant or control group. In this case, all samples from the 4 conditions (E(z) 
and Su(z)12 mutant and control) were generated in the same timeframe and libraries were also 
prepared at the same time with the same library preparation method. Therefore it seems likely 
that the genetic background is in this case the source of the observed difference. As with the 
histone mutants, I do want to mention, however, that these potential differences do not affect 
the analysis here since all samples are only compared in differential expression analysis to their 
internal control, and not to the other samples. PC3, which explains 9 .9% of all variance, is then 
the component where separation along H3K27me3 depletion is observed: All mutant samples are 
at the bottom of the plots, and therefore low in PC3, while the matching control samples are at 
the top and high in PC3. This co-variation along PC3 indicates that there is a common change 
across the samples that is likely related to the loss of PRC2 related functions in the mutant 
plasmatocytes. 
Therefore, I compared the individual mutant samples with their matching control to identify 
differentially expressed genes using edgeR. The resulting differences I plotted as volcano plots.  
For the comparison of ∆HisC 12xHisGU H3wt to ∆HisC 12xHisGU H3K27R (Figure 36B), there is a far 
larger number of genes up-regulated than down-regulated (924 up vs. 106 down). This is well 
consistent with the fact that the ∆HisC; 12xHisGU H3K27R mutation causes loss of repression, 
therefore a large number of genes is up-regulated. Additionally, a set of the most strongly 
regulated genes is also labeled by name in the volcano plot, and the Hox genes among them are 
marked in red. Here all Hox genes of the Bithorax complex (Ubx, abd-A, Abd-B) are strongly up-
regulated in H3K27R mutants, as previous data predicts for the loss of Polycomb silencing. 89 
However, the genetic backgrounds of the 12 HisGU H3K27R and the 12 HisGU H3wt transgenes are 
not entirely matched, because these previously established constructs were generated in part in 
different land sites for transgene integration. Therefore, differential expression of individual 
genes could derive from the H3K27R mutation or in some instances, from other differences in 
genetic background. For the E(z)731 mutant (Figure 36C) and the Su(z)124 mutant (Figure 36D) a 
larger number of genes is up-regulated than down-regulated in both, E(z) mutants (down: 70, up: 
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355) and Su(z)12 mutants (down:81, up:733). As for H3K27R mutants, Hox genes are strongly up-
regulated in both PRC2 mutants, specifically those from the bithorax complex. 
 
 
Figure 36: PRC2 and histone H3K27R mutants show concordant transcriptional changes. A: PCA of RNA-
seq from sorted mosaics of H3K27me3 depletion mutants from unchallenged plasmatocytes. Mosaics were 
induced in plasmatocytes and mutant and matching control cells were sorted by FACS. Red: Mosaics in 
Su(z)12, Green: Mosaics in E(z), Blue: Histone cluster mosaics. Light colors indicate wild type plasmatocyte 
samples, dark colors mutant samples. B-D: Volcano plots of all detected genes for the plasmatocyte mosaic 
comparisons ∆HisC; 12xHisGU-H3K27R vs ∆HisC; 12xHisGU-H3wt (B), E(z)731 vs E(z)wt (C) and Su(z)124 vs 
Su(z)12wt (D). P-values are plotted log-transformed against the log2 fold change (LFC). P-values were 
calculated using a GLM negative binomial model (edgeR) and significant genes were selected with a cut-
off false discovery rate corrected p-value = 0.05 and an LFC = 1 (marked by vertical dashed lines). The most 
outlying genes are marked by name, and Hox genes are marked with red labels. 
Results 
 
 105 
 
The difference in the number of up-regulated genes is, however, unexpected, considering that 
both proteins E(z) and Su(z)12 act as part of the same complex for silencing.40,41 It is possible that 
differences in noise levels caused a different number of genes that passed the significance 
threshold, independent of the true number of differently expressed genes. Additionally, the 
different up-regulation of yellow (y) in E(z)731 and Su(z)124, but not H3K27R is striking. This does, 
however, derive from a previously undescribed uas driven y+ expression in the MARCM stock.  
Together, this shows that H3K27R, E(z)731 and Su(z)124 mutants, while their genetic background is 
diverse, show a component of concordant gene up-regulation that includes many Hox genes. 
Since all three mutants, H3K27R, E(z)731 and Su(z)124, have a large number of genes that are induced 
I addressed the overlap between those up-regulated genes. It is well characterized that Hox 
genes are induced after PRC2 loss.25,89 Therefore I selected the Hox-like homeobox transcription 
factors according to Burglin and Affolter 293 and calculated from these genes sample wise 
regularized log-transformed expression values. I plotted these expression values as z-scores in a 
heatmap (Figure 37A). As described for the RNA-seq after septic injury, I only included genes that 
had a minimum of 1 read mapped to them per 1 million reads in at least 5 samples. Interestingly, 
most of the Hox-like homeobox transcription factors do not meet this criterion and out of the 17 
genes in this category, 9 are below the read count threshold (pb, zen, zen2, bcd, ftz, eve, ind, btn 
and ro). Therefore, these genes appear unaffected by the loss of PcG silencing. The others Hox-
like genes are plotted in the heatmap. Here, the genes towards the top of the heatmap, which 
include the Bithorax complex Hox genes and Antennapedia (Antp) are highly consistent in their 
up-regulation after H3K27me3 loss. Further, labial (lab) and Deformed (Dfd) are slightly less 
consistent up-regulated, such that they have each 2 outliers in E(z) and Su(z)12 mutants 
respectively. Interestingly, outliers for these genes are not observed in H3K27R mutants, where 
they are the most highly differentially expressed across all genes in the heatmap. This is well 
consistent with the volcano plot (Figure 36), which showed that genes from the H3K27R mutants 
showed larger fold changes compared to the other mutants. The more pronounced and more 
consistent activation of repressed genes indicates a more extensive loss of gene repression in the 
H3K27R mutants when compared to the E(z) and Su(z)12 mutants, though the cause of this remains 
unclear. 
Subsequently, I identified the general overlap of up-regulated genes between the different 
conditions of H3K27me3 depletion. I selected genes that were up-regulated with at least a 2-fold 
change and p < 0.05, which I then plotted as a Venn diagram (Figure 37B). There is a large overlap, 
with 137 genes being up-regulated in all conditions, which compares favorably to the 355 total 
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genes that are up-regulated in E(z)731.  In fact, of those 355 genes 303 overlap at least with one of 
the other two conditions, H3K27R or Su(z)124. At the same time both, Su(z)12 and H3K27R mutants, 
have a large number of genes that are only up-regulated in those mutants and in none of the 
other conditions (399 and 604 respectively). The overall larger number of genes that are up-
regulated in H3K27R mutants in comparison to either E(z) or Su(z)12 mutants, will in part explain 
why these genes are not detected as differentially expressed in the other conditions, but Su(z)12 
mutants only have a slightly smaller number of genes up-regulated than H3K27R mutants. 
Therefore, it seems likely, that other factors contribute to this non-overlap. Potentially, the 
differences in genetic background, which I already discussed, contribute to differences in up -
regulated genes as well. At the same time, it is possible that Su(z)12 and H3K27R act in part in 
biologically different ways, for example, that either one of them interacts with other components 
in an exclusive fashion. In summary, while many genes, and Hox-genes in particular, are 
concordantly regulated in all H3K27me3 depletion mutants, there are also a number of differently 
regulated genes. Particularly the H3K27R mutant appears to both have the largest number of 
regulated genes and the strongest induction of Hox-genes. 
 
 
 
Figure 37: Differentially expressed genes in H3K27me3 depletion mutants. A: Heatmap of Homeobox 
transcription factors in plasmatocyte mosaics. Regularized logarithmic transformed (DESeq2) gene read 
counts were normalized by a z-score transformation. Blue indicates higher expression than the mean in 
that sample, while red indicates lower expression than the mean. B: Venn diagram of up-regulated genes 
in plasmatocyte mosaics. Genes that were up-regulated when comparing plasmatocyte mosaics of 
12xHisGU H3K27R vs HisC 12xHisGU H3wt (blue), E(z)731 vs E(z)wt (green) and Su(z)124 vs Su(z)12wt (red) with a 
false discovery rate corrected p-value < 0.05 and an LFC > 1 were selected. Numbers indicate the number 
of genes in that overlap. 
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Further, I determined the type of cellular functions that are disturbed in the H3K27me3 depletion 
mutants. Therefore, as with the RNA-seq of 6h post septic injury plasmatocytes from chapter 
5.1.3, I calculated enriched GO terms: All comparisons of Su(z)124, E(z)731 and H3K27R to their 
matching non-mutant samples were subjected to the limma goana gene enrichment analysis. I 
plotted the results, with the size of the circles indicating the effect size of enrichment, the 
transparency indicates the p-value and the color the directionality of the change (Figure 38).  
In addition, I grouped the GO modules into 3 major groups: Developmental terms, metabolic 
terms and those that fit neither category. First, most GO modules that are enriched significantly 
are enriched among up-regulated genes, which is well consistent with the observation that there 
is a far larger number of up-regulated genes than down-regulated genes. Additionally, this 
indicates that there is no previously annotated biological process that specifically counteracts the 
loss of H3K27me3. Interestingly, H3K27R appears to have the lowest p-values and effect sizes for 
many of the terms, and developmental terms specifically. At the same time, I showed that the 
regulation of Hox-like homeobox transcription factors is, if anything, more consistent in H3K27R 
mutants. In general, however, GO annotations in Drosophila are much more unreliable than 
vertebrate model organisms294, and therefore the completeness and reliability of the terms 
presented here is, perhaps, debatable. Simultaneously, the samples of E(z) and Su(z)12 mutants 
are much more similar in their p-values of enriched gene modules to each other than they are 
similar to H3K27R mutants. This observation is both consistent with the level of difference in the 
PCA (Figure 36) as well as the fact that they are both parts of one protein complex (PRC2) and 
should, therefore, act together.40 Importantly, even though the p-values of the enrichments 
differ strongly between the comparisons, developmental modules are strongly enriched across 
all genes up-regulated in H3K27me3 depletion mutants.  
The reason for the enrichment of metabolic terms is less evident. It is possible, that some level of 
loss of cell identity causes shifts in metabolism. On the other hand, the terms listed here are 
either related directly to amino acid metabolism or macromolecule biosynthesis, which includes 
RNA and protein synthesis. Therefore, these terms could be caused by an overall shift of the cell 
to increased protein production. This might be caused by a loss of gene repression, which then, 
in turn, requires an increase in the RNA and protein synthesis machinery. Among the “other” 
terms, many also relate to development. While not directly containing the term development, 
genes associated with terms like cell fate specification, regionalization and cell-cell adhesion 
clearly contribute to it. Additionally, terms related to the regulation of transcription include many 
developmental genes that are transcription factors. Therefore, it appears that the prime targets 
of up-regulation in H3K27me3 depletion mutants are both developmental and metabolic genes. 
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Figure 38: GO-term enrichment in RNA-seq of H3K27me3 depletion mutant plasmatocytes. GO-term 
enrichment was performed using the goana module implemented in edgeR. Rows are GO modules with 
the highest significance, while columns are individual comparisons and, where not otherwise noted, the 6h 
post septic injury plasmatocyte samples were compared to the RNA-seq of control plasmatocytes. The 
effect size is (b/n)/(B/N) where b is the number of genes that are regulated and carry the GO-term, n is the 
number of genes regulated in that direction, B is the total number of genes with that GO -term, and N is 
the total number of genes in the comparison. GO-terms are sorted by manual selection to reflect common 
groups of gene functions. 
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In addition to using GO terms to infer biological function, I compared the observed transcriptional 
changes to both the chromatin states and H3K27me3 gene states I established earlier (chapter 
5.2.3). Therefore, I applied the limma fry algorithm to the E(z)731 vs. E(z)wt, Su(z)124 vs. Su(z)12wt 
and 12xHisGU H3K27R vs. 12xHisGU H3wt comparisons using both the gene level overlap with the 
7-state chromatin model and the 3-state gene wide H3K27me3 model as gene modules (Figure 
39A). Here, as indicated by the blue color, modules are only enriched among up-regulated genes, 
which is well consistent with the overall small number of down-regulated. Chromatin state 7 is 
absent from the plot because it was not significantly enriched in any of the comparisons. At the 
same time, genes overlapping chromatin state 6 are only slightly enriched and only in the H3K27R 
mutants (p = 0.02), which is expected, as chromatin state 6 like chromatin state 7 marks active 
genes that should be mostly unaffected by the loss of H3K27me3.  Unsurprisingly55, the strongest 
enrichment, both by effect size and p-value, is observed for genes overlapping chromatin state 5 
and H3K27me3 high state genes. These chromatin states correspond to and identify genes 
strongly targeted by H3K27me3, for example, Hox genes. Hox-like homeobox transcription 
factors are not expressed in wild type plasmatocytes (Figure 37A) and a subset of them is 
consistently and strongly induced after H3K27me3 loss, which makes a strong enrichment of the 
H3K27me3 high state likely.  
Further, there is some level of enrichment for both of the enhancer chromatin states that I 
identified, chromatin states 2 and 4.  Interestingly chromatin state 2 is consistently more strongly 
enriched by effect size and p-value compared to chromatin state 4, which is only enriched in 
Su(z)124 and H3K27R mutants. This might be explained by the hypothesis that chromatin state 2 
represents a more repressed type of enhancer, while chromatin state 4 are active enhancers. 
Last, there is an enrichment for the three repressive gene states which are targeted by 
intermediate levels of H3K27me3, chromatin state 1 and 3 as well as H3K27m3 medium genes. 
These states are all very similar in their enrichment, both in effect sizes and p-values for each of 
the comparisons, and they are very strongly enriched. This indicates that H3K27me3 
intermediate levels are indeed instructive for silencing in unchallenged plasmatocytes. The lower 
levels of enrichment of H3K27me3 medium states compared to  H3K27me3 high states has 2 
confounding factors: In contrast to H3K27me3 high state genes, not all H3K27me3 medium state 
genes are fully silent in unchallenged cells, and H3K27me3 high state genes respond either very 
strongly to the loss of H3K27me3 or not at all. Therefore, the list of most highly differentially 
expressed genes is led by the H3K27me3 high state genes, after which the H3K27me3 medium 
state genes follow. Hence, the H3K27me3 high state genes will appear to have a higher gene 
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module enrichment, but this does not mean that the loss of repression at H3K27me3 medium 
state genes is any less relevant than that at H3K27me3 high state genes. 
 
 
 
Figure 39: Enrichment of chromatin states among H3K27me3 depletion mutants. A: RNA-seq 
comparisons of H3K27R, Su(z)124 and E(z)731 mutants to their wild type matched samples are analyzed for 
enrichment of chromatin states and H3K27me3 gene states (Figure 12 and Figure 15) using the fry 
algorithm. B: GSEA of 12x HisGU H3wt vs. 12x HisGU H3K27R checking for the enrichment of chromatin state 
overlap. Bottom panels: Log2 fold change of H3K27R vs. wild type H3 over gene rank. Top panels: Density of 
genes positive for the chromatin state. Middle: GSEA score by gene rank. P-values by permutation: 
Chromatin states 1, 2, 3 and 5: p < 1*10-5; Chromatin states 4,6 and 7: n.s. 
 
Hence, I checked if this enrichment patterns – strong enrichment of H3K27me3 medium state 
genes and H3K27me3 high state genes, with a slightly higher enrichment of the H3K27me3 high 
states – is also reproduced by an alternative analysis method. Therefore, I applied the gene set 
enrichment analysis algorithm (GSEA)280,295 to visualize the enrichment of chromatin states and 
calculate their p-values (Figure 39B). Here I sorted genes by their log2 fold changes between 
12xHisGU H3K27R and 12xHisGU H3wt (bottom panel), then marked genes by their overlap with 
either of the 7 chromatin states, whose density is plotted in the top panel. Then enrichment 
scores were calculated as described in the methods. The results are similar to the fry algorithm 
enrichment statistics. The enrichment scores of genes overlapping chromatin state 5 rises the 
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fastest and hits its maximum enrichment score at a very low gene rank. Only a few gene ranks 
afterwards however, the H3K27me3 intermediate chromatin state 3 also reaches a similar 
enrichment score. This indicates that both states are similarly de-repressed, however, the extent 
of the response after the loss of silencing is greater in H3K27me3 high genes in comparison to 
H3K27me3 intermediate genes. At the same time, the gene module of genes overlapping 
chromatin state 1, which I appeared to be constitutive heterochromatin, hits its maximum 
enrichment score around the same gene rank as chromatin state 3, but that enrichment score is 
lower, indicating a weaker overall enrichment. Further, chromatin state 2 is here enriched among 
up-regulated genes, perhaps showing that this is a repressed enhancer state that is activated by 
the loss of H3K27me3. The enrichment of all these 4 chromatin states (1, 2, 3 and 5) is highly 
significant with p < 1*10-5. Last, in GSEA neither of the chromatin state 4, 6 or 7 are significantly 
enriched, which is in contrast to the fry-algorithm based analysis, where states 4 and 6 were 
significant. This likely reflects the differences in rotation and permutation-based analysis 
methods. The p-values of the fry algorithm are however reflected in the order of the maximum 
enrichment scores produced by the GSEA: chromatin states 4 has the highest enrichment scores 
among the active chromatin states, while chromatin states 7, which was not significantly 
enriched using the fry algorithm either, has the lowest enrichment score among all states. In 
summary, this demonstrates that all repressive states rely to some extent on H3K27me3 
mediated silencing, as genes that overlap these repressive states are induced in H3K27me3 
depletion mutants. This specifically includes the newly identified H3K27me3 medium state and 
chromatin state 3, where genes overlapping these states show a highly significant enrichment 
among up-regulated genes. 
Since there is strong enrichment of H3K27me3 high and medium states in plasmatocytes after 
H3K27me3 loss, this makes it clear that both chromatin states are actively silenced by H3K27me3, 
irrespective of the level of the modification. Since I showed earlier that immune genes are 
targeted by H3K27me3, I then characterized how loss of H3K27me3 affects these genes 
specifically. Therefore, I applied the same analysis that I used above to check for chromatin states 
now using immune induced gene sets. I defined the set of immune induced genes as all genes 
that were up-regulated at either 3h, 6h or 18h after septic injury with p < 0.05 and fold change > 
2. Using these gene sets I applied the fry algorithm as above using the E(z)731, Su(z)124 and H3K27R 
comparisons (Figure 40A). All H3K27me3 depletion mutants are enriched for genes up-regulated 
6h post septic injury genes, but this is not the case for other time points after septic injury. 
Samples from Su(z)124 are not enriched for either the 18h or the 3h post septic injury genes set, 
while genes up-regulated in E(z)731 mutants are not enriched for the 3h post septic injury. At the 
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same time, H3K27R mutants show the strongest enrichment for 6h and 18h immune induced genes 
by p-value (2*10-9 and 8*10-9 respectively). This is likely explained by the observation that the 
H3K27R mutation induced the strongest loss of repression among all the H3K27me3 depletion 
mutants.   
 
 
Figure 40: Plasmatocyte immune regulated genes are induced after the loss of H3K27me3. A: RNA-seq 
comparisons of H3K27R, Su(z)124 and E(z)731 mutants to their wild type matched samples are analyzed for 
enrichment of genes up-regulated in plasmatocytes after 3h, 6h or 18h post septic injury using the fry 
algorithm. B: GSEA of 12x HisGU H3wt vs. 12x HisGU H3K27R checking for the enrichment of genes induced 
in plasmatocytes after septic injury. Bottom panel: Log2 fold change of 12x HisGU H3wt vs. 12x HisGU H3K27R  
over gene rank. Top panels: Density of genes positive for the gene module. Middle: GSEA score by gene 
rank. P-values by permutation: 6h and 18h post septic injury: p < 1*10-5; 3h post septic injury: n.s. 
 
Therefore, I applied GSEA using the set of immune induced genes and the 12xHisGU H3K27R over 
12xHisGU H3wt comparison (Figure 40B).  Here, there is strong enrichment of genes that are up-
regulated at 6h or 18h post septic injury (both p < 1*10-5), with this time the  18h post septic injury 
gene set having stronger enrichment. In this analysis method, 3h post septic injury up-regulated 
genes are not significantly enriched. However, it is important to consider that in the 3h post septic 
injury-induced genes only a small fraction of them were H3K27me3 positive (Figure 19). Therefore 
it is likely that perturbance of H3K27me3 levels does not affect genes from this set to the same 
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extent as those from 6h post septic injury. Together this shows that depletion of H3K27me3 leads 
to an induction of immune genes, as H3K27me3 depletion mutants are enriched for genes 
induced in plasmatocytes after septic injury. 
The enrichment of immune induced genes in all of the H3K27me3 depletion mutants clearly 
indicates that those immune genes are generally regulated by H3K27me3. To characterize to 
what extent the same genes are differentially expressed across all H3K27me3 depletion mutants, 
and what fraction are affected at all I took the gene set induced in E(z), Su(z)12 and H3K27R mutants 
(Figure 37B) and additionally overlaid all genes that were up-regulated at 6h post septic injury 
and in a H3K27me3 positive chromatin state (Figure 28). I then visualized the overlap between 
these gene sets as a Venn diagram (Figure 41). Only about half of all genes that are up-regulated 
at 6h post septic injury and are H3K27me3 positive (green circle) overlap with any other 
H3K27me3 depletion mutants, and most of them only with the H3K27R mutant. In fact, only 3 of 
the 6h post septic injury overlaps with all 3 of the H3K27me3 depletion mutants. 
 
 
Figure 41: Venn diagram of H3K27me3 depletion mutants and immune induced H3K27me3 positive 
genes. Venn diagram of up-regulated genes in H3K27me3 depletion plasmatocyte mosaics compared to 
immune induced genes. Genes were selected for those which were up-regulated when comparing 
plasmatocyte mosaics of 12x HisGU H3wt vs. 12x HisGU H3K27R (magenta), E(z)731 vs E(z)wt (orange) and 
Su(z)124 vs Su(z)12wt (purple) with a false discovery rate corrected p-value < 0.05 and an LFC > 1. 
Additionally, genes that were up-regulated with p-value < 0.05 and an LFC > 1 at 6h post septic injury and 
were in an H3K27me3 positive gene state were selected (green). Numbers indicate the number of genes in 
that overlap. 
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This raises the question, why only a fraction of H3K27me3 positive immune genes is affected by 
the loss of H3K27me3. First, it appears that the number of overlapping genes correlates with the 
total number of differentially expressed genes. It is possible, that the immune genes are 
“drowned out” by a large number of other induced genes, that is, the conservative false discovery 
correction will cut these genes of as potential noise if a large number of other genes is changed 
more strongly. Second, it is possible that the immune genes only sporadically activate after the 
loss of H3K27me3 in a fashion that is unrelated to the exact mutation. This would cause higher 
variability between replicates, and in turn, this would result in weaker phenotypes of H3K27me3 
loss, like those observed in E(z) and Su(z)12 mutants, finding fewer significant immune genes. 
Therefore, it seems likely that some variance in immune signaling and not differences in 
H3K27me3 regulation cause the differences in up-regulated genes. 
Further, I identified how genes that were differentially modified by H3K27me3 and HK37ac after 
septic injury respond to the loss of H3K27me3 by mutation of writer enzymes or histones. The 
advantage of comparing the H3K27me3 depletion mutants to differentially modified genes over 
differentially expressed genes is, that these factors are directly linked: Genes that are 
differentially modified are more likely to be also regulated by that modification, if such a 
regulation exists at all, while differentially expressed genes could be differentially expressed for 
a number of other reasons that are unrelated to H3K27me3.  
 
 
Figure 42: Differentially modified genes and H3K27me3 depletion mutants. RNA-seq comparisons of 
H3K27R, Su(z)124 and E(z)731 mutants to their wild type matched samples are analyzed for enrichment of 
genes, which were identified to be differentially modified by H3K27me3 (Figure 22) or H3K27ac (Figure 23). 
Gene groups were identified by applying MACS2 or EM to the differential ChIP samples and finding 
overlapping genes. Enrichment was tested using the fry algorithm 
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Therefore, I applied the limma fry algorithm to the set of differentially modified genes that at 6h 
post septic injury were either increased in H3K27me3 or reduced in H3K27ac, as determined by 
MACS2 and EM (Figure 22 and Figure 23), using the E(z)731, Su(z)124 and H3K27R comparisons and 
plotted them (Figure 42). As for the enrichment of chromatin states and differentially expressed 
genes, modules are only enriched among up-regulated genes. Genes that are reduced in 
H3K27me3 in plasmatocytes after immune challenge according to MACS2 or EM (Figure 42, left 
columns) are enriched, irrespective of the method used for detecting differential histone 
modification. Comparing the different mutants with reduced H3K27me3 levels shows that H3K27R 
produces the strongest enrichment by p-value, while Su(z)12 mutants are slightly less enriched 
and E(z) mutants are lowest. For genes increased in H3K27ac (Figure 42, right columns) there is a 
similar pattern, though here the difference between Su(z)12 mutants and E(z) mutants is less 
pronounced. H3K27R having the strongest enrichment in differentially modified genes is consistent 
with the overall more prominent loss of repression in the H3K27R mutants, when compared to the 
PRC2 mutants. But overall, for all mutants, it is apparent that those genes which lose H3K27me3 
after septic injury (or gain H3K27ac) are also up-regulated when H3K27me3 levels are reduced 
genetically. This observation confirms the notion that H3K27me3 is instructive in silencing these 
genes in unchallenged plasmatocytes. 
In summary, I showed that genetic mosaics can be used to generate plasmatocytes that lack the 
repressive H3K27me3 modification. For this, I used mutants in components of the H3K27me3 
writer complex PRC2, specifically in E(z) and Su(z)12, or a direct histone mutation changing 
histone H3 into H3K27R. In these mutants, a set of genes that were repressed by H3K27me3 in the 
H3K27me3 high or H3K27me3 medium states is released from repression. Interestingly, this up-
regulation of silenced genes was most pronounced in H3K27R mutants, but it is not clear at this 
time, whether this is due to differences in the persistence of H3K27me3 mediated repression after 
mutant clones are induced. Further, I showed that in either of these conditions that deplete the 
H3K27me3 modification, there is an ectopic up-regulation of immune genes, indicating that 
H3K27me3 is indeed instructive in repressing immune genes in unchallenged plasmatocytes. 
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6 DISCUSSION 
Histone modifications have been described as important regulators of transcription in 
Drosophila.14 In this context, the H3K27me3 histone mark and the Polycomb group (PcG) proteins 
which are responsible for this modification have been extensively studied for their function in 
development.113 Here in this work, I expanded this understanding by demonstrating a role for 
H3K27me3 and PcG proteins in regulating immune genes in Drosophila plasmatocytes. First, I 
characterized the immune transcriptome and the histone modification landscape of 
plasmatocytes. I then showed that H3K27me3 is associated with immune genes in a newly 
identified chromatin state which is distinct from ‘classical’ Polycomb chromatin found at 
epigenetically silenced developmental genes. I could demonstrate that the H3K27me3 histone 
mark is lost concomitant with the activation of immune induced genes and that in resting state 
plasmatocytes this modification is functionally relevant to prevent erratic activation of immune 
genes in the absence of a pathogenic insult. In the following I want to briefly discuss the 
implications that these observations have and what models might be used to explain them. 
 
6.1 Plasmatocytes as a model system for dynamic gene regulation 
There is a large body of work demonstrating that Drosophila plasmatocytes can respond to a wide 
range of signals, including JAK-STAT signaling296, hedgehog signaling297, Notch signaling126, TNF 
signaling197 and Toll/Imd signalling.192,298,299 To some, if not all, of these signaling modules 
plasmatocytes have to respond in a circumstantial fashion, which means not according to a 
predetermined developmental program but as a response to an stochastic event such as an 
immune challenge. As a consequence, plasmatocytes display a high degree of transcriptional 
plasticity, similar to vertebrate immune cells like monocytes.300,301 At the level of individual genes 
this plasticity translates into a large number of genes that need to remain inactive for an 
‘undefined’ period of time before they are activated. Clearly, activation of sequence specific 
transcription factors through the various signaling modules is critical for such dynamic 
transcriptional responses.  On the chromatin level however, this raises two questions. First, if 
transcription factor based activation is entirely absent for most of the time, how do inactive 
genes escape permanent epigenetic silencing? Or alternatively, if there is constant low level input 
from the respective signaling modules, how is aberrant activation of supposedly inactive genes 
prevented?  
Here, I used the immune activation of plasmatocytes by gram-positive and gram-negative 
bacteria, which signal through the Toll and Imd signaling pathways repectively.232 Such signaling 
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will activate NF-κB like transcription factors, thereby promoting the transcription of immune 
genes.302,303 I was therefore interested in how the histone modification landscape in Drosophila 
plasmatocytes would contribute to this regulation.  
In a first step I therefore characterized the plasmatocyte transcriptome and the expression 
changes after NF-κB signaling. Prior genome-wide studies on transcriptomes of plasmatocytes 
used microarray based system141,192,251, whereas I used RNA-seq. In contrast to microarrays, RNA-
seq allows me to accurately determine the absolute transcriptome, in this case of 
plasmatocytes.304 Furthermore, prior data on immune induced transcriptome changes used a 
hemocyte like cell line instead of primary cells, they analyzed only a single time point after 
immune challenge, and only used gram-negatives for immune activation.192 Hence, here I can 
show for the first time the full immune response of plasmatocytes to bacteria, including their 
temporal dynamics. I can demonstrate, that a number of immune genes is induced by the 
immune signaling, and that this response is comprised of two separate components, an early 
response that encompasses a large number of genes, and a late response, which includes many 
AMPs. 
Then I characterized the histone modification landscape of Drosophila plasmatocytes with the 
aim to determine the chromatin state of inactive but inducible (immune-) genes. This is to my 
knowledge the first ChIP-seq of primary Drosophila immune cells and may be the largest ChIP-
seq experiment of homogeneous Drosophila primary samples today. Other experiments that can 
be found on Gene Expression Omnibus (GEO)305 or modEncode306 include mostly whole animals 
of various developmental stages, or cell lines. There are however a few ChIP experiments 
performed on wing discs, adult heads or ovaries. While these are definitely more specific than 
performing ChIP on whole animals, there still remains a well described heterogeneity in each of 
these samples: Wing discs are divided in multiple zones that are specific in their gene expression 
and developmental fate307, and so are ovaries, which contain among others follicle cells, nurse 
cells and oocytes308, and while heads are enriched for neurons they still contain a variety of other 
cells.  Altogether, these tissues are best studied for their developmentally regulated changes in 
gene expression and do not present a very good model for stochastic gene activation. At the 
same time however, it could be argued that cell lines are exactly such a model system that is 
additionally composed of a pure cell population. And while cell lines may indeed be a good model 
for the respective tissue that they are associated with309, they definitely have some 
shortcomings: First, they are not primary, and the process of transformation that allowed them 
to grow in culture changed their transcriptome, which often specifically involves epigenetic 
changes in histone modifications, sometimes by mutation in the histone modification 
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machinery310-312 Therefore it is essentially impossible to determine to what extend they reflect 
the situation observed in untransformed cells. And second, Drosophila cell lines are genomically 
highly unstable to a point where even cells in one culture will vary drastically in karyotype313, and, 
therefore, cell to cell variability in detecting DNA associated factors by high throughput 
sequencing have to be considered with care. 
For these reasons I think that the ChIP-seq profiles of primary plasmatocytes that I present here 
in this thesis are a valuable data set that can help to understand how histone modifications are 
distributed in individual cells in Drosophila at a level that will be difficult to improve on. 
This assertion however comes with a caveat: It requires the plasmatocytes that I isolate to truly 
be a homogeneous cell type, which additionally is stable across the manipulations that I perform. 
While plasmatocytes have been shown to be derived from several hematopoietic origins, namely 
embryonic plasmatocytes152,154, lymph gland plasmatocytes156,158, and plasmatocytes derived 
from larval hematopoietic hubs162,163, so far, no classification of plasmatocytes into further 
subgroups could be established, neither by function nor by transcriptional patterns. It is a valid 
concern that plasmatocyte population may change as a response to infection and therefore 
confound the transcriptional changes. Anderl, et al. 151 for instance have demonstrated that after 
wasp parasitization of Drosophila larvae emergency hematopoiesis releases additional 
hemocytes into circulation. They do however demonstrate that in their model lamellocytes are 
also released, something I never observed in the septic injury experiments in this thesis. Further, 
for all RNA-seq experiments with septic injury, RNA yields were determined for each sample (see 
Table 8), which can be considered as a good approximation of cell numbers. These RNA yields 
were stable across all conditions, indicating that septic injury did not result in increased release 
of plasmatocytes in my hands. This means that even if there is a level of heterogeneity in the 
larval plasmatocytes used in this thesis, this is likely to be the same across all different treatment 
conditions used here. 
 
6.2 Dynamic Polycomb Chromatin 
Based on the ChIP-seq data from primary plasmatocytes, in combination with the transcriptional 
changes observed in those plasmatocytes after immune activation, I propose to subdivide 
Polycomb chromatin into two distinct chromatin states: Canonical Polycomb chromatin that is 
characterized by high levels of H3K27me3 and found for example at epigenetically repressed 
developmental genes, and dynamic Polycomb chromatin that is characterized by intermediate 
levels of H3K27me3 and includes inactive but still inducible genes. 
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Since the levels of H3K27me3 signal intensity are a critical factor for subdividing Polycomb 
chromatin it is important to consider whether the intermediate level of H3K27me3 could 
represent an artifact caused by a modification different from H3K27me3 for which the antibody 
used in this study has a lower, but still significant affinity. In fact, LaMere, et al. 314 described that 
much of the genome of mouse ESCs is covered be H3K27me2, which is also placed by PRC2, and 
that this H3K27me2 prevents enhancer activation. This explanation is however inconsistent with 
the observations I made in this thesis. First, an antibody recognizing both H3K27me2 and 
H3K27me3 showed high enrichment in some genomic regions, but only much lower enrichment 
in the dynamic Polycomb chromatin state. Therefore, this chromatin state might be higher in 
H3K27me2 than canonical Polycomb chromatin, but it is importantly marked by the presence of 
H3K27me3. Further, antibodies used in this thesis are verified for their specificity for the histone 
modifications, and this includes the H3K27me3 antibody.315 Here, no cross-reactivity for 
H3K27me2 or any other alternative histone modification is described, ruling out that the 
observed effect is due to a mix up of histone H3 lysine 27 modifications. 
There are prior reports that use chromatin state models that include more than one H3K27me3 
positive Polycomb like state. These reports, however, do not address the relevance of such a state 
and their assignments differ from mine in some key factors. Kharchenko, et al. 55, who build a 9 
state model from a combination of Drosophila cell lines using HMM, find one chromatin state 
which has H3K27me3 levels between those states that they identify as Polycomb and active 
states. Throughout their work they identify these areas as background, noting that they are poor 
in genes or at most intronic. In contrast, my results show that dynamic Polycomb chromatin is 
similarly dense in genes compared to canonical Polycomb chromatin, and much denser than 
H3K9me3 positive heterochromatin. Kundaje, et al. 316 on the other hand uses human ChIP-seq 
data from the Encode consortium to build an 18 state model and they identify a distinct 
chromatin state, which they term weak repressed Polycomb, acknowledging that this state is 
likely associated with PcG proteins, and this state carries intermediate levels of H3K27me3, but 
is low in H3K9me3. Again, they do not address potential function that such a weak repressive 
Polycomb chromatin state might have. Evans, et al. 167 address chromatin states in Caenorhabditis 
elegans using data from modEncode to build a model consisting of a total of 20 chromatin states, 
among which they identify 3 Polycomb states. While they do not go into much detai l regarding 
most of the states, they mention that one of the Polycomb states with intermediate H3K27me3 
levels is enriched for odorant receptors, a class of genes which are only expressed in a small 
subset of cells. Therefore, this state might resemble the dynamic Polycomb chromatin described 
here targeting non-developmental genes with a high degree of temporal and special regulation. 
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Kharchenko, et al. 55, Kundaje, et al. 316 and Evans, et al. 317 all use Hidden Makarov Models (HMM), 
whereas I use a mathematically distinct binomial expectation maximization model. Therefore, it 
is important that both model building strategies, using gene level H3K27me3 and a combination 
of all histone marks, I arrive at a model that predicts the dynamic Polycomb chromatin state, 
which carries the intermediate levels of H3K27me3 described by others.55,167,316 At the same time, 
I do observe a large number of genes in this chromatin state, and while I demonstrated that 
immune genes are among them, I also want to show that there is a general class of genes that 
are contained in dynamic Polycomb chromatin. To demonstrate this, I identified enriched Gene 
Ontology (GO) terms in all state models build in this thesis using a hypergeometric model. From 
these GO terms I selected those, which were most variant across the different chromatin states 
and plotted their probabilities, with circle transparency indicating p-values and circle size the 
effect size (Figure 43). First, active gene and enhancer chromatin states (states 4, 6, 7 and 
H3K27me3 low) are strongly associated with many basic cellular processes of metabolism and 
transcription, all listed at the top. At the bottom, there are a number of gene modules that are 
either related to development or generally belong to RNA, transcription or gene expression, most 
likely representing transcription factors. These categories are enriched in both active states and 
the highly repressed canonical Polycomb states (state 5 and H3K27me3 high). Interestingly, no 
GO terms from the top or the bottom of the list are enriched in the newly defined dynamic 
Polycomb chromatin state (state 3 or H3K27me3 medium), in which instead a group of GO terms 
in the middle of the plot is enriched. These terms appear to be GO terms which are related to 
more dynamically expressed genes, including signaling factors and pathways. Interestingly 
olfactory receptors are enriched among this dynamic Polycomb chromatin as well (for example 
detection of chemical stimulus involved in sensory perception of smell), which mirrors the 
observations for the H3K27me3 intermediate state in C. elegans.317 
Given that the dynamic Polycomb chromatin contains many genes, but these genes appear to be 
in a functional category separate from those genes which are either constitutively active or 
targeted by Polycomb, it is likely that this represents a true chromatin state that cannot be simply 
assigned as background, as others have suggested.55 However, since Kharchenko, et al. 55, 
Kundaje, et al. 316 and Evans, et al. 317 restrict themselves to building the chromatin state models, 
they do not further test the function of the identified states, including the H3K27me3 
intermediate states. In contrast, by depleting H3K27me3 and by inducing physiological immune 
signaling, I showed here that the dynamic Polycomb chromatin state which I observe for immune 
genes and many other genes is functional in repressing genes and dynamically regulated in 
response to signaling. 
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Figure 43: Genes with a high special and temporal variability are enriched on dynamic Polycomb 
chromatin. Genes were grouped into genes overlapping with one of the 7 chromatin states or genes with 
low, medium or high H3K27me3 states. For all genes GO annotation was derived from the Gene Ontology 
consortium318 and enrichment was tested using a hypergeometric distribution. Among all GO terms, those 
with the highest variance in module associated genes were selected and plotted. Plotted were all 
enrichments with p < 0,05, plotting p-values as circle transparency and effect size as circle size. 
 
6.3 Molecular basis of dynamic Polycomb chromatin 
Defining two Polycomb chromatin states by the levels of H3K27me3 raises the question, how 
distinctly different levels of this modification could be implemented on a molecular level. 
Individual nucleosomes contain exactly 2 copies of H38, and therefore 3 different levels for 
individual histone modifications in one nucleosome are possible: either 0, 1 or 2 modifications per 
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nucleosome can be found for a specific amino acid residues. Therefore, an H3K27me3 low state 
could consist of nucleosomes that carry no histone H3 lysine 27 trimethylation at all, while in a 
H3K27me3 high state almost every nucleosome is modified twice. For dynamic Polycomb 
chromatin, which is characterized by intermediate levels of H3K27me3, two scenarios could then 
be considered. On one hand, nucleosomes could be hemi-modified homogeneously over the cell 
population and the two homologous chromosomes. On the other hand, the degree of 
modification may be variable in such chromatin regions with some nucleosomes skipped or 
doubly modified, but averaging out to an overall intermediate modification level. 
Homogeneous hemi-modification might well explain the observed levels of H3K27me3 at gene 
levels, but it is difficult to imagine how such a pattern could be maintained, unless there exists a 
co-factor that checks modification of one H3 per nucleosome to then prevent the same 
modification on the second H3. While a similar but positive regulation could be implemented 
through the ability of Extra sex combs (ESC) to bind H3K27me3 and recruit PRC2 for further 
modification114, a factor that antagonizes H3K27me3 modification analogously has not been 
described yet. Therefore, it is likely that the H3K27me3 intermediate chromatin state involves 
stochastic or sparse modification of nucleosomes with H3K27me3. 
It is important to note however that ChIP methods that rely on populations of cells necessarily 
fail to discriminate between a scenario in which a given chromatin region is sparsely modified in 
all cells of the population, and a scenario in which the same region is highly modified in some cells 
but not at all in other cells of the population. In other words, they fail to determine at which level 
the stochastic element comes into play – at the chromatin level or at level of the cell population.  
Accordingly, in the most extreme case of population level diversity even in an ontologically 
homogeneous cell populations like plasmatocytes, dynamic Polycomb chromatin could not 
actually reflect a distinct chromatin state but in fact chromatin regions that are active in some 
cells and ‘classically’ repressed Polycomb chromatin in others. Two observations argue against 
this possibility. First, many genes that I assigned to dynamic Polycomb chromatin are not 
expressed across the population in resting plasmatocytes. This is not consisten t with a significant 
portion of cells with non-repressed genes in these chromatin regions, given that they are up-
regulated after H3K27me3 depletion and therefore actively repressed. Second, upon stimulation, 
H3K27me3 is actually lost from up-regulated genes. Hallmark of ‘classic’ Polycomb chromatin is 
that genes remain silenced even ‘against’ transcriptional input.319 This strongly argues for 
dynamic Polycomb chromatin as a functionally distinct chromatin state.  
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A final answer, however, about how this chromatin state is implemented on the chromatin level 
would require high coverage single cell methods to identify histone modifications in an allelic 
fashion, which do not exist at the moment. 
 
 
6.4 Functional dynamics of H3K27me3 
Regardless of how exactly the dynamic Polycomb chromatin is established, whether it derives 
from a homogeneous intermediate level of H3K27me3 or a mixture of active and repressed gene 
states with cell-to-cell variability, it is characterized, and distinguished from constitutive 
Polycomb chromatin, by a dynamic removal of the H3K27me3 mark upon transcriptional 
activation of genes. I demonstrated that immune genes, which were targeted by H3K27me3 in 
unchallenged plasmatocytes, are depleted in that histone modification after septic injury 
concordant with their transcriptional activation. Such reduction could either represent a sporadic 
removal of H3K27me3 in the homogeneous H3K27me3 model, or a switching of genes in a 
number of cells from a H3K27me3 positive repressed state to a H3K27me3 negative active states. 
Either process would involve the removal of H3K27me3 from associated genes, a process which 
could in principle happen in one of 2 ways: Either H3K27me3 is enzymatically removed by the 
dedicated demethylase Utx, or the entire modified H3, perhaps even the entire nucleosome, is 
evicted from its position and replaced by a fresh or unmodified H3 or nucleosome. This histone 
exchange can happen in a number of ways, both co-transcriptionally, where RNA polymerase II 
recruits a number of chromatin remodelers320, or in the absence of transcription, where for 
example the chaperon of the variant histone H3.3 Hira321,322 and the SWItch/Sucrose Non-
Fermentable (SWI/SNF) complex323 have been shown to help the eviction of present histones to 
allow the insertion of unmodified ones. 
The fact that I observe a loss in H3K27me3 is crucial, particularly in light of the cell-to-cell 
variability model of intermediate levels of H3K27me3. If there was a system were some 
plasmatocytes had their immune genes repressed by H3K27me3 while another subset had their 
immune genes in an active chromatin state, those cells with active immune genes could alone be 
responsible for the increase in immune gene transcription after septic injury, without changes in 
H3K27me3. Only because I can show a loss of H3K27me3 after septic injury, I can be sure that this 
intermediate H3K27me3 state is truly a dynamic Polycomb chromatin state. 
Interestingly, I also see a gain in H3K27ac after immune stimulation. This mark is placed by the 
acetyltransferase nej, a member of the Trithorax group (TrxG), a group of proteins which has been 
well described to counteract the activity of proteins of the Polycomb group (PcG) in 
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development.324,325 In Drosophila, the activity of TrxG prevents the silencing of developmental 
genes to which they are targeted, permitting a stable “on” gene state.28,119 Therefore it is possible 
that TrxG proteins are also recruited to immune genes in plasmatocytes after septic injury to help 
overcoming Polycomb silencing and prevent the reestablishment of a silenced gene state. 
Interestingly, it has previously been demonstrated in human macrophages, that H3K27ac is 
differentially regulated in response to immune activation, and that this may play a role in a 
process that creates ‘immune memory’ that persists for several days.241 Similarly, the activity of 
TrxG members and the placement of H3K27ac may stabilize the expression of target immune 
genes in plasmatocytes or increase future inducibility of those genes after a first immune 
activation.  
 
6.5 Targeting of the dynamic Polycomb chromatin state 
In this work I also showed that the establishment of silencing by dynamic Polycomb chromatin in 
principle involves the same mechanisms that are used to establish constitutive Polycomb 
chromatin: The PRC2 complex modifies histone H3 at lysine 27 to produce H3K27me3, which then 
causes gene silencing.25 In Drosophila it is well described that the classic Polycomb silencing 
mechanism involves dedicated genetic elements, called PREs, which bind PRC2 in a sequence 
depended manner and are sufficient to confer silencing to adjacent genes.122 However, so far only 
very few PREs have been predicted, i.e. by Ringrose, et al. 276 who predicted 167 PREs and Zeng, 
et al. 275 who predict several hundred PREs. This is in contrast to the several thousand of genes 
that I demonstrated here to be targeted by either canonical or dynamic Polycomb chromatin. 
This raises the question whether PREs are also involved in the silencing of dynamic Polycomb 
chromatin, and if they are, why they were not predicted based on a sequence motive analysis. It 
is possible, that PREs that target dynamically regulated genes are quite different from the well-
characterized PREs at developmental genes, which would prevent sequence-based prediction. 
Importantly, if PREs are responsible for establishing dynamic Polycomb chromatin as well, based 
on the characteristics I observed here they must differ in at least one fundamental way: Classic 
PREs have been identified for their capacity to confer silencing to transgenic constructs in a 
fashion that will not be overcome by later transcriptional activation.102 The genes I describe here 
are however activated by physiological transcriptional signaling. This even raises the question, 
whether such sequences that recruit PRC2, if they existed in dynamic Polycomb chromatin, 
would eventually fit the strict definition of PREs.  
Many alternative models have been proposed in vertebrate systems by which Polycomb factors 
could be recruited to regions which are to be silenced, including long non-coding RNAs, nascent 
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transcripts and CpG islands.326 One interesting model proposes that absence of gene expression 
itself is sufficient to cause H3K27me3 placement. Both Riising, et al. 327 and Hosogane, et al. 328 
found that gene inactivity preceded the recruitment of PRC2 and the placement of H3K27me3 at 
relevant genes. They therefore conclude that PcG protein recruitment appears not instructive for 
silencing, but is a consequence of inactivity. Such observations have led to the development of 
the “chromatin sampling” model, where PcG proteins randomly sample chromatin regions and 
then modify histones in places where they are not quickly displaced by transcriptional activity. 329 
It is important to point out however, that the model of gene inactivity preceding stable Polycomb 
silencing in no way contradicts the PRE based Drosophila model: It is well described that PREs are 
primarily memory elements that maintain silencing, but they do not carry the information 
required to establish the cellular pattern of silencing (which is instead formed by segment specific 
enhancers).118 And while earlier reports proposed that transcriptional activity at silenced PREs 
would be sufficient to neutralize their activity and allow activation of adjacent genes 121, recent 
reports contradict this hyothesis.319 
One factor that has frequently been discussed, particular in vertebrate development, is the idea 
of bivalent chromatin states, which refers to chromatin that is modified at the same time with 
active histone marks by TrxG proteins and with repressive marks by PcG proteins.330 Such genes 
are then often described as poised for transcription, that is that they are inactive but can be 
activated by transcriptional signaling. In vertebrates a poised state consisting of genes which are 
simultaneously positive for H3K27me3 and H3K4me3 is the best described bivalent state 331, while 
in Drosophila a bivalent state with H3K27me3 and H3K4me1 has been proposed.332 I can however 
not identify any H3K4me3 H3K27me3 double positive chromatin regions, ruling out such bivalent 
states. In my data, H3K4me1 H3K27me3 double positive regions can be seen on a small number 
of developmental genes, including Hox genes, where there are localized at either site of sharp 
RNA-PolII peaks in regions far away from transcriptional start sites, likely marking gene 
enhancers.256 Interestingly, these observations are restricted to silent genes, which are, as 
plasmatocytes are fully differentiated cells, unlikely to ever be activated, and therefore resemble 
the description of Bonn, et al. 333. At the same time those immune genes which are targeted by 
intermediate levels of H3K27me3 do not appear to be associated with such H3K27me3 H3K4me1 
double positive enhancers, which reasons against bivalent chromatin states as a cause of 
transcriptional inducibility. 
In contrast Sneppen and Ringrose 66 have proposed that bistability is the mode in which poised 
chromatin is controlled. This means that depending on external signaling either active or inactive 
gene states are preferred. A similar mechanism could be at work here (Figure 44), where inducible 
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genes are generally kept in a silenced state, which suppresses gene transcription at signaling 
levels close the background noise. Once a specific activation threshold is met, however, the gene 
turns to an active chromatin state, which is permissive of transcriptional activity, and the gene 
can produce transcript relative to the level of signaling input. In such a model genes in individual 
cells or even individual alleles could switch states with a probability dependent on the signaling 
levels experienced by that individual gene, therefore resulting in a non-linear switching of 
individual cells as for example immune signaling increases. 
 
 
 
Figure 44: Model of a bistable system in dynamic Polycomb chromatin. Dynamic Polycomb chromatin 
(right) is repressed or silent when no or low transcriptional signaling is present, but at higher signaling levels 
switches to an active or permissive state. Therefore, the transcriptional output is offset by a threshold (left). 
In low signaling situations, no transcription can take place, and the gene does not respond to the 
transcription factor. Once a threshold is met, the gene turns active, and further transcriptional signaling 
can trigger increased transcriptional output. 
 
6.6 Relevance of dynamic Polycomb chromatin 
In the immune response two main potential uses for this non-linear behavior of dynamic 
Polycomb chromatin come to mind: Preventing chronic immune activation and enabling 
transcriptional immune memory. With regard to chronic immune activation, in the vertebrate 
system autoinflammation is well described.334,335 There, it is caused by mutations or 
misregulation in a number of pathways and manifests itself through many symp toms including 
Discussion 
 
 127 
fevers and chronic pain.334,335 In Drosophila only few reports on chronic immune activation are 
available. Guillou, et al. 336 describe a mutant, in which chronic cytokine signaling disrupts gut 
homeostasis and reduces the lifespan of mutant animals, while Libert, et al. 337 demonstrate that 
artificial sterile activation of NFB leads to a chronic inflammation-like state, which is marked by 
increased resistance against infection, but with reduced longevity in uninfected animals. 
Therefore, it is well possible that in the dynamic Polycomb chromatin state H3K27me3 serves to 
suppress low level NFB immune activation caused by microbial patterns derived from the 
environment in non-infected animals. At the same time in high signaling situations, when a 
pathogen is encountered, the chromatin switches to an active state and transcription of effectors 
can proceed just as it would if the repressive state had never existed. Hence, dynamic Polycomb 
chromatin can help Drosophila to get the best of both worlds, low chronic expression of immune 
genes with quick and strong immune responses after and infectious challenge. 
Further, immune gene targeting by dynamic Polycomb chromatin could be relevant in the 
transcriptional immune memory. In vertebrates, systems of innate immune memory have been 
described, for example in human monocytes, that allow cells to react transcriptionally different ly 
to an immune activator when encountering it for a second time. This can lead to either an 
enhanced (trained) or a reduced (tolerant) reponse.338 Histone modifications are one of the 
mechanism proposed by which this immune memory could be established.241 In Drosophila such 
a mechanism that alters transcriptional immune responses to a bacterial challenge has to my 
knowledge not yet been described. It is nonetheless possible that dynamic Polycomb chromatin 
helps to establish just such a memory mechanism. Depending on how long an active ch romatin 
state is maintained after H3K27me3 is lost, it is possible that these genes can then produce 
antimicrobial factors in anticipation of a future challenge or be more rapidly induced should such 
a second immune challenge occur. 
Thus, gene regulation by dynamic Polycomb chromatin could be beneficial in many situations 
beyond immunity, in circumstances where incorrect or sporadic expression of genes could cause 
harm to the animal. Hence, I propose that dynamic Polycomb chromatin servers as a general 
mechanism to threshold inducible silenced genes to prevent aberrant or detrimental 
transcription, as I showed here for the regulation of immune genes in Drosophila plasmatocytes. 
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7 MATERIAL AND METHODS 
7.1 Lab Methods 
7.1.1 BACTERIAL CULTURES 
Escherichia coli strain DH5 (ThermoFisher) and Staphylococcus aureus  strain 8325-4339,340 were 
picked from frozen glycerol stocks, were plated on LB agar plates and grown overnight at 37°C. 
The resulting plates were stored at 4°C for up to one week. Larger liquid cultures were generated 
by picking individual colonies from the LB agar plates and inoculating 100 ml LB medium in 500 
ml Erlenmeyer flasks. The flasks were then incubated shaking at 180 rpm at 37°C overnight. To 
harvest the bacteria and generate bacterial pellets for septic injury, the OD600 of a 1:10 dilution of 
the overnight culture in LB was measured using the Ultrospec 2100pro. Bacterial cultures of E. 
coli and S. aureus were then pooled at a 1:1 OD600 ratio and centrifuged down at 4000xg for 10 
minutes at room temperature. The resulting pellet was used for septic injury. 
 
7.1.2 FLY RAISING 
Flies were raised and maintained on standard cornmeal food at 25°C or room temperature. For 
experiments on wild type OrR, adult fly collections were left to lay eggs on apple juice agar plates 
with yeast paste overnight at 25°C. After 24h hatched larvae were washed of the plate and further 
larvae were allowed to hatch for 2h. Then, larvae were picked of the plate and transferred into 
36mm food tubes with yeast paste at a density of 120 larvae per tube and raised at 25°C. The 
resulting larval collection tubes would reach 3rd instar wandering stage around 4 days after 
hatching, at which stage plasmatocytes were extracted. 
 
7.1.3 STERILE AND SEPTIC INJURY 
Sharpened tungsten needles were generated by electrolytically removing material from the tip 
of 0,25mm tungsten wire. A piece of tungsten wire was connected to a 6V AC power supply and 
dipped into a 10% solution of NaOH, in which the wire of the other electrode was dipped. 
Periodically, the wire was inspected for the progress of sharpening.   
Sharpened tungsten needles were then used to perform septic injury. The wire was mounted in a 
Moria pin holder. Larvae were taken from food tubes by washing out all larvae with a 20% sucrose 
solution. Larvae were quickly washed in PBS, then dried on paper towels and transferred to a 
rubber dish. Larvae were then pricked with the tungsten needle either sterilized by 70% EtOH 
(sterile injury) or dipped into the bacterial pellet (septic injury). Larvae were then transferred back 
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into normal food tubes with 3 drops of PBS and incubated at 25°C for the indicated time. For 
infection time courses plasmatocytes were always extracted around the same time (15.00 to 
18.00), and injuries were performed 3h, 6h or 18h prior.  
 
7.1.4 LARVAL RNA  ISOLATION AND QPCR 
For RNA isolation from total larvae, they were collected 6h after treatment into 1,5 ml Eppendorf 
tubes and snap frozen in liquid nitrogen. Larvae were then lysed by adding 900 µl of TRIz ol and 
disrupting them with a micropestle. Tubes were briefly centrifuged (16000g, room temperature, 
2 minutes) to remove debris, then the supernatant was moved to a fresh prespun phase lock 
heavy tube. Next, 250 µl chloroform was added to samples, they were mixed thoroughly and 
centrifuged (12000g, room temperature, 15 minutes). The upper aqueous phase was then moved 
to a fresh DNA LoBind tube, making sure not to disrupt the interphase or phenol phase, and 
mixed with 550 µl isopropanol and 1 µl glycogen (20 mg/ml, RNAse free). Samples were mixed by 
inverting and incubated for 30 minutes in the freezer at -20°C. Afterwards samples were 
centrifuged (16ooog, 4°C, 10 minutes) and the supernatant was removed carefully without 
disrupting the pellet. The pellet was resuspended in 100 µl ultra-pure water with 300 mM sodium 
acetate and 1 µl glycogen (20 mg/ml, RNAse free). Next, 300 µl EtOH added and the sample was 
incubated for 20 minutes at -20°C, then centrifuged (16000g, 4°C, 10 minutes) and the 
supernatant was discarded. The pellet was then washed 2 times by adding 1 ml of 70% EtOH 
(prepared with ultra-pure water), each time spinning down the pellet (16000g, 4°C, 3 minutes). 
Afterwards all supernatant was drained and the pellet was dried until no liquid was visib le. The 
pellet was then resuspended in 15 µl of ultra-pure water. 
This RNA was quantified by Nanodrop and reverse transcribed into cDNA using the QuantiTect 
kit according to the manufacturer’s instructions. The resulting cDNA was diluted 1:4 in ultra-pure 
water and 2 µl of cDNA dilution per well was mixed with 10 µl Fast SYBR Green master mix, 2 µl 
of primers (see table below) and 6 µl ddH2O in a MicroAmp qPCR plate. 
 
Target Forward primer Reverse primer 
Rp49 GACGCTTCAAGGGACAGTATCTG AAACGCGGTTCTGCATGAG 
Dpt GCTGCGCAATCGCTTCTACT TGGTGGAGTGGGCTTCATG 
Drs CGTGAGAACCTTTTCCAATATGATG TCCCAGGACCACCAGCAT 
 
The plate was then sealed using MicroAmp transparent film and run on a QuantStudio3 using 
standard SYBR green fast run settings. From the resulting Ct values, re lative expression values 
were calculated as: 
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𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 = 2𝐶𝑡𝑟𝑝49−𝐶𝑡𝐴𝑀𝑃 
7.1.5 PLASMATOCYTE ISOLATION FOR DIRECT RNA EXTRACTION 
For plasmatocyte extraction and RNA isolation, treated or untreated 3 rd instar wandering larvae 
were collected from food tubes and washed in PBS. At the same time Schneider’s medium with 
FCS with 10 mM N-Acetyl-L-Cysteine was prepared in a well of a 24-well tissue culture plate 
(Sarstedt). Larvae were dried on paper towels and transferred to the tissue culture well with 
medium. Then they were ripped by holding the head with forceps (Dumont) and with another 
forceps ripping open the cuticula along the body of the larvae without disrupting the gut. In this 
ways 80 larvae were bled for each sample. The larval carcass was then removed and the 
plasmatocytes were allowed to attach for 10-15 minutes. Afterwards, the plasmatocytes were 
washed 4 times with PBS, then all supernatant was aspirated and they were lysed, either in 500 
µl TRIzol or in 63 µl RNAdvance lysis buffer. TRIzol samples were stored at -80°C, while 
RNAdvance lysed samples were processed immediately. 
7.1.6 CROSSES FOR MUTANT MOSAICS 
Crosses for Su(z)12 and E(z) mosaics were set up using the crosses from Table 7 as: 
 
ℎ𝑠𝐹𝐿𝑃, 𝑡𝑢𝑏𝐺𝑎𝑙4, 𝑢𝑎𝑠𝐺𝐹𝑃𝑛𝑙𝑠; ;
𝑡𝑢𝑏𝐺𝑎𝑙80, 𝐹𝑅𝑇80𝐵
𝑇𝑀6𝐵, 𝑡𝑏1
   𝑥   
𝑡𝑢𝑏𝐺𝑎𝑙80, 𝐹𝑅𝑇2𝐴
𝑇𝑀3, 𝑆𝑏1
 
                                                                    ⇓ 
ℎ𝑠𝐹𝐿𝑃, 𝑡𝑢𝑏𝐺𝑎𝑙4, 𝑢𝑎𝑠𝐺𝐹𝑃𝑛𝑙𝑠
𝑌
; ;
𝑡𝑢𝑏𝐺𝑎𝑙80, 𝐹𝑅𝑇2𝐴
𝑇𝑀6𝐵, 𝑡𝑏1
  𝑥  
𝑆𝑢(𝑧)124, 𝐹𝑅𝑇2𝐴
𝑇𝑀6𝐵, 𝑡𝑏1
 𝑜𝑟 
𝐸(𝑧)731, 𝐹𝑅𝑇2𝐴
𝑇𝑀6𝐶, 𝑡𝑏1
 
                                                                                      ⇓ 
                    ℎ𝑠𝐹𝐿𝑃, 𝑡𝑢𝑏𝐺𝑎𝑙4, 𝑢𝑎𝑠𝐺𝐹𝑃𝑛𝑙𝑠; ;
𝑆𝑢(𝑧)124, 𝐹𝑅𝑇2𝐴 𝑜𝑟 𝐸(𝑧)731, 𝐹𝑅𝑇2𝐴
𝑡𝑢𝑏𝐺𝑎𝑙80, 𝐹𝑅𝑇2𝐴
 
 
Crosses for histone mutants were set up using the crosses from Table 7 as: 
 
       ℎ𝑠𝐹𝐿𝑃;
+
𝑇(2; 3)𝑇𝑆𝑇𝐿
;
𝐷3
𝑇(2; 3)𝑇𝑆𝑇𝐿
   𝑥   
∆𝐻𝑖𝑠𝐶 , 𝐹𝑅𝑇40𝐴
𝐶𝑦𝑂, 𝑓𝑡𝑧
; 6𝑥𝐻𝑖𝑠𝐺𝑈 
                                                                    ⇓ 
ℎ𝑠𝐹𝐿𝑃
𝑌
;
∆𝐻𝑖𝑠𝐶 , 𝐹𝑅𝑇40𝐴
𝑇(2; 3)𝑇𝑆𝑇𝐿
;
6𝑥𝐻𝑖𝑠𝐺𝑈
𝑇(2; 3)𝑇𝑆𝑇𝐿
  𝑥  𝑢𝑏𝑖𝐺𝐹𝑃, 𝐹𝑅𝑇40𝐴; 6𝑥𝐻𝑖𝑠𝐺𝑈 
                                                                   ⇓ 
                                             
ℎ𝑠𝐹𝐿𝑃
𝑌
; 
∆𝐻𝑖𝑠𝐶 , 𝐹𝑅𝑇40𝐴
𝑢𝑏𝑖𝐺𝐹𝑃, 𝐹𝑅𝑇40𝐴
; 6𝑥𝐻𝑖𝑠𝐺𝑈 
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The crosses for the final larvae were left to lay eggs for 4h using 20 female and 10 male flies. The 
resulting larvae were then heat shocked twice, once in the 1st instar stadium (24h-48h after egg 
laying) and once in the 2nd instar stadium (48h-72h after egg laying). Then 3rd instar wandering 
non-tb female larvae were collected for further processing. 
 
7.1.7 PLASMATOCYTE ISOLATION AND FACS  SORTING 
For FACS sorting of plasmatocytes appropriate 3rd instar wandering larvae were collected. These 
were either OrR and Hml-dsRed larvae (see Table 7), or non-tb female larvae from mosaic crosses 
(see 7.1.6). These larvae were washed in PBS, dried on paper towels and transferred to Nunclon 
Sphera ultra-low attachment dishes filled with 0,5 ml Schneider’s medium with FCS with 10 mM 
N-Acetyl-L-Cysteine. Larvae were then bled by holding the head with forceps (Dumont) and with 
another forceps ripping open the cuticula along the body of the larvae without disrupting the gut. 
Carcasses were then removed and the cell suspension was cell stained using 70 µm cell FlowMi 
cell strainers. DAPI was added to a final concentration of 1 µg/ml to mark dead cells. For all 
analysis plots shown in this thesis cells were then sorted using MACSquant Analyzer, dsRed was 
detected using 488nm excitation and 585/40 filters, GFP was detected using 488nm excitation 
and 525/50 filters and DAPI was detected using 405nm excitation and 450/50 filters. FACS data 
was analyzed using FlowJo10. 
Sorting of cells for RNA isolation was performed in the Flow Cytometry Core Facility (DRFZ), 
using the BD FACSAria ROWLF, sorting for GFP using a 488nm laser for excitation and a 530/30 
filter for emission and sorting for DAPI negative cells using a 405nm laser for excitation and a 
450/40 filter for emission. The resulting cells were collected, spun down (2000g, 4°C, 5 minutes) 
and lysed either in 500 µl TRIzol or 63 µl RNAdvance lysis buffer. TRIzol samples were stored at -
80°C, RNAdvance samples were isolated immediately. 
 
7.1.8 RNA ISOLATION BY TRIZOL 
Frozen TRIzol samples were thawed at room temperature, adjuster to 900 µl with TRIzol and 
moved to fresh prespun phase lock heavy tube. 250 µl chloroform was added to each sample, 
they were mixed thoroughly and centrifuged (12000g, room temperature, 15 minutes). The upper 
aqueous phase was then moved to a fresh DNA LoBind tube, making sure not to disrupt the 
interphase or phenol phase, and mixed with 550 µl isopropanol and 1 µl glycogen (20 mg/ml, 
RNAse free). Samples were mixed by inverting and incubated for 30 minutes at in the freezer at -
20°C. Afterwards samples were centrifuged (16ooog, 4°C, 10 minutes) and the supernatant was 
removed carefully without disrupting the pellet. The pellet was resuspended in 100 µl ultra-pure 
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water with 300 mM sodium acetate and 1 µl glycogen (20 mg/ml, RNAse free). Next, 300 µl EtOH 
was added and the sample was incubated for 20 minutes at -20°C, then centrifuged (16000g, 4°C, 
10 minutes) and the supernatant was discarded. The pellet was washed 2 times by adding 1 ml of 
70% EtOH (prepared with ultra-pure water), each time spinning down the pellet (16000g, 4°C, 3 
minutes). Afterwards all supernatant was drained and the pellet was dried until no liquid was 
visible. The pellet was then resuspended in 15 µl of ultra-pure water and stored at -80°C. 
 
7.1.9 RNA ISOLATION BY RNADVANCE 
RNA was isolated from freshly lysed plasmatocytes samples using the RNAdvance cell v2 kit 
following manufacturer’s instructions using a DynaMag-2 magnetic rack. DNase digestion was 
performed as suggested in the manual using Ambion DNase. Resulting RNA samples were eluted 
in 20 µl ultra-pure water and stored at -80°C. 
 
7.1.10 RNA QUALITY CONTROL 
RNA concentration of RNA samples for library preparation was measured using the Qubit RNA 
high sensitivity kit and the Qubit 2.0 fluorometer using 2 µl of RNA sample according to 
manufacturer instructions where applicable. 1 µl of RNA was then diluted to 1 ng/µl and run on 
an Agilent bioanalyzer RNA Pico by the Max Planck Institute for Infection Biology DNA/RNA 
analysis core facility. If the resulting samples had the expected RNA concentrations and showed 
the characteristic ribosomal RNA peaks on the bioanalyzer without signs of degradation, they 
were used for subsequent library preparation. 
 
7.1.11 RNA LIBRARY PREPARATION 
Libraries for FACSed plasmatocytes from histone mutants and matching controls were 
generated by the Max Planck Genome Centre (Cologne). All other libraries were prepared by me 
and were made using the NEBNext Ultra II Directional RNA Library Prep with Sample Purification 
Beads, the NEBNext Poly(A) mRNA Magnetic Isolation Module and the NEBNext Multiplex 
Oligos for Illumina sets according to manufacturer's instruction. Adaptor concentrations were 
adjusted according to manual instructs. The number of PCR cycles was adjusted depending on 
starting RNA amount (see Table 8). The final libraries were eluted into 12 µl ultra-pure water and 
stored at -20°C. 
 
7.1.12 PLASMATOCYTE ISOLATION AND CROSSLINKING FOR CHIP 
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For plasmatocyte extraction and chromatin fixation, untreated or 6h septic injury 3rd instar 
wandering larvae were collected from food tubes and washed in PBS. At the same time 
Schneider’s medium FCS with 10 mM N-Acetyl-L-Cysteine was prepared in a well of a 6-well 
tissue culture plate (Sarstedt). Larvae were dried on paper towels and transferred to the tissue 
culture well with medium. Then they were ripped by holding the head with forceps (Dumont) and 
with another forceps ripping open the cuticula along the body of the larvae without disrupting 
the gut. 100 larvae were bled this way for each sample. The larval carcass was then removed and 
the plasmatocytes were allowed to attach for 10-15 minutes. Afterwards, the plasmatocytes were 
washed 4 times with PBS, then all supernatant was aspirated and plasmatocytes were fixed for 
10 minutes at room temperature with 1,8% Formaldehyde in PBS. Afterwards, fixation was 
quenched for 3 minutes using 100 µl 2M glycine. Then cells were scraped of the dish using a cell 
scraper and transferred to 1,5 ml tube on ice. After a 5-minute incubation on ice, plasmatocytes 
were centrifuged (3000g, 4°C, 5 minutes), then washed 2x with PBS-Tx (PBS + 0,1% Triton X-100 
w/v), each time spinning the cells down (3000g, 4°C, 5 minutes). After the final wash, as much 
supernatant as possible was removed from the pellet, without losing it, then the tube was snap 
frozen in liquid nitrogen and stored at -80°C until the ChIP. 
 
7.1.13 CHIP PROTOCOL 
For ChIP a number of tubes corresponding to the appropriate number of fixed larval 
plasmatocytes (see Table 9) was thawed on ice. All tubes were then resuspended in ice cold PBS-
Tx (PBS + 0,1% Triton X-100 w/v) and pooled. If several different ChIPs were performed in one 
run, they derive from a common cell pool. If replicates of a ChIP were performed in one run, these 
samples derive from separate cell pools. Pooled fixed plasmatocytes were centrifuged down 
(4500g, 4°C, 10 minutes) and all supernatant was drained. Cells were then resuspended in RIPA 
buffer supplemented with protease inhibitor cocktail, PhosSTOP and 20 mM sodium butyrate to 
a final concentration of 3 larval equivalents of plasmatocytes per µl. Plasmatocytes were then 
dissociated using a syringe with a G26 needle by passing the cell suspension through it 10 times 
and afterwards incubated for 30 minutes on ice. The chromatin suspension was next split into 
prechilled Bioruptor microtubes at 100 µl per tube and then sonicated in a Bioruptor Pico using 
30s on 30s off cycles at 4°C. Sonication was performed first for 3 cycles and then 2 times for 4 
cycles with in-between vortexing of tubes. Sonicated chromatin samples were then spun down 
to remove unsheared debris (16000g, 4°C, 10 minutes) and the supernatant was pooled into a 
fresh DNA LoBind tube. Samples were then split into chilled tubes according to the required 
plasmatocyte counts (see Table 9) holding a small amount back as input. Volumes were adjusted 
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to 100 µl using RIPA and antibodies were added at appropriate concentrations (see Table 1). The 
chromatin antibody mixture was then incubated on a rotating wheel at 4°C overnight. The next 
day a 1:1 mixture of protein A and protein G Dynabeads was washed 3 times using a DynaMag-2. 
Then the beads were resuspended in a small volume and beads were added to the overnight 
samples to make a final amount corresponding to 5 µl of each protein A and G beads. Bead -
antibody-chromatin samples were incubated on a rotating wheel at 4°C for 4 hours. Then room 
beads were pulled down using a DynaMag-2 in a cold, resuspended in fresh RIPA and washed for 
10 minutes on a rotating wheel. This washing was repeated 4 times with RIPA500, once with LiCl 
buffer and 2 times with TE buffer, for which washing was limited to 5 minutes. Finally, the beads 
were resuspended in 100 µl RIPA and the same was done for the untreated input sample. Then 1 
µl of RNase (10 mg/ml) was added to each sample and they were incubated for 1h at 37°C. Then 
4 µl 10% SDS and 3 µl Proteinase K (20 mg/ml) was added to each sample and they were 
incubated overnight at 65°C shaking at 1200 rpm. The next day the magnetic beads were 
removed using the DynaMag-2, and DNA was isolated from the supernatant using the Zymo ChIP 
DNA clean and concentrator kit according to the manual. The DNA was finally eluted in 30 µl 
ultra-pure water and stored at -80°C. 
 
7.1.14 CHIP QUALITY CONTROL 
ChIP samples were checked for concentration of DNA using 5 µl of ChIP sample in the Qubit DNA 
high sensitivity kit using the Qubit 2.0 fluorometer. Differential enrichment of genomic regions 
by ChIP was then confirmed by qPCR. 2 µl of each ChIP was diluted across reactions for 8 regions 
with 2 replicates each and qPCR was performed using the Fast SYBR Green master mix with 
primers targeted against well characterized genomic regions (see Table 6) according to the 
manufacturer’s instructions. All samples passed these quality control tests. 
 
7.1.15 CHIP LIBRARY PREPARATION 
ChIP-seq libraries were prepared from the final ChIP samples using the NEBNext Ultra II DNA kit 
and the NEBNext Multiplex Oligos for Illumina sets according to the manual with one minor 
adjustment: Size selection of the library was performed after PCR amplification. For this, after 
PCR amplification 27,5 µl of AMpure XP beads was added to each sample and incubated for 5 
minutes. Then, the tubes were placed on a DynaMag-2 and the supernatant was moved to fresh 
tubes, while the beads were discarded. To the supernatant 22,5 µl AMpure XP beads was added, 
they were incubated for 5 minutes at room temperature, then pulled down using the DynaMag-
2 and the supernatant was discarded.  
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The beads were washed 2 times on the magnetic rack with 80% EtOH and then resuspended in 
17 µl ultra-pure water. After incubating for 2 minutes at room temperature, the magnetic beads 
were pulled down and the supernatant containing the final libraries was moved to fresh tubes. 
The libraries were then stored at -20°C. 
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7.1.16 LIBRARY QUANTIFICATION AND POOLING 
Both RNA-seq and ChIP-seq libraries were processed the same way for quality control and 
sequencing. First DNA concentration was determined in all libraries using the Qubit DNA high 
sensitivity kit. 1 µl of the library was then diluted down to 1 ng/µl using EB buffer and run on an 
Agilent bioanalyzer high sensitivity DNA ChIP by the Max Planck Institute for Infection Biology 
DNA/RNA analysis core facility. If the library was sufficiently concentrated and no adaptors were 
visible in the bioanalyzer tracks library concentrations were then determined using the KAPA 
library quantification kit. Therefore, all libraries were diluted 1:300000 and run in 2 wells of a 
MicroAmp plate in the QuantStudio3 according to the KAPA kit instructions. From the Ct values 
relative molar abundances of each library was calculated as 2-Ct and from this pooling ratio 
volumes were determined, that would yield to desired read count for each library. Where 
necessary libraries were diluted in EB buffer. 
 
7.1.17 LIBRARY SEQUENCING 
All libraries were sequenced either at Max Planck Genome Centre (Cologne) or at the Max Planck 
Institute for Molecular Genetics (Berlin). Which library was sequenced where and further run 
conditions are listed in Table 8 and Table 9. 
 
7.1.18 PLASMATOCYTE ISOLATION AND IMMUNOFLUORESCENCE 
For immunofluorescence of Su(z)12 and E(z) MARCM mosaics, heat shocked female non -tb 3rd 
instar wandering larvae of the cross described in 7.1.6 were collected from food tubes and washed 
in PBS. At the same time Schneider’s medium FCS with 10 mM N-Acetyl-L-Cysteine was 
prepared in 8-well ibidi microscopy slides. Larvae were dried on paper towels and transferred to 
the ibidi dish well with medium. Then they were ripped by holding the head with forceps 
(Dumont) and with another forceps ripping open the cuticula along the body of the larvae without 
disrupting the gut. In this ways 20 larvae were bled for each well. The larval carcass was then 
removed and the plasmatocytes were allowed to attach for 10-15 minutes. Afterwards, the 
plasmatocytes were washed 4 times with PBS, then all supernatant was aspirated and 
plasmatocytes were fixed with 4% PFA in PBS for 5 minutes at room temperature. Plasmatocytes 
were washed 3 times with PBS-Tx (PBS + 0,1% Triton X-100 w/v), quenched for 5 minutes with 
PBS-Tx with 20 mM glycine and then permeabilized for 15 minutes with PBS with 0,4% Triton X-
100. Next the samples were blocked in PBS-Tx with 10% goat serum for 20 minutes. Then 
H3K27me3 or H3K27ac antibodies were added at a 1:500 dilution (see Table 1) in PBS-Tx with 10 
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% goat serum. The primary antibody staining was incubated over night at 4°C and then washed 
3 times for 5 minutes with PBS-Tx. In parallel, the secondary antibody (1:400, see Table 1) solution 
was prepared in PBS-Tx with 10% goat serum and quickly spun down to remove antibody 
aggregates. Plasmatocytes samples were stain with the secondary antibody solution for 1h at 
room temperature. Afterwards, the plasmatocytes were washed 3 times for 5 minutes with PBS-
Tx, then washed for 5 minutes with PBS-Tx with 1 µg/ml DAPI, washed once with ultra-pure water 
and then mounted in ProLong Diamond. The plasmatocyte samples were imaged on a Leica SP8, 
using 405nm, 488nm and 563nm lasers at 20x magnification for 8-10 positions per well. This was 
repeated for 3 independent experiments. The resulting data was processed in ImageJ. First cell 
nuclei were automatically identified by the DAPI staining: A 0.4-micron gaussian blur was 
applied, then the image was thresholded using the default auto threshold method. Cells were 
identified by the Analyze particles algorithm using a circularity of 0.5-1 and a size of 5-40 square 
microns. For these regions of interest, the signal was determined for each individual picture in all 
3 channels, GFP, DAPI and antibody staining. The data was then transferred to R, where a manual 
threshold for the GFP staining was determined and the antibody staining intensity was 
normalized to the DAPI intensity. This cell level normalized intensity was then used as a metric 
for histone modification abundance in GFP positive (mutant) and GFP negative (wild type) 
plasmatocytes. 
 
7.2 NGS Bioinformatics 
7.2.1 RNA DATA MAPPING AND QUALITY CONTROL 
All sequencing data was transferred from the Max Planck Genome Centre (Cologne) or the Max 
Planck Institute for Molecular Genetics (Berlin) as fastq files that were pre-split according to 
library indexes with a 0 mismatch de-multiplexing. The completeness and intactness of 
transferred data was checked by MD5 sums. The quality of the sequencing run was determined 
using FastQC.  
The reference genome fasta sequence file of the Berkeley Drosophila Genome Project assembly 
dm6 and the related gtf genome annotation file for dm6 of ensembl release 91 (dm6.91) were 
downloaded from ensembl (www.ensmbl.org).341 A reference genome index was generated using 
dm6.91 using STAR-2.7.0e342 calling 
STAR --runMode genomeGenerate --runThreadN 10 --genomeDir TargetDir  
--genomeFastaFiles SourceDir/Drosophila_melanogaster.BDGP6.dna.toplevel.fa  
--sjdbGTFfile SourceDir/Drosophila_melanogaster.BDGP6.91.gtf 
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The resulting index was used to map the fastq files to the genome using 
STAR --genomeDir GenomeDir –readFilesIn ForwardMate.fastq.gz ReverseMate.fastq.gz  
--readFilesCommand gunzip -c --outSAMtype BAM SortedByCoordinate  
--alignIntronMin 12 --outFileNamePrefix OutputDir --runThreadN 6 
 
Next, an index file was generated for the resulting bam file using samtools343 
samtools index TargetBam 
 
And duplicate reads were removed using Picard tools 
java -Xmx32G -jar picard-2.8.2.jar MarkDuplicates INPUT=StarOutput.bam 
OUTPUT=NoDuplicateFile.bam METRICS_FILE=SampleID_MarkDuplicates_metrics.txt 
OPTICAL_DUPLICATE_PIXEL_DISTANCE=2500 CREATE_INDEX=true TMP_DIR=/tmp 
REMOVE_DUPLICATES=true ASSUME_SORTED=true 
 
BigWig signal track files were generated from the duplicate free bam file using IGVtools 344 and 
UCSCtools345 
igvtools count --minMapQuality 30 NoDuplicateFile.bam stdout dm6 | wigToBigWig -clip 
dm6.chrom.sizes NoDuplicateFile.bw 
 
These BigWig files were used to visualize genome tracks in IGV344 
Quality control of RNA-seq mapping was further performed using RSeQC346 applying the 
functions bam_stat, clipping_profile, inner_distance, infer_experiment, insertion_profile, 
junction_annotation, read_distribution, read_dupplication, RPKM_saturation and 
geneBody_coverage according to the RSeQC manual. 
All quality control files for FastQC, STAR mapping, Picard tools and RSeQC were aggregated and 
visualized using MultiQC347 and all data was checked to make sure the library and sequencing was 
of good quality. 
Once a data set passed quality control, the gene level read counts were determined from 
duplicate free bam files using the subread package348 
featureCounts -p -s 2 -t exon -g gene_id -a Drosophila_melanogaster.BDGP6.91.gtf -o RunID.count 
NoDup1.bam NoDup2.bam NoDup3.bam … 
 
These read counts were then used for further analysis. 
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7.2.2 RNA SEQ GENERAL DIFFERENTIAL EXPRESSION ANALYSIS 
The gene level read counts were then loaded into R. For PCA analysis the matrix of gene level 
read counts was transformed using the DESeq2349 rlog function, from which the 1000 most 
variant genes were selected, PCA analysis was performed using the stats package prcomp 
function and visualized using the plot3D package.  
For differential expression analysis, gene level read counts were processed using the edgeR 
package with the quasi-likelihood general linear model approach350,351  according to the manual: 
y <- DGEList(CountMatrix, group = group, genes =geneID) 
y <- y[rowSums(cpm(y)>1) >= 4, , keep.lib.sizes=FALSE] 
y <- calcNormFactors(y) 
y <- estimateDisp(y, design = designMatrix, robust = T) 
 
fit <- glmQLFit(y, designMatrix, robust=TRUE) 
results <- glmQLFTest(fit, contrast = ContrastOfInterest) 
DifferentialTest <- decideTests.DGELRT(results, lfc = 1) 
 
Here, the results object contains gene level log2 fold changes and p-values, while the 
DifferentialTest object determines differential expression with false discovery correction. The 
resulting data was plotted using ggplot2. For heatmaps DESeq2349 rlog transformed read counts 
were transformed to z-scores using the R base package scale function and plotted with ggplot2. 
Hierarchical clustering was done using the stats hclust function on euclidian distances of gene 
vectors. 
For GO term analysis the limma352 function goana was used after converting the Flybase gene IDs 
to EntrezIDs using the ensembl 91 release and biomaRt353. For custom gene sets, the limma352 
function fry was used and results were visualized using ggplot 2, or an implementation of the 
GSEA algorithm (see source code Code Snippet 2) was used. For the GSEA algorithm genes were 
ranked by their log fold change and for each rank the enrichment score for a gene at rank 𝑖 𝑔𝑖  was 
calculated as 
𝐸𝑆(𝑔𝑖 ) =  ∑
|𝑙𝑜𝑔2𝐹𝐶𝑗 |
𝑁𝑅𝑔𝑗∈𝑆
𝑗 ≤ 𝑖 
 − ∑
1
(𝑁 −  𝑁𝐻)𝑔𝑗∈𝑆
𝑗 ≤ 𝑖 
 ,      𝑤ℎ𝑒𝑟𝑒 𝑁𝑅 =  ∑ |𝑙𝑜𝑔2𝐹𝐶𝑗 |
𝑔𝑗∈𝑆
 
where S are the genes in the set and 𝑁𝐻  is the number of genes in the set. P values were then 
calculated by randomly assigning 𝑁𝐻  genes to S, calculating the maximum enrichment score and 
determining the number of permutations with greater enrichment scores than the real set. Venn 
diagrams were visualized using the VennDiagram venn.diagram function. 
For GO term analysis using hypergeometric testing, GO term annotations and GO term relations 
were downloaded from the Gene Ontology consortium.318 Gene annotations were extended to 
Material and Methods 
 
 140 
ancestor GO terms for each annotation, and genes were grouped as described. Hypergeometric 
testing was then performed using Code Snippet 4. From the resulting list elements with highest 
row variance of annotated elements in the target set was selected and plotted. 
 
7.2.3 CHIP DATA MAPPING AND QUALITY CONTROL 
As for RNA-seq, all sequencing data was transferred from the Max Planck Genome Centre 
(Cologne) or at the Max Planck Institute for Molecular Genetics (Berlin) as fastq files that were 
pre-split according to library indexes with a 0 mismatch de-multiplexing. The completeness and 
intactness of transferred data was checked by MD5 sums. The quality of the sequencing run was 
determined using FastQC.  
The reference genome fasta sequence file of the Berkeley Drosophila Genome Project assembly 
dm6 and the related gtf genome annotation file for dm6 of ensembl release 91 (dm6.91)  were 
downloaded from ensembl (www.ensmbl.org).341 A reference genome index was generated using 
dm6.91 using STAR-2.7.0e342 calling 
STAR --runMode genomeGenerate --runThreadN 10 --genomeDir TargetDir  
--genomeFastaFiles SourceDir/Drosophila_melanogaster.BDGP6.dna.toplevel.fa  
--sjdbGTFfile SourceDir/Drosophila_melanogaster.BDGP6.91.gtf 
 
The resulting index was used to map the fastq files to the genome using 
STAR --genomeDir GenomeDir –readFilesIn ForwardMate.fastq.gz ReverseMate.fastq.gz  
--readFilesCommand gunzip -c --outSAMtype BAM Unsorted –alignIntronMax 1  
--outFileNamePrefix OutputDir --runThreadN 6 
 
Next, the bam files were sorted and an index file was generated for the resulting bam file using 
samtools343 
samtools sort TargetBam 
samtools index TargetBam 
 
For quality control insert size and alignment metrics were collected using Picard tools 
java -Xmx32G -jar picard-2.8.2.jar CollectAlignmentSummaryMetrics I=StarOutput.bam 
O=AlignmentMetrics.txt R=Drosophila_melanogaster.BDGP6.dna.toplevel.fa & 
java -Xmx32G -jar picard-2.8.2.jar CollectInsertSizeMetrics I=StarOutput.bam O=InsertSizeMetrics.txt 
P=InsertSizeHistogram.pdf 
 
Duplicate reads were removed using Picard tools 
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java -Xmx32G -jar picard-2.8.2.jar MarkDuplicates INPUT=StarOutput.bam 
OUTPUT=NoDuplicateFile.bam METRICS_FILE=SampleID_MarkDuplicates_metrics.txt 
OPTICAL_DUPLICATE_PIXEL_DISTANCE=2500 CREATE_INDEX=true TMP_DIR=/tmp 
REMOVE_DUPLICATES=true ASSUME_SORTED=true 
 
All quality control files for FastQC, STAR mapping and Picard tools were aggregated and 
visualized using MultiQC347 and all data was checked to make sure the library and sequencing was 
of good quality. 
BigWig signal track files were generated from the duplicate free bam file using IGVtools 344 and 
UCSCtools345 
igvtools count --minMapQuality 30 NoDuplicateFile.bam stdout dm6 | wigToBigWig -clip 
dm6.chrom.sizes NoDuplicateFile.bw 
 
These BigWig files were used to visualize genome tracks in IGV344 
For ChIP heatmaps, PCAs and gene signal profiles, ChIP bam files were processed using a local 
version of Deeptools255 according to the manual, data was transferred to R and visualized using 
ggplot2. 
 
7.2.4 EXPECTATION MAXIMIZATION ANALYSIS 
For applying the binomial expectation maximization algorithm to gene level ChIP signals, gene 
level read counts from mapped duplicate free ChIP-seq bam files were counted using the subread 
package348 
featureCounts -BCpO -Q 30 -T 4 -t exon -g gene_id -a Drosophila_melanogaster.BDGP6.91.gtf -o 
RunID.count NoDup1.bam NoDup2.bam NoDup3.bam … 
 
To extract bin level read counts from ChIP-seq bam files the bamsignals  bamProfile function with 
a bin size of 200 was done in R 
parallel::mcmapply(bamsignals::bamProfile, bampath=ChIPFilesWithPath, MoreArgs =   
list(gr=gr,binsize = 200, paired.end="midpoint", tlenFilter = c(70, 500), 
filteredFlag = 1024, verbose = F), mc.cores = 5, SIMPLIFY = F) 
The resulting counts were processed into 2 data matrixes, 1 for ChIP signal and 1 for input signal, 
in which each row represents a gene or bin and each column represents a library or sample. These 
matrixes were then used to call the BinomEMwrapperParallel function (see source code in Code 
Snippet 1). This function performs binomial EM analysis as described in chapter 5.2.2. From the 
resulting fit object, group assignments were used for downstream analysis.  
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For the PCA analysis, from the same data matrixes that were used to call the EM algorithm bin 
level enrichments were calculated using sequencing counts normalized to the total number of 
reads as 
𝐸𝑛𝑟𝑖𝑐ℎ𝑚𝑒𝑛𝑡(𝑏𝑖𝑛𝑖) =  
𝑠𝑖
𝑠𝑖 +  𝑟𝑖
=  
# 𝑟𝑒𝑎𝑑𝑠 𝑖𝑛 𝐶ℎ𝐼𝑃 𝑎𝑡 𝑏𝑖𝑛𝑖
# 𝑟𝑒𝑎𝑑𝑠 𝑖𝑛 𝐶ℎ𝐼𝑃 𝑎𝑛𝑑 𝑖𝑛𝑝𝑢𝑡 𝑎𝑡 𝑏𝑖𝑛𝑖
  
 
 
and the transposed data matrix was subjected to PCA analysis using the stats prcomp package. 
From this a random selection of 3000 data points was plotted using plot3D, coloured according 
to the EM cluster assignment. 
For assignment of gene overlap with clusters the GenomicRanges354 findOverlap function was 
used with a minimum overlap of 1. Enrichment analysis was performed as described in 7.2.2. 
 
7.2.5 DIFFERENTIAL CHIP-SEQ 
For differential ChIP-seq data was mapped as described in the ChIP-seq chapter (7.2.3). For 
differential analysis with MACS2260 first extension sizes were called using 
macs2 predictd -i ChIPrep1.bam ChIP2.bam 
 
And the resulting extension sizes were used to call peaks using the broad peak algorithm 
macs2 callpeak --broad -g dm -B -t ChIPrep1.bam ChIP2.bam -c Input1.bam Input2.bam -n infected --
nomodel --extsize extsize 
 
Then, differential regions were called using the bdgdiff function 
macs2 bdgdiff --t1 cond1_treat_pileup.bdg --c1 cond1_control_lambda.bdg --t2 cond2_treat_pileup.bdg -
-c2 cond2_control_lambda.bdg --d1 cond1ControlTags --d2 cond2ControlTags -g 60 -l 120 --o-prefix 
diff_c1_vs_c2 
 
The resulting broadPeak and diff_c1_vs_c2.bed flies were loaded into R and overlap between 
differential peak regions and all peaks as well as between peak regions and genes was 
determined using the GenomicRanges354 findOverlap function with a minimum overlap of 1.  
For analysis of differential region by the EM algorithm, data matrixes for gene level data 
(H3K27me3) and 500 bp downstream of TSS (H3K27ac) are generated as described in 7.2.4, but 
were then used in the EM algorithm such that the data matrix of ChIP -seq from one of the 
plasmatocyte treatment conditions replaced the input matrix. The resulting gene overlap was 
than determined as in 7.2.4. 
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Enrichment analysis was performed as described in 7.2.2, and heatmap and fingerprint plots were 
generated using Deeptools255. 
Quantile normalization was performed using the function from Code Snippet 1. Resulting 
genome profiles and heatmaps were generated as described in 7.2.3 and 7.2.2. Bootstrapped 
confidence intervals were generated using R hmisc smean.cl.boot function and plotted using 
ggplot2. Linear models of H3K27me3 and gene expression correlation were generated using the 
stats lm and cor.test functions and visualized using ggplot2. 
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7.3 Material Tables 
 
7.3.1 ANTIBODIES 
Antigen Species use dilution/ 
amount 
Cat. No Lot Reference 
H3K27me3 rabbit 
polyclonal 
ChI
P 
0,25 µg C15410195 A0821D Diagenode SA, Belgium 
CTD4H8 RNA 
polymerase II 
mouse 
monoclonal 
ChI
P 
1 µg 05-623 2885186 Merck Millipore, USA 
H3K9ac rabbit 
polyclonal 
ChI
P 
0,3 µg C1541000
4 
A1435-
0012D 
Diagenode SA, Belgium 
H3K9me3 rabbit 
polyclonal 
ChI
P 
0,2 µg C15410193 A1671-001P Diagenode SA, Belgium 
H3K4me1 rabbit 
polyclonal 
ChI
P 
0,15 µg C1541019
4 
A1862D Diagenode SA, Belgium 
H3K27ac rabbit 
polyclonal 
ChI
P 
0,15 µg C1541019
6 
A1723-
0041D 
Diagenode SA, Belgium 
H3K36me3 rabbit 
polyclonal 
ChI
P 
0,15 µg C1541019
2 
A1845P Diagenode SA, Belgium 
H4K20me1 mouse 
monoclonal 
ChI
P 
0,4 µg C15200147 003 Diagenode SA, Belgium 
H3K4me3 rabbit 
polyclonal 
ChI
P 
0,1 µg ab8580 GR240214-2 Abcam, UK 
H3K27me2/me
3 
mouse 
monoclonal 
ChI
P 
0,15 µg 39535 33311011 Active Motif, Belgium 
H3K27me3 rabbit 
polyclonal 
IF 1:500 39155 25812014 Active Motif, Belgium 
H3K27ac rabbit 
polyclonal 
IF 1:500 39133 25812006 Active Motif, Belgium 
anti-rabbit, 
Alexa 568 
goat 
polyclonal 
IF 1:400 A11011 1842719 Thermo Fisher Scientific, 
USA 
Table 1: List of antibodies used in this thesis 
 
7.3.2 CHEMICALS 
Reagent Ref. # Manufacturer 
1M Tris pH8,0 AM9855G Thermo Fisher Scientific, USA 
3M Sodium acetate R1181 Thermo Fisher Scientific, USA 
Agencourt AMPure XP A63880 Beckman Coulter Inc., USA 
Ambion DNase (RNAse free) AM2222 Thermo Fisher Scientific, USA 
Chloroform C2432-1L Honeywell Research Chemicals, 
Germany 
cOmplete, Mini, EDTA-free Protease Inhibitor 
Cocktail 
4693159001 Roche, Switzerland 
Dynabeads Protein A 10001D Thermo Fisher Scientific, USA 
Dynabeads Protein G 10003D Thermo Fisher Scientific, USA 
Ethanol 1.00983.251 Merck Millipore, USA 
Fast SYBR Green Master Mix 4385612 Thermo Fisher Scientific, USA 
Fetal Bovine Serum S0115 Merck Millipore, USA 
Formaldehyde solution, 37% F8775 Sigma-Aldrich, USA 
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Glycine 3790.2 Carl Roth, Germany 
Glycogen, RNA grade, 20mg/ml R0551 Thermo Fisher Scientific, USA 
Isopropanol P/7490/21 Fisher Scientific, USA 
LB-Agar X969.2 Carl Roth, Germany 
LB-Medium X968.2 Carl Roth, Germany 
N-Acetyl-L-cysteine A9165 Sigma-Aldrich, USA 
Normal Goat Serum S26-100ML Merck Millipore, USA 
Paraformaldehyde (PFA) P6148 Sigma-Aldrich, USA 
PBS Dulbecco w/o Ca L182-50 Merck Millipore, USA 
Pen Strep 15140-122 Thermo Fisher Scientific, USA 
PhosSTOP 4906845001 Roche, Switzerland 
ProLong Diamond P36951 Thermo Fisher Scientific, USA 
Proteinase K, 20mg/ml 26160 Thermo Fisher Scientific, USA 
PureBlu DAPI Nuclear Staining Dye 1351303 Bio-Rad Laboratories, USA 
RNAse, DNase free EN0531 Thermo Fisher Scientific, USA 
Schneider's Insect Medium S0146 Sigma-Aldrich, USA 
SDS Solution 10% w/v V6551 Promega, USA 
Sodium butyrate B5887 Sigma-Aldrich, USA 
Sucrose S9378 Sigma-Aldrich, USA 
Triton X-100 T8787 Sigma-Aldrich, USA 
TRIzol Reagent 15596-026 Thermo Fisher Scientific, USA 
Tween-20 P9416 Sigma-Aldrich, USA 
Ultra-Pure Water, RNAse free, DNase free L0020 Merck Millipore, USA 
Table 2: List of chemicals used in this thesis 
 
7.3.3 CONSUMABLES 
Consumable Ref. # Manufacturer 
1.5 ml Bioruptor Microtubes C30010016 Diagenode SA, Belgium 
5Prime Phase Lock Gel Heavy 2ml 2302830 Quantabio, USA 
Cell scraper 83.1830 Sarstedt, Germany 
DNA LoBind Tubes 30108051 Eppendorf AG, Germany 
Eppendorf Micropestle 30120973 Eppendorf AG, Germany 
FlowMi cell strainers, 70µm, sterile 136800070 Sigma-Aldrich, USA 
MicroAmp Fast 96-Well reaction plate 4346907 Thermo Fisher Scientific, USA 
MicroAmp Optical Adhesive Film 4311971 Thermo Fisher Scientific, USA 
Nunclon Sphera 35mm Dish 174943 Thermo Fisher Scientific, USA 
Qubit assay tubes Q32856 Thermo Fisher Scientific, USA 
Syringe with Sub-Q Needle G26 305501 Becton Dickinson, USA 
TC-plate 24 Well Standard,F 833.922 Sarstedt, Germany 
Tungsten wire, 0,25mm 10408 Alfa Aesar, USA 
µ-Slide 8 Well 80826 ibidi GmbH, Germany 
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Table 3: List of consumables used in this thesis 
 
 
7.3.4 KITS 
Kit Ref. # Manufacturer 
Agencourt RNAdvance Cell v2 Kit A47942 Beckman Coulter Inc., 
USA 
Agilent High Sensitivity DNA Kit 5067-4626 Agilent Technologies, 
USA 
Agilent RNA 6000 Pico Kit 5067-1513 Agilent Technologies, 
USA 
ChIP DNA  Clean & Concentrator D5205 Zymo Research, USA 
Kapa Library Quant Kit (Illumina) 7960140001 Roche, Switzerland 
NEBNext Multiplex Oligos for Illumina (Index Primers Set 1) E7335 New England Biolabs, 
USA 
NEBNext Multiplex Oligos for Illumina (Index Primers Set 2) E7500 New England Biolabs, 
USA 
NEBNext Multiplex Oligos for Illumina (Index Primers Set 3) E7710 New England Biolabs, 
USA 
NEBNext Poly(A) mRNA Magnetic Isolation Module E7490 New England Biolabs, 
USA 
NEBNext Ultra II Directional RNA Library Prep with Sample 
Purification Beads 
E7765 New England Biolabs, 
USA 
NEBNext Ultra II DNA Library Prep with Sample Purification 
Beads 
E7103 New England Biolabs, 
USA 
QuantiTect Reverse Transcription Kit 205311 Qiagen, Germany 
Qubit dsDNA HS Assay Kit Q32854 Thermo Fisher 
Scientific, USA 
Qubit RNA HS Assay Kit Q32852 Thermo Fisher 
Scientific, USA 
Table 4: List of kits used in this thesis 
 
7.3.5 INSTRUMENTS 
Instrument Manufacturer 
DynaMag-2 Thermo Fisher Scientific, USA 
NEBNext Magnetic Separation Rack New England Biolabs, USA 
Dumont #5 Forceps, Biology Dumont Tools, Switzerland 
Nanodrop 2000 Spectrophotometer Thermo Fisher Scientific, USA 
Moria Nickel Plated Pin Holder Fine Science Tools, Germany 
Bioruptor Pico Diagenode SA, Belgium 
QuantStudio3 Thermo Fisher Scientific, USA 
MACSQuant Analyzer Miltenyi Biotec, Germany 
Ultrospec 2100pro Harvard Bioscience, USA 
Qubit 2.0 Fluorometer Thermo Fisher Scientific, USA 
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TSC SP8 Confocal microscope Leica, Germany 
Table 5: List of instruments used in this thesis 
 
7.3.6 QPCR PRIMER FOR CHIP TEST 
Target Forward primer Reverse primer Chromatin 
region 
abd-A TTTCCCTGTAAGCCAGCCAG CCAGAGCCTCGATCCAATCC repressed 
bxd GGCCAAATTATCCGAACGCC CTACATCCCATCCGCTTCCC repressed 
dimm AAGGTGGGCGAAGGCTATTC AGCCCGACAGATGAGAGAGT repressed 
Ubx CGCAGCGATAAAACCGAAGG TTGCCAGCTCAGCAGATGAA repressed 
Gapdh1 GCGTCGAACACAGACGAATG TGGATCTTACCGTCCGCTTG active 
Hml GCAAGTGTCCTTTGGCTGTG CCGTGCTGGTTACACTCCTT active 
rpl13 TGGTCCATTCCACTTCCGTG ATCATGGAACTGCGCCTCAA active 
rpl32 CGGCTGCCTAAGAGAGTGAG CCTGCACTGTTCGAGTGGAT active 
Table 6: qPCR primer used for testing ChIP enrichment 
 
7.3.7 MEDIA AND BUFFER 
Fly food (25l): 
Agar-Agar 125 g 
Yeast 360 g 
Soy flour 200 g 
Yellow cornmeal 1600 g 
Light malt extract 1600 g 
Golden syrup 440 g 
Propionic acid 150 ml 
Nipagin 20 g 
 
Apple juice agar (500 ml): 
Agar-Agar 10 g 
Sucrose 12,5 g 
Apple juice 125 ml 
Nipagin 1 g 
 
Schneider’s medium with FCS: 
Schneider’s  
medium 
500 ml 
Fetal Bovine  
Serum 
50 ml 
Pen/Strep 5 ml 
 
RIPA buffer: 
10 mM Tris-HCl (pH 8.0) 
140 mM NaCl 
1 mM EDTA 
1% (v/v) Triton X-100 
0.1% (w/v) SDS 
0.1% (w/v) sodium 
deoxycholate 
  
RIPA 500 buffer: 
10 mM Tris-HCl (pH 8.0) 
500 mM NaCl 
1 mM EDTA 
1% (v/v) Triton X-100 
0.1% (w/v) SDS 
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0.1% (w/v) sodium 
deoxycholate 
 
 
 
 
 
 
LiCl buffer:   
10 mM Tris-HCl (pH 8.0) 
250 mM LiCl 
1 mM EDTA 
0.5% (v/v) IGEPAL CA-630 
0.5% (w/v) sodium 
deoxycholate 
 
TE buffer: 
10 mM Tris-HCl (pH 8.0) 
1 mM EDTA 
 
EB buffer: 
10 mM Tris-HCl (pH 8.0) 
0,05% Tween-20 
  
Material and Methods 
 
 149 
7.3.8 FLY STOCKS 
Genotype Description Reference 
OrR reference stock (wild type) As used in 
modENCODE355 
RelE20 Mutant of imd signalling  Bloomington, 
55714 
Rel[E20] spz[4]/TM6C, Sb[1] Tb[1] Mutant of imd and toll signalling Bloomington, 
55718 
w*; P{Hml-dsRed.Δ}/SM6a plasmatocytes and crystal cells are 
marked in red 
Clark, et al. 247 
P{ry[+t7.2]=hsFLP}1, y[1] w[*]; D3/T(2;3)TSTL, CyO: 
TM6B, Tb[1] 
FLP expression after heat shock, used 
for histone mutants 
Dr. Alf Herzig 
w*; Df(2L)HisC, P{neoFRT}40A/CyO, P{ry[+t7.2]=ftz-
lacC}USC1; M{3xHisGU.wt}ZH-86Fb, 
Pbac{3xHisGU.wt}VK00033 
∆HisC, rescued with wild type HisGU Dr. Alf Herzig 
w*; Df(2L)HisC, P{neoFRT}40A/CyO, P{ry[+t7.2]=ftz-
lacC}USC1; M{3xHisGU.H3K27R}ZH-86Fb, 
Pbac{3xHisGU.H3K27R}VK00033 
∆HisC, rescued with HisGUH3K27R Dr. Alf Herzig 
w*; P{w[+mC]=Ubi-GFP(S65T)nls}2L 
P{ry[+t7.2]=neoFRT}40A; M{3xHisGU.wt}ZH-86Fb, 
Pbac{3xHisGU.wt}VK00033 
GFP marked FRT40A with wild type 
HisGU, used for histone mutants 
Dr. Alf Herzig 
w*; P{w[+mC]=Ubi-GFP(S65T)nls}2L 
P{ry[+t7.2]=neoFRT}40A; M{3xHisGU.H3K27R}ZH-
86Fb, Pbac{3xHisGU.H3K27R}VK00033 
GFP marked FRT40A with 
HisGUH3K27R, used for histone 
mutants 
Dr. Alf Herzig 
P{ry[+t7.2]=hsFLP}1, P{w[+mC]=tubP-GAL4}1, 
P{w[+mC]=UAS-GFP.T:Myc.T:nls2}1, y[1] w[*]; 
RpS17[4] P{w[+t*] ry[+t*]=white-un1}70C 
P{w[+mC]=tubP-GAL80}LL9 
P{ry[+t7.2]=neoFRT}80B/TM6B, Tb[1] 
MARCM stock used for Su(z)12 and 
E(z) mosaics 
Bloomington, 
42732 
y[1] w[*]; P{w[+mC]=tubP-GAL80}LL9 
P{w[+mW.hs]=FRT(w[hs])}2A/TM3, Sb[1] 
tubGal80 marked FRT2A, used for 
MARCM mosaics of Su(z)12 and E(z) 
Bloomington, 
5190 
w*; E(z)731 P{1xFRT.G}2A/TM6C, Sb1 Tb1 E(z) mutant for mosaics Bloomington, 
24470 
w*;;Su(z)122,e,P{w+mW.hs=FRT(whs)}2A/TM6B, Hu, tb Su(z)12 mutants for mosaics Derived from 
Bloomington, 
24469 
Table 7: List of Drosophila stocks used in this thesis. Bloomington: Bloomington Drosophila Stock Center, 
IN, USA. Dr. Alf Herzig, Max Planck Institute for Infection Biology, Berlin, Germany.  
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7.3.9 RNA-SEQ LIBRARIES 
Condition Sample 
isolation 
date 
RNA 
isolation 
method 
Cell # Yield 
(ng) 
Library 
prep 
date 
Library kit PCR 
cycle 
# 
Library 
yield (ng) 
Sequencing 
Location 
Run 
ID 
Sample 
ID 
Run 
condition 
# 
reads 
(M) 
% 
mapped 
% unique 
6h 
infection 
20.09.17 RNAdvance n.d. 177 16.10.17 NEB Next Ultra II 
Directional RNA 
11 1200 MPGC 3381 81783 2x75 8,9 98,9 71,9 
control 20.09.17 RNAdvance n.d. 173 16.10.17 NEB Next Ultra II 
Directional RNA 
11 1020 MPGC 3381 81784 2x75 16,5 98,9 61,5 
sterile 
injury 
20.09.17 RNAdvance n.d. 213 16.10.17 NEB Next Ultra II 
Directional RNA 
11 1110 MPGC 3381 81785 2x75 11,2 98,6 67,8 
18h 
infection 
21.09.17 RNAdvance n.d. 197 16.10.17 NEB Next Ultra II 
Directional RNA 
11 1200 MPGC 3381 81786 2x75 9,5 98,7 68,9 
6h 
infection 
21.09.17 RNAdvance n.d. 155 16.10.17 NEB Next Ultra II 
Directional RNA 
11 627 MPGC 3381 81787 2x75 8,5 98,7 67,9 
control 21.09.17 RNAdvance n.d. 204 16.10.17 NEB Next Ultra II 
Directional RNA 
11 1200 MPGC 3381 81788 2x75 5,8 98,6 69,9 
sterile 
injury 
21.09.17 RNAdvance n.d. 161 18.10.17 NEB Next Ultra II 
Directional RNA 
11 1200 MPGC 3381 81789 2x75 8,3 98,7 70,0 
18h 
infection 
22.09.17 RNAdvance n.d. 231 18.10.17 NEB Next Ultra II 
Directional RNA 
11 1200 MPGC 3381 81790 2x75 8,8 98,7 70,4 
18h 
infection 
22.09.17 RNAdvance n.d. 188 18.10.17 NEB Next Ultra II 
Directional RNA 
11 1200 MPGC 3381 81791 2x75 7,8 98,8 67,3 
3h 
infection 
22.09.17 RNAdvance n.d. 173 18.10.17 NEB Next Ultra II 
Directional RNA 
11 1160 MPGC 3381 81792 2x75 6,0 98,5 69,7 
control 22.09.17 RNAdvance n.d. 124 18.10.17 NEB Next Ultra II 
Directional RNA 
11 242 MPGC 3381 81793 2x75 7,6 97,6 61,8 
18h 
infection 
25.09.17 RNAdvance n.d. 171 18.10.17 NEB Next Ultra II 
Directional RNA 
11 998 MPGC 3381 81794 2x75 7,9 98,4 69,8 
3h 
infection 
25.09.17 RNAdvance n.d. 87,1 08.11.17 NEB Next Ultra II 
Directional RNA 
11 427,5 MPGC 3381 81795 2x75 14,2 98,5 62,8 
sterile 
injury 
25.09.17 RNAdvance n.d. 111 08.11.17 NEB Next Ultra II 
Directional RNA 
11 1036,5 MPGC 3381 81796 2x75 13,5 98,5 66,6 
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Condition Sample 
isolation 
date 
RNA 
isolation 
method 
Cell # Yield 
(ng) 
Library 
prep 
date 
Library kit PCR 
cycle 
# 
Library 
yield (ng) 
Sequencing 
Location 
Run 
ID 
Sample 
ID 
Run 
condition 
# 
reads 
(M) 
% 
mapped 
% unique 
3h 
infection 
26.09.17 RNAdvance n.d. 81,9 08.11.17 NEB Next Ultra II 
Directional RNA 
11 357 MPGC 3381 81797 2x75 7,7 98,7 69,8 
6h 
infection 
26.09.17 RNAdvance n.d. 146 08.11.17 NEB Next Ultra II 
Directional RNA 
11 837 MPGC 3381 81798 2x75 12,9 98,8 66,3 
control 26.09.17 RNAdvance n.d. 164 08.11.17 NEB Next Ultra II 
Directional RNA 
11 783 MPGC 3381 81799 2x75 7,1 98,7 69,8 
3h 
infection 
09.10.17 RNAdvance n.d. 113 08.11.17 NEB Next Ultra II 
Directional RNA 
11 631,5 MPGC 3381 81800 2x75 9,6 98,8 66,1 
6h 
infection 
09.10.17 RNAdvance n.d. 179 08.11.17 NEB Next Ultra II 
Directional RNA 
11 894 MPGC 3381 81801 2x75 7,2 98,8 71,5 
sterile 
injury 
09.10.17 RNAdvance n.d. 171 08.11.17 NEB Next Ultra II 
Directional RNA 
11 1006,5 MPGC 3381 81802 2x75 8,9 98,7 68,7 
su(z)12 
GFP- 
24.01.18 RNAdvance 62000 n.d. 01.02.18 NEB Next Ultra II 
Directional RNA 
13 1340 MPGC 3506 A1 2x150 8,8 94,0 80,0 
E(z) GFP+ 24.01.18 RNAdvance 6700 n.d. 01.02.18 NEB Next Ultra II 
Directional RNA 
13 64,8 MPGC 3506 A2 2x150 18,2 91,5 70,7 
su(z)12 
GFP+ 
24.01.18 RNAdvance 4700 n.d. 01.02.18 NEB Next Ultra II 
Directional RNA 
13 45,6 MPGC 3506 A3 2x150 14,1 90,2 83,2 
E(z) GFP- 24.01.18 RNAdvance 28000 n.d. 01.02.18 NEB Next Ultra II 
Directional RNA 
13 618 MPGC 3506 A4 2x150 8,5 93,9 74,3 
E(z) GFP+ 29.01.18 RNAdvance 4600 n.d. 01.02.18 NEB Next Ultra II 
Directional RNA 
13 33,3 MPGC 3506 A5 2x150 15,5 90,2 77,1 
E(z) GFP- 29.01.18 RNAdvance 20000 n.d. 01.02.18 NEB Next Ultra II 
Directional RNA 
13 325 MPGC 3506 A6 2x150 10,8 93,9 68,1 
su(z)12 
GFP+ 
29.01.18 RNAdvance 3700 n.d. 01.02.18 NEB Next Ultra II 
Directional RNA 
13 37,5 MPGC 3506 A7 2x150 15,5 90,5 81,4 
su(z)12 
GFP- 
29.01.18 RNAdvance 37000 n.d. 01.02.18 NEB Next Ultra II 
Directional RNA 
13 766 MPGC 3506 A8 2x150 11,6 94,0 61,9 
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Condition Sample 
isolation 
date 
RNA 
isolation 
method 
Cell # Yield 
(ng) 
Library 
prep 
date 
Library kit PCR 
cycle 
# 
Library 
yield (ng) 
Sequencing 
Location 
Run 
ID 
Sample 
ID 
Run 
condition 
# 
reads 
(M) 
% 
mapped 
% unique 
E(z) GFP+ 31.01.18 RNAdvance 7000 n.d. 08.02.18 NEB Next Ultra II 
Directional RNA 
13 203 MPGC 3506 A9 2x150 12,5 91,7 79,3 
E(z) GFP- 31.01.18 RNAdvance 38000 n.d. 08.02.18 NEB Next Ultra II 
Directional RNA 
13 1120 MPGC 3506 A10 2x150 12,3 93,3 55,2 
su(z)12 
GFP+ 
31.01.18 RNAdvance 6600 n.d. 08.02.18 NEB Next Ultra II 
Directional RNA 
13 158 MPGC 3506 A11 2x150 13,9 90,3 80,9 
su(z)12 
GFP- 
31.01.18 RNAdvance 62000 n.d. 08.02.18 NEB Next Ultra II 
Directional RNA 
13 1690 MPGC 3506 A12 2x150 8,0 94,5 78,6 
E(z) GFP+ 05.02.18 RNAdvance 4000 n.d. 08.02.18 NEB Next Ultra II 
Directional RNA 
13 206 MPGC 3506 A13 2x150 12,3 92,3 53,6 
E(z) GFP- 05.02.18 RNAdvance 30000 n.d. 08.02.18 NEB Next Ultra II 
Directional RNA 
13 1270 MPGC 3506 A14 2x150 13,0 93,9 76,2 
su(z)12 
GFP+ 
05.02.18 RNAdvance 3000 n.d. 08.02.18 NEB Next Ultra II 
Directional RNA 
13 132 MPGC 3506 A15 2x150 15,7 91,6 35,3 
su(z)12 
GFP- 
05.02.18 RNAdvance 40000 n.d. 08.02.18 NEB Next Ultra II 
Directional RNA 
13 1350 MPGC 3506 A16 2x150 10,6 94,0 78,9 
E(z) GFP+ 06.02.18 RNAdvance 4000 n.d. 15.02.18 NEB Next Ultra II 
Directional RNA 
13 126 MPGC 3506 A17 2x150 16,3 86,1 62,8 
E(z) GFP- 06.02.18 RNAdvance 20000 n.d. 15.02.18 NEB Next Ultra II 
Directional RNA 
13 1430 MPGC 3506 A18 2x150 12,2 93,0 62,2 
su(z)12 
GFP+ 
06.02.18 RNAdvance 3000 n.d. 15.02.18 NEB Next Ultra II 
Directional RNA 
13 94,5 MPGC 3506 A19 2x150 17,3 90,2 78,5 
su(z)12 
GFP- 
06.02.18 RNAdvance 37000 n.d. 15.02.18 NEB Next Ultra II 
Directional RNA 
13 1350 MPGC 3506 A20 2x150 13,8 94,1 56,4 
E(z) GFP+ 07.02.18 RNAdvance 7000 n.d. 15.02.18 NEB Next Ultra II 
Directional RNA 
13 109 MPGC 3506 A21 2x150 18,7 90,4 76,5 
E(z) GFP- 07.02.18 RNAdvance 18000 n.d. 15.02.18 NEB Next Ultra II 
Directional RNA 
13 854 MPGC 3506 A22 2x150 14,6 92,1 59,0 
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Condition Sample 
isolation 
date 
RNA 
isolation 
method 
Cell # Yield 
(ng) 
Library 
prep 
date 
Library kit PCR 
cycle 
# 
Library 
yield (ng) 
Sequencing 
Location 
Run 
ID 
Sample 
ID 
Run 
condition 
# 
reads 
(M) 
% 
mapped 
% unique 
su(z)12 
GFP+ 
07.02.18 RNAdvance 2750 n.d. 15.02.18 NEB Next Ultra II 
Directional RNA 
13 34,5 MPGC 3506 A23 2x150 17,8 87,1 76,8 
su(z)12 
GFP- 
07.02.18 RNAdvance 27000 n.d. 15.02.18 NEB Next Ultra II 
Directional RNA 
13 55,1 MPGC 3506 A24 2x150 9,1 92,9 75,0 
H3 wt 02.11.16 TRIzol n.d. 48,2 MPGC MPGC 2537 A1 2x150 10,0 84,1 72,5 
H3 K27R 02.11.16 TRIzol n.d. 74,7 MPGC MPGC 2537 A2 2x150 9,7 82,7 73,5 
H3 wt 07.11.16 TRIzol n.d. 49,5 MPGC MPGC 2537 A3 2x150 10,2 81,2 69,5 
H3 K27R 07.11.16 TRIzol n.d. 40,8 MPGC MPGC 2537 A4 2x150 9,1 82,7 75,1 
H3 wt 08.11.16 TRIzol n.d. 65,7 MPGC MPGC 2537 A5 2x150 8,5 81,6 75,0 
H3 wt 09.11.16 TRIzol n.d. 53,6 MPGC MPGC 2537 A6 2x150 9,0 80,1 71,5 
H3 K27R 08.11.16 TRIzol n.d. 68,2 MPGC MPGC 2537 A7 2x150 10,4 80,9 71,3 
H3 K27R 09.11.16 TRIzol n.d. 124 MPGC MPGC 2537 A8 2x150 9,1 79,9 74,0 
H3 wt 14.11.16 TRIzol n.d. 77,4 MPGC MPGC 2537 A9 2x150 9,5 81,5 70,8 
H3 K27R 14.11.16 TRIzol n.d. 73 MPGC MPGC 2537 A10 2x150 8,8 79,8 72,2 
Table 8: List of RNA-Seq libraries generated in this thesis. 
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7.3.10 CHIP-SEQ LIBRARIES 
Condition Antibody # Bled 
larvae 
ChIP date 
(finish) 
Yield 
(ng) 
Library prep 
date 
Library kit PCR 
cycle 
# 
Library 
yield 
(ng) 
Sequencing 
Location 
Run ID Sample 
ID 
Run 
condition 
# 
reads(M) 
% 
mapped 
% 
unique 
untreated Input 105 17.08.16 36,60 22.08.16 NEB Next 
Ultra II DNA 
12 1296 MPIMG CH_075 538 2x50 85,7 96,0 
untreated H4K20me1 525 17.08.16 0,56 22.08.16 NEB Next 
Ultra II DNA 
12 244,8 MPIMG CH_075 539 2x50 66,0 79,2 
untreated H3K4me3 350 17.08.16 2,53 22.08.16 NEB Next 
Ultra II DNA 
12 1027,2 MPIMG CH_075 541 2x50 79,9 97,1 
untreated H3K36me3 350 17.08.16 2,37 22.08.16 NEB Next 
Ultra II DNA 
12 732 MPIMG CH_075 542 2x50 90,2 92,7 
untreated H3K27me2/me3 120 17.08.16 0,49 22.08.16 NEB Next 
Ultra II DNA 
12 240 MPIMG CH_075 543 2x50 68,7 78,1 
untreated H3K4me1 120 17.08.16 0,97 22.08.16 NEB Next 
Ultra II DNA 
12 400,8 MPIMG CH_075 544 2x50 86,5 90,9 
untreated Input 105 03.08.16 79,13 04.08.16 NEB Next 
Ultra II DNA 
12 751,2 MPIMG CH_077 556 2x50 68,9 98,7 
untreated H4K20me1 525 03.08.16 1,98 04.08.16 NEB Next 
Ultra II DNA 
12 110,64 MPIMG CH_077 557 2x50 63,7 96,0 
untreated H3K4me3 350 03.08.16 0,64 04.08.16 NEB Next 
Ultra II DNA 
12 29,28 MPIMG CH_077 559 2x50 77,3 99,5 
untreated H3K36me3 350 03.08.16 1,58 04.08.16 NEB Next 
Ultra II DNA 
12 102 MPIMG CH_077 560 2x50 73,4 98,0 
untreated H3K27me2/me3 120 03.08.16 3,36 04.08.16 NEB Next 
Ultra II DNA 
12 226,8 MPIMG CH_077 561 2x50 56,9 96,2 
untreated H3K4me1 120 03.08.16 1,39 04.08.16 NEB Next 
Ultra II DNA 
12 71,28 MPIMG CH_077 562 2x50 68,7 98,5 
untreated Input 90 01.03.17 34,60 20.04.17 NEB Next 
Ultra II DNA 
13 578,4 MPIMG CH_098 802 2x50 82,1 95,7 
untreated H3K27ac 510 01.03.17 0,85 20.04.17 NEB Next 
Ultra II DNA 
13 169,8 MPIMG CH_098 803 2x50 92,9 93,9 
untreated Input 90 09.03.17 52,00 20.04.17 NEB Next 
Ultra II DNA 
13 810 MPIMG CH_098 804 2x50 84,6 97,1 
untreated H3K27ac 510 09.03.17 0,51 20.04.17 NEB Next 
Ultra II DNA 
13 156 MPIMG CH_098 805 2x50 91,4 90,7 
untreated Input 30 25.08.17 40,00 28.08.17 NEB Next 
Ultra II DNA 
12 1200 MPIMG CH_105 897 2x50 86,4 98,7 
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Condition Antibody # Bled 
larvae 
ChIP date 
(finish) 
Yield 
(ng) 
Library prep 
date 
Library kit PCR 
cycle 
# 
Library 
yield 
(ng) 
Sequencing 
Location 
Run ID Sample 
ID 
Run 
condition 
# 
reads(M) 
% 
mapped 
% 
unique 
untreated H3K9ac 210 25.08.17 0,40 28.08.17 NEB Next 
Ultra II DNA 
12 179 MPIMG CH_105 898 2x50 89,6 84,8 
untreated H3K9me3 210 25.08.17 1,95 28.08.17 NEB Next 
Ultra II DNA 
12 365 MPIMG CH_105 899 2x50 70,0 84,7 
untreated 4H8CTD 450 25.08.17 0,53 28.08.17 NEB Next 
Ultra II DNA 
12 357 MPIMG CH_105 900 2x50 82,3 91,7 
untreated Input 30 08.09.17 20,15 13.09.17 NEB Next 
Ultra II DNA 
12 1030 MPIMG CH_105 901 2x50 85,6 99,1 
untreated H3K9ac 270 08.09.17 0,76 13.09.17 NEB Next 
Ultra II DNA 
12 478 MPIMG CH_105 902 2x50 90,3 97,4 
untreated H3K9me3 150 08.09.17 1,53 13.09.17 NEB Next 
Ultra II DNA 
12 418 MPIMG CH_105 903 2x50 66,5 94,4 
untreated 4H8CTD 450 08.09.17 0,93 13.09.17 NEB Next 
Ultra II DNA 
12 471 MPIMG CH_105 904 2x50 84,1 92,2 
untreated H3K27me3 390 09.08.18 1,30 14.08.18 NEB Next 
Ultra II DNA 
9 171 MPGC 3772 94326 2x75 76,90 84,4 73,8 
untreated Input 10 09.08.18 5,30 14.08.18 NEB Next 
Ultra II DNA 
9 1100 MPGC 3772 94327 2x75 73,96 83,2 76,4 
untreated H3K27me3 390 09.08.18 2,20 14.08.18 NEB Next 
Ultra II DNA 
9 206 MPGC 3772 94328 2x75 106,78 85,2 72,2 
untreated Input 10 09.08.18 4,98 14.08.18 NEB Next 
Ultra II DNA 
9 1120 MPGC 3772 94329 2x75 66,09 84,1 78,7 
6h septic 
injury 
Input 10 30.11.18 4,11 12.12.18 NEB Next 
Ultra II DNA 
9 1520 MPGC 4054 A1 2x150 28,20 94,0 94,0 
6h septic 
injury 
Input 10 30.11.18 6,53 12.12.18 NEB Next 
Ultra II DNA 
9 2168 MPGC 4054 A2 2x150 24,63 93,0 93,0 
6h septic 
injury 
H3K27ac 260 30.11.18 3,42 12.12.18 NEB Next 
Ultra II DNA 
9 1140 MPGC 4054 A3 2x150 24,72 93,5 93,5 
6h septic 
injury 
H3K27ac 260 30.11.18 4,06 12.12.18 NEB Next 
Ultra II DNA 
9 1200 MPGC 4054 A4 2x150 26,23 93,1 93,1 
6h septic 
injury 
H3K27me3 530 30.11.18 4,70 12.12.18 NEB Next 
Ultra II DNA 
9 610 MPGC 4054 A5 2x150 31,58 88,7 88,7 
6h septic 
injury 
H3K27me3 530 30.11.18 4,78 12.12.18 NEB Next 
Ultra II DNA 
9 710 MPGC 4054 A6 2x150 23,04 91,1 91,1 
Table 9:  List of ChIP-seq libraries generated in this study
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7.4 Source code 
7.4.1 EXPECTATION MAXIMIZATION 
library(Rfast) 
library(foreach) 
library(doParallel) 
library(doSNOW) 
 
 
# Algorithms for Parameter Estimation in Normal Distibutions -------------- 
 
piEst = function(E){ 
  require(Rfast) 
  # function to calculate pi values in EM model 
  # E is n by k matrix (n: number of data points, k: number of cluster groups) 
  colsums(E)/dim(E)[1] 
} 
 
 
# Algorithms for Parameter Estimation and Expectation in Binomial Distribution ------------ 
 
BinomLnTheta = function(N, S, E){log(crossprod(S,E)) - log(crossprod(N,E))} 
 
BinomLnA = function(N, S, lnT, empi){ 
  if(is.vector(N)){ 
    nSamples = length(N) 
  }else{ 
    nSamples = dim(N)[1] 
  } 
  S %*% lnT + (N-S) %*% log(1-exp(lnT)) + matrix(rep(log(empi), nSamples), nrow = nSamples, byrow = T) 
} 
 
 
LnARowSums = function(lnA){ 
  require(Rfast) 
  # lnA is n by k matrix as calculated by the lnA type functions (n: number of data points, k: number of cluster 
groups) 
  lnARmax <- rowMaxs(lnA, value = T) 
  lnARSum <- lnARmax + log(rowsums(exp(lnA - lnARmax))) 
} 
 
# Wrappers for Binomials -------------------------------------------------- 
 
BinomMultiDimEMcycle = function(N, S, k, maxiter = 1000, maxtol = 1E-20){ 
  require(Rfast) 
  # X is vector of length n (n: number of data points) 
  # k is number of components/models to by fitted 
  # maxiter and maxtol are thresholds for exiting the optimization 
   
  nDim = dim(N)[2] 
  nSamples = dim(N)[1] 
   
  # start bby initilazing a potential E 
  lnT <- runif(k, 0, 1) 
  lnT <- lnT[order(lnT)] 
  lnT <- matrix(rep(lnT, nDim), nrow = nDim, byrow = T) 
  lnT = log(lnT) 
   
   
  empi = runif(k) 
  empi = empi/sum(empi) 
   
  # setting likelyhood of initial (random) model 
  postlnL = NA  
  # starting loop to find optimum 
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  niter = 0 
  con = F 
   
  while(!con){ 
     
    # writing over some variables for comparison 
    niter = niter + 1 
    priorlnL = postlnL 
     
    # Ex step 
    lnA = BinomLnA(N, S, lnT, empi) 
    lnArs = LnARowSums(lnA)  
    E = exp(lnA - lnArs) 
     
    # Max step 
    lnT = BinomLnTheta(N, S, E) 
    empi = piEst(E) 
     
     
    # checking for likelyhood convergence 
    postlnL = sum(lnArs) 
    if(niter > 5){ 
      if((postlnL - priorlnL)^2 < maxtol){ 
        converged = T 
        con = T 
        return(list(Expectaion = E, BinomPropabilites = exp(lnT), GroupSizePi = empi, ModelLnLikelyhood = 
postlnL, converged = converged)) 
      } 
    } 
    if(niter > maxiter){ 
      converged = F 
      con = T 
      return(ModelLnLikelyhood = -Inf, converged = F) 
    } 
  } 
} 
 
 
BinomEMwrapperParallel = function(N, S, k, maxiter = 1000, maxtol = 0.0001, ntrys = 10, ncores = 
parallel::detectCores()/2){ 
  require(foreach) 
  # k is number of components/models to by fitted 
  # maxiter and maxtol are thresholds for exiting the optimization 
  cl = parallel::makeCluster(ncores) 
  parallel::clusterExport(cl, c(lsf.str())) 
  doParallel::registerDoParallel(cl) 
  fit = foreach(i=1:ntrys, .packages = "Rfast", .combine = "ForeachCombineHandler") %dopar% { 
      source("/Users/streeck/Desktop/EM-Project/EMcalc.R") 
      return(tryCatch(BinomMultiDimEMcycle(N, S, k), error = function(w){list(ModelLnLikelyhood = -Inf)})) 
    } 
  parallel::stopCluster(cl) 
  fit$Group = as.character(rowMaxs(fit$Expectaion)) 
  return(fit) 
} 
Code Snippet 1: Binomial Expectation Maximization function 
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7.4.3 GEN SET ENRICHMENT ANALYSIS 
MyMultiGesa = function(sorter, featurer, cnames, outxlab = "Gene Rank by Log2 Fold Change", RankingType 
= "Log Fold Change", lineplotdensity = T, niter = 10000){ 
  require(ggplot2) 
  orderer = order(sorter, decreasing = T) 
  featurer = as.matrix(featurer) 
  sorter.sorted = sorter[orderer] 
  featurer.sorted = as.matrix(featurer[orderer,]) 
   
   
  xaxis = 1:length(sorter) 
  ES = matrix(data = NA, nrow = dim(featurer.sorted)[1], ncol = dim(featurer.sorted)[2]) 
  colnames(ES) = cnames 
  t = colsums(featurer.sorted) 
   
   
  for(i in 1:(dim(featurer.sorted)[2])){ 
    ES[featurer.sorted[,i],i] = abs(sorter.sorted[featurer.sorted[,i]])/sum(abs(sorter.sorted[featurer.sorted[,i]]))  
    ES[!featurer.sorted[,i],i] = -1/(dim(featurer.sorted)[1]-t[i]) 
    ES[,i] = cumsum(ES[,i]) 
  } 
  ESs = colMaxs(ES, value = T) 
  iters = matrix(nrow = niter, ncol = dim(featurer.sorted)[2]) 
  pvals = numeric(length = dim(featurer.sorted)[2]) 
  names(pvals) = cnames 
  for(j in 1:(dim(featurer.sorted)[2])){ 
    for (i in 1:niter) { 
      ESi = numeric(length = dim(featurer.sorted)[1]) 
      fselect = sample(featurer.sorted[,j]) 
      ESi[fselect] = abs(sorter.sorted[fselect])/sum(abs(sorter.sorted[fselect])) 
      ESi[!fselect] = -1/(dim(featurer.sorted)[1]-t[j]) 
      iters[i,j] = max(cumsum(ESi)) 
    } 
    pvals[j] = max(sum(iters[,j] > ESs[j]),1)/niter 
  } 
  print(pvals) 
   
  plot.data = data.frame(x = xaxis, sortstat = sorter.sorted) 
  plot.data = cbind(plot.data, ES) 
  plot.datamelt = reshape2::melt(plot.data, id.vars = c(1,2)) 
   
  top = ggplot(plot.datamelt, aes(x, value, color = variable)) + geom_line(size = 1.5) + theme_classic() + 
ylab("Gene Set Enrichment Score") + xlab("Gene Rank") + theme(axis.title.x=element_blank(), 
axis.text.x=element_blank(), panel.grid.major = element_line(color = "grey", linetype = 15)) +  
    scale_color_brewer(palette = "Dark2") + theme(legend.justification = c(1.2, 1.2), legend.position = c(1, 1), 
legend.title=element_blank(), axis.line.x = element_blank(), axis.ticks.x = element_blank(), 
plot.margin=grid::unit(c(5.5,5.5,.5,5.5), "pt"), legend.background = element_rect(color = "black")) 
  if(lineplotdensity == F){ 
    plot.data.lines = data.frame(x = numeric(), set = character()) 
    for(i in 1:(dim(featurer.sorted)[2])){ 
      x = xaxis[featurer.sorted[,i]] 
      set = rep(cnames[i], length(x)) 
      plot.data.lines = rbind.data.frame(plot.data.lines, data.frame(x = x, set = set))  
    } 
    mid = ggplot(plot.data.lines, aes(x, set)) + geom_vline(data = plot.data.lines, aes(xintercept = x, color = 
set), size = .25, alpha = .7) + theme_classic()+ 
      ylab("    ") + xlab("Gene Rank") + geom_blank() + xlim(min(xaxis), max(xaxis)) +  
      theme(axis.ticks.y=element_blank(), axis.text.y=element_blank(), axis.title.x=element_blank(),  
            axis.text.x=element_blank(), strip.background = element_blank(), strip.text.x = element_blank(),  
            axis.line.x = element_blank(), axis.ticks.x = element_blank(),  
            plot.margin=grid::unit(c(.5,5.5,.5,5.5), "pt"), panel.border = element_rect(size = 1, fill = NA)) +  
      scale_color_brewer(palette = "Dark2", guide = F) + facet_wrap(~ set, ncol = 1) 
  } 
  if(lineplotdensity == T){ 
    if(dim(featurer)[2] > 3){ 
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      plot.data.lines = data.frame(x = numeric(), y = numeric(), set = character(), w = numeric(), xmin = 
numeric(), xmax = numeric(), ymin = numeric(), ymax = numeric()) 
      for(i in 1:(dim(featurer.sorted)[2])){ 
        d = stats::density(xaxis[featurer.sorted[,i]]) 
        y = d$y[d$x >=min(xaxis) & d$x <= max(xaxis)] 
        x = d$x[d$x >=min(xaxis) & d$x <= max(xaxis)] 
        xmin = c(min(xaxis), x[1:(length(x)-1)]) 
        xmax = c(x[1:(length(x)-1)], max(xaxis)) 
        ymin = rep(i-1, length(x)) 
        ymax = rep(i, length(x)) 
        set = rep(cnames[i], length(x)) 
        w = rep(max(xaxis)/length(x), length(x)) 
        plot.data.lines = rbind.data.frame(plot.data.lines, data.frame(x = x, y = y, set = set, w = w, xmin = xmin, 
xmax = xmax, ymin = ymin, ymax = ymax)) 
      } 
      mid = ggplot(plot.data.lines, aes(x, set, width = w)) + geom_blank() + xlim(min(xaxis), max(xaxis)) +  
        geom_rect(data = plot.data.lines, aes(xmin = xmin, xmax = xmax, ymin = ymin, ymax = ymax, alpha = y, 
fill = set)) +  
        theme_classic()+ scale_alpha_continuous(guide = F) + scale_fill_brewer(palette = "Dark2", guide = F) + 
        ylab("    ") + xlab("Gene Rank") + geom_blank() +  
        theme(axis.ticks.y=element_blank(), axis.text.y=element_blank(),  
              axis.title.x=element_blank(), axis.text.x=element_blank(),  
              strip.background = element_blank(), strip.text.x = element_blank(),  
              axis.line.x = element_blank(), axis.ticks.x = element_blank(),  
              plot.margin=grid::unit(c(.5,5.5,.5,5.5), "pt"),  
              panel.border = element_rect(size = 1, fill = NA), 
              panel.spacing.y = grid::unit(c(0), "pt")) 
    }else{ 
      plot.data.lines = data.frame(x = numeric(), y = numeric(), set = character(), w = numeric(), xmin = 
numeric(), xmax = numeric(), ymin = numeric(), ymax = numeric()) 
      for(i in 1:(dim(featurer.sorted)[2])){ 
        d = stats::density(xaxis[featurer.sorted[,i]]) 
        y = d$y[d$x >=min(xaxis) & d$x <= max(xaxis)] 
        x = d$x[d$x >=min(xaxis) & d$x <= max(xaxis)]  
        xmin = c(min(xaxis), x[1:(length(x)-1)]) 
        xmax = c(x[1:(length(x)-1)], max(xaxis)) 
        ymin = rep(0, length(x)) 
        ymax = rep(1, length(x)) 
        set = rep(cnames[i], length(x)) 
        w = rep(max(xaxis)/length(x), length(x)) 
        plot.data.lines = rbind.data.frame(plot.data.lines, data.frame(x = x, y = y, set = set, w = w, xmin = xmin, 
xmax = xmax, ymin = ymin, ymax = ymax)) 
      } 
      mid = ggplot(plot.data.lines, aes(x, 1, width = w)) + geom_blank() + xlim(min(xaxis), max(xaxis)) +  
        geom_rect(data = plot.data.lines, aes(xmin = xmin, xmax = xmax, ymin = ymin, ymax = ymax, alpha = y, 
fill = set)) +  
        theme_classic()+ scale_alpha_continuous(guide = F) + scale_fill_brewer(palette = "Dark2", guide = F) + 
        ylab("    ") + xlab("Gene Rank") + geom_blank() +  
        theme(axis.ticks.y=element_blank(), axis.text.y=element_blank(),  
              axis.title.x=element_blank(), axis.text.x=element_blank(),  
              strip.background = element_blank(), strip.text.x = element_blank(),  
              axis.line.x = element_blank(), axis.ticks.x = element_blank(),  
              plot.margin=grid::unit(c(.5,5.5,.5,5.5), "pt"),  
              panel.border = element_rect(size = 1, fill = NA)) + facet_wrap(~ set, ncol = 1) 
    } 
  } 
  bottom = ggplot(plot.data, aes(x, sortstat)) + geom_line(size = .5) + geom_area(fill = "black") + 
theme_classic()+ 
    ylab(RankingType) + xlab(outxlab) + theme(panel.grid.major = element_line(color = "grey", linetype = 15), 
plot.margin=grid::unit(c(.5,5.5,5.5,5.5), "pt")) 
  gA <- ggplotGrob(top) 
  gB <- ggplotGrob(mid) 
  gC <- ggplotGrob(bottom) 
  maxWidth = grid::unit.pmax(gA$widths[2:5], gB$widths[2:5], gC$widths[2:5]) 
  gA$widths[2:5] <- as.list(maxWidth) 
  gB$widths[2:5] <- as.list(maxWidth) 
  gC$widths[2:5] <- as.list(maxWidth) 
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  gridExtra::grid.arrange(gB, gA, gC, ncol=1, heights = c(1.5,7,4)) 
} 
Code Snippet 2: Gene Set Enrichment Analysis function 
 
7.4.4 QUANTILE NORMALIZATION 
quantNorm = function(X, round = F){ 
  require(Rfast) 
  X = as.matrix(X) 
  ndim = dim(X)[2] 
  OrderMat = matrix(nrow = dim(X)[1], ncol = ndim) 
  for(i in 1:ndim){ 
    OrderMat[,i] = base::order(X[,i]) 
    X[,i] = X[OrderMat[,i],i] 
  } 
  if(round == F){ 
    RowMeans = Rfast::rowsums(X)/ndim 
  }else{ 
    RowMeans = round(Rfast::rowsums(X)/ndim) 
  } 
  for(i in 1:ndim){ 
    X[OrderMat[,i],i] = RowMeans 
  } 
  X 
} 
Code Snippet 3: Quantile normalization function 
 
7.4.5 GO TERM ENRICHMENT HYPERGEOMETRIC TEST 
GOhyper = function(GAFfile, TargetSet, BackgroundSet){ 
  require(plyr) 
  GAFfile = GAFfile[GAFfile$gene_id %in% BackgroundSet,] 
  GAFfile$target = GAFfile$gene_id %in% TargetSet 
  GOout = ddply(GAFfile, .(GOid), summarise, x = sum(target[!duplicated(gene_id)]), m = 
length(unique(gene_id))) 
  GOout$n = length(unique(BackgroundSet)) - GOout$m 
  GOout$k = length(unique(TargetSet)) 
  GOout$logP = phyper(GOout$x-1, GOout$m, GOout$n, GOout$k, log.p = T, lower.tail = F) 
  GOout$EffSize = (GOout$x/GOout$k)/(GOout$m/(GOout$n+GOout$m)) 
  return(GOout) 
} 
 
GOmulti = function(GAFfile, TargetSets, BackgroundSets){ 
  for (i in 1:length(TargetSets)) { 
    GOinter = GOhyper(GAFfile, TargetSets[[i]], BackgroundSets[[i]]) 
    GOinter$set = names(TargetSets)[i] 
    if(i == 1){ 
      GOout = GOinter 
    }else{ 
      GOout = rbind(GOout, GOinter) 
    } 
  } 
  return(GOout) 
} 
Code Snippet 4: GO term enrichment analysis using hypergeometric testing 
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8.3 Abbreviations 
 Term Full Name Description 
 
∆HisC Df(2L)HisC Loss of core histone complex 
A 
 
AMP Antimicrobial peptide Class of proteins and peptides with 
antimicrobial activities 
 
ANOVA Analysis of variance Statistical method for detecting 
group differences 
 
AttC Attacin-C Antimicrobial peptide against gram-
negative bacteria 
B 
 
BDGP Berkeley Drosophila Genome 
Project 
Consortium that assemble the 
Drosophila reference genome 
C 
 
C. elegans Caenorhabditis elegans 
 
 
Cec Cecropin Group of antimicrobial peptide 
against gram-negative bacteria 
 
ChIP Chromatin ImmunoPrecipitation Method for the isolation of protein 
DANN complexes 
 
ChIP-seq ChIP-sequencing ChIP followed by high throughput 
sequencing 
 
CZ Cortical zone Part of the Drosophila lymph gland 
D 
 
DAMP Danger Associated Molecular 
Patterns 
Host derived molecules that signal 
danger 
 
DAPI 4′,6-diamidino-2-phenylindole Fluorescent DNA stain 
 
Dpt Diptericin Antimicrobial peptide against gram-
negative bacteria 
 
DptB DiptericinB Antimicrobial peptide against gram-
negative bacteria 
 
Drs Drosomycin Antimicrobial peptide against gram-
positive bacteria 
E 
 
E. coli Escherichia coli Gram-negative bacterium 
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E(z) Enhancer of zeste Protein component of PRC2, H3K27 
methylase 
 
EM Expectation Maximization Algorithm for fitting mixture models, 
here binomial mixtures 
 
EtOH ethanol 
 
F 
 
FACS Fluorescence-activated cell sorting Cell sorting based on cell size and 
fluorescent markers 
 
FCS fetal calf serum 
 
 
FLP flippase recombinase Recombinase protein performing FRT 
site-directed recombination 
 
FRT flippase recognition target DNA sequence targeted by FLP 
recombination 
 
FSC Forward Scatter FACS parameter of cell size 
G 
 
Gal4 Gal4 transcription factor Initiates transcription downstream of 
uas sequences 
 
Gal80 Gal80 repressor Repressor of Gal4 
 
GFP Green fluorescent protein Aequorea victoria fluorescent protein 
 
GO Gene Ontology Gene function annotation project 
 
GSEA Gene set enrichment analysis Method for testing gene set 
enrichment in ranked data 
H 
 
H3 histone H3 canonical core histone H3 
 
HisGU Histone gene unit Drosophila gene complex of core 
histones H1, H2A, H2B, H3 and H4 
 
Hml Hemolectin Clotting factor expressed exclusively 
by hemocytes 
 
HMM Hidden Markov Model Mathematical method for data 
classification 
I 
 
IGV Integrative Genomics Viewer Tool for high throughput sequencing 
visualization 
 
Imd Immune deficiency pathway for immune signaling and 
protein in that pathway 
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K 
 
kb kilobases DNA length (1000 base pairs) 
L 
 
lfc Log fold change Log2 ratio of signals 
 
LPS Lipopolysaccharides bacterial PAMP 
M 
 
MACS Model-based Analysis for ChIP-Seq Tool for ChIP-seq peak calling 
 
MARCM Mosaic analysis with a repressible 
cell marker 
Drosophila method for marking 
genetic mosaics 
 
Mtk Metchnikowin Antimicrobial peptide against fungi 
 
MZ Medullary zone Part of the Drosophila lymph gland 
N 
 
NF-kB  nuclear factor 'kappa-light-chain-
enhancer' of activated B-cells) 
Transcription factor involved in 
immunity and development 
O 
 
OD600 optical density 600 nm measurement of bacterial 
concentration 
 
OrR Oregon-R wild-type drosophila strain 
P 
 
p p-value Probability of observed data if the 
null hypothesis was correct 
 
PAMP Pathogen Associated Molecular 
Patterns 
Pathogen derived molecules that 
signal danger to the host 
 
PBS Phosphate-buffered saline Isotonic buffer 
 
PC Principal component Individual dimensions determined by 
the PCA 
 
PCA Principal component analysis Mathematical transformation for the 
analysis of large data sets 
 
PcG Polycomb group Group of proteins which maintain 
gene repression 
 
PGRP Peptidoglycan recognition protein Group of PAMP receptors 
 
polyA RNA Polyadenylated RNA Here used as mark for enrichment of 
mRNA 
 
PPO Prophenoloxidase Enzyme involved in melanization 
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PRC2 Polycomb Repressive Complex 2 Protein complex involved in 
H3K27me3 placements and PcG 
silencing 
 
PRE Polycomb response element Genomic location of sequence based 
Polycomb binding 
 
PSC posterior signaling center Part of the Drosophila lymph gland 
 
PTM Post-translational modification Enzymatic change of protein amino 
acids 
Q 
 
qPCR quantitative polymerase chain 
reaction 
Method for detecting DNA sequence 
abundance 
R 
 
Rel Relish NF-kB Transcription factor involved 
in immunity 
 
RNA-PolII RNA polymerase II Protein enzyme complex catalyzing 
mRNA production 
 
RNA-seq RNA-sequencing high throughput sequencing of cDNA 
converted RNA 
 
ROAST rotation gene set testing Method for testing gene set 
enrichment in ranked data 
 
ROS reactive oxygen species group of chemically reactive chemical 
species containing oxygen 
 
RT-qPCR Reverse Transcription Quantitative 
PCR 
Method for detecting single target 
mRNA abundance 
S 
 
S. aureus Staphylococcus aureus Gram-positive bacterium 
 
spz spätzle Signaling factor for Toll 
 
SSC Side Scatter FACS parameter of inner cell 
complexity 
 
Su(z)12 Suppressor of zeste 12 Protein component of PRC2 
T 
 
TEP Thioester-containing protein Group of immune genes 
 
TES Transcription end site Genomic positions of transcriptional 
termination 
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TPM Tags per million Measure of absolute transcript 
abundance based on RNA-seq 
 
TrxG Trithorax Group Group of proteins which maintain 
active gene transcription 
 
TSS Transcription start site Genomic positions of transcriptional 
initiation 
 
Tx Triton X-100 
 
U 
 
uas Upstream Activation Sequence Sequence of Gal4 binding 
 
Utx Utx histone demethylase H3K27me3 demethylase 
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